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I. Summary 
Type IV secretion systems (T4SSs) are able to transport DNA and effector proteins across the inner 
and outer membranes of prokaryotes. T4SSs consist of a transport complex which forms the channel 
across the inner and outer membrane, the so called mating pair formation complex (MPF), and DNA 
processing and transfer proteins (Dtr proteins). A unique T4SS is encoded in the gonococcal genomic 
island which is found in most Neisseria gonorrhoeae strains. Remarkably, this secretion system is the 
first T4SSs that was shown to secrete ssDNA during all phases of growth directly into the 
environment. This property might facilitate functional studies on the transport mechanisms used by 
T4SSs. Remarkably, the T4SS encoded within the GGI consists of a MPF complex that is homolgous to 
the MPF complex of the E. coli F-plasmid (MPFF family) and Dtr proteins that belong to the MOBH 
family of targeting factors. Although many different members of the MOBH family have already been 
identified, almost no information is currently available on this novel group of targeting factors.  
To study the conservation of GGI-like T4SSs, similar T4SS were identified in a computational analysis 
of all currently completely sequenced chromosomes and plasmids. Next to N. gonorrhoeae very 
similar conserved T4SSs have been found in several other bacteria. These T4SSs are either encoded 
within the chromosome or on plasmids. Most of the genes encoded in the GGI between the ltgX and 
exp1 genes, the region which encodes mainly the MPFF proteins, were highly conserved in allmost all 
of the identified systems, even though, several of theses genes have been shown previously not to be 
important for ssDNA transport. Remarkably, all identified chromosomal GGI-like T4SSs encode mpf 
genes of the MPFF family and dtr genes of the MOBH family; whereas, the plasmid encoded GGI-like 
T4SSs always contain dtr genes of the MOBF family and mpf genes of the MPFF family. This suggests 
that relaxases of the MOBH family are preferentially found in chromosomally encoded T4SSs.  
To elucidate the functional mechanism of the DNA processing reaction of this unique DNA secretion 
system a biochemical approach was set up to functionally characterize the coupling protein TraD, the 
relaxase TraI and the hypothetical protein Yaf which are different key enzymes of the Dtr proteins of 
N. gonorrhoeae. 
The overexpression and purification of coupling proteins and relaxases of other T4SSs has previously 
been shown to be inherently difficult. Although many different approaches using E. coli as host for a 
recombinant overexpression have been tested, it was not possible to obtain soluble TraD and large 
amounts of inclusion bodies were produced. Small amounts of TraD have been detected in isolated 
inner membranes of E. coli, but all performed solubilization attempts failed. Finally, TraD was 
isolated and purified from inclusion bodies under denaturing conditions, but all further refolding 
approaches with the purified protein resulted either in the loss or the aggregation of TraD. 
Therefore, it was not possible to characterize the enzymatic activity of the neisserial coupling protein 
TraD.   
The hypothetical protein Yaf, which is encoded in same operon with traI and traD was sucessfully 
overexpressed and purified. Interestingly, Yaf forms different oligomeric states in solution. The most 
abundant oligomer of native Yaf was the dimeric state. The dynamic equilibrium of the different 
oligomeric states was strongly dependent on the concentration of the protein and the buffer 
conditions. The interconversion between the different oligomeric states is a slow process. The 
presence of an N-terminal His-tag strongly stabilized the tetrameric form. Limited proteolysis 
experiments showed that Yaf is highly resistant against trypsin and most likely has a very compact 
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and stable structure. Tetrameric Yaf showed a higher resistance against proteolytic digestion than 
dimeric Yaf. Remarkably, the introduction of different point mutations into the sequence of Yaf 
resulted in a destabilization of the protein and a strong decrease in the amount of soluble protein. 
Different activity assays have been performed with the purified protein to study the function of Yaf. 
DNA binding assays showed binding of dimeric and tetrameric Yaf to dsDNA with low affinity 
(>5 μM). Furthermore, a metal dependent sequence unspecific nuclease activity was observed 
associated with elution fractions containing dimeric and tetrameric Yaf. This nuclease activity was 
specific for dsDNA fragments and oligonucleotides that contained secondary structures. In the 
presence of different divalent metals, a relaxation activity on supercoiled plasmid DNA has been 
observed for fractions containing dimeric and tetrameric Yaf, and was strongly enhanced in the 
presence of Mn2+ and Co2+, but was also observed in the presence of Mg2+. To obtain further 
information on the structure and function of Yaf, crystallization attempts have been started in close 
collaboration with Dr. S. Smits in the group of Prof. Dr. L. Schmitt (Heinrich Heine University in 
Düsseldorf). Small crystals of N-terminally His-tagged Yaf diffracted up to 3 Å. Remarkably, no crystals 
have been obtained for native Yaf in any of the tested conditions. Recentyl, crystals of N-terminal 
His-tagged Yaf with incorporated selenomethionine have been obtained. 
To characterize the MOBH relaxase TraI, many different overexpression and purification approaches 
have been tested. Finally, an overexpression and purification method could be established to purify 
soluble TraI. Isolated TraI formed stable dimers in solution, and limited proteolysis revealed the 
presence of at least three trypsin resistant domains in TraI. DNA binding assays showed that TraI 
binds to ssDNA and dsDNA with high affinity in a sequence unspecific manner. The minimal binding 
frame of TraI for ssDNA substrates has been determined with 9 nucleotides. Furthermore, a metal 
dependent sequence unspecific relaxation activity of TraI on supercoiled plasmids has been 
observed, with Mn2+ as preferred metal cofactor. The relaxation activity of TraI is similar to the 
activity of E. coli Topoisomerase I, but differs within the preferred metal cofactor and the lack of 
detectable intermediates during the relaxation reaction of TraI. DNA cleavage assays performed with 
different ssDNA substrates demonstrated that TraI cleaves oligonucleotides containing the putative 
oritT sequence of the GGI or the oriT region of the E. coli F-plasmid strand specific in a Mn2+ 
dependent manner. The complementary strands and a polyT oligonucleotide were not cleaved by 
TraI. Analysis of the putative cleavage sites did not show any sequence similarity between both 
cleaved oligonucleotides. To obtain structural information about TraI, crystallization attempts in 
close collaboration with Dr. S. Smits in the group of Prof. L. Schmitt (Heinrich Heine University in 
Düsseldorf) were started.  
Besides the characterization of the enzymatic activity of TraI and Yaf, pull down assays were 
performed to test whether these proteins interact with each other or with the T4SS ATPase TraC. 
Unfortunately, no protein-protein interactions were detected between these three proteins. 
The experimental results from the current study help to understand the DNA processing mechanism 
of the unique T4SS of N. gonorrhoeae. Important steps have been made in the functional 
overexpression and the purification of Yaf and TraI. The hereby obtained results from the 
biochemical characterization of TraI represent the first reported biochemical data which is available 
on the novel MOBH relaxase family. Furthermore, this study revealed first insights into a possible 
enzymatic activity of the previously uncharacterized hypothetical protein Yaf, even though the 
function of this protein still remains unknown. 
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II. Zusammenfassung 
Typ IV Sekretionssysteme (T4SSs) transportieren DNA und verschiedenen Effektorproteine über die 
innere und äußere Zellmembran von Prokarioten. Sie bestehen aus einem Transportkomplex, dem 
sogenannten MPF-Komplex („mating pair formation“), der einen Kanal durch die innere und äußere 
Membran bildet und aus DNA Prozessierungs- und Transferproteine (Dtr Proteine). 
Ein neues und bisher einzigartiges T4SS ist innerhalb des „gonococcal genomic island“ lokalisiert, 
welchen in den meisten Neisseria gonorrhoeae Stämmen vorkommt. Dieses T4SS ist das erste T4SS, 
das einzelsträngige DNA in allen Wachstumsphasen direkt in seine Umgebung sekretiert. Diese 
Eigenschaft macht das T4SS von N. gonorrhoeae zu einen vielversprechendem Forschungsobjekt für 
Studien über den Transportmechanismus von T4SSs. Das GGI-T4SS besteht aus einem MPF-Komplex, 
der große Ähnlichkeit mit dem MPF-Komplex des F-Plasmides von E. coli hat (die sogenannte MPFF
 
Familie), und aus Dtr Proteinen die zu der MOBH Familie der Prozessierungs- und 
Lokalisationsfaktoren gehören.  
Um die Verteilung und Konservierung GGI ähnlicher T4SSs zu untersuchen wurden mittels 
bioinformatischer Analysen ähnliche T4SSs aus allen derzeitig sequenzierten Genomen und 
Plasmiden identifiert. Neben dem T4SS aus N. gonorrhoeae wurde weitere ähnlich konservierte 
T4SSs in anderen Bakterien identifiziert. Diese T4SSs sind entweder genomisch oder befinden sich auf 
Plasmiden. Die meisten der GGI Gene innerhalb der Region zwischen ltgX und exp1 kodieren für 
MPFF Proteine und sind hoch konserviert in allen identifizierten T4SSs, auch wenn einige dieser Gene 
nicht in den Transfer von Einzelstrand-DNA involviert sind. Bemerkenswerterweise enthalten alle 
identifizierten genomischen T4SSs mpf Gene der MPFF Familie und dtr Gene der MOBH Familie; die 
Plasmid-kodierten T4SSs hingegen enthalten mpf Gene der MPFF Familie und dtr Gene der MOBF 
Familie. Die zeigt, dass Relaxasen der MOBH Familie hauptsächlich in genomischen T4SSs vorhanden 
sind.  
Um den Mechanismus der DNA Prozessierung des einzigartigen T4SSs aus N. gonorrhoeae zu 
studieren wurden in dieser Arbeit die Schlüsselenzyme TraD (das Kopplungsprotein), TraI (die 
Relaxase) und das hypothetische Protein Yaf aus N. gonorrhoeae biochemisch charakterisiert.  
Die Überexpression und die Aufreinigung von Kopplungsproteinen und Relaxasen von T4SSs ist eine 
schwierige Herausforderung und obwohl viele verschiedene Versuche unternommen wurden um 
TraD rekombinant in E. coli zu überexprimieren, war es nicht möglich lösliches Protein zu isolieren. 
Stattdessen wurden große Mengen von Einschlusskörperchen gebildet. Kleine Mengen von TraD 
wurden in isolierten inneren Zellmembranen von E. coli detektiert, allerdings konnte dieses Protein 
nicht aus den Membranen herausgelöst werden. Schließlich wurde TraD unter dentaurierenden 
Bedingungen aus Einschlusskörperchen isoliert und aufgereinigt, allerdings schlugen alle weiteren 
Neufaltungsversuche fehl und führten entweder zum Verlust des Proteins oder zu Aggregation. 
Deshalb war es nicht möglich die enzymatische Aktivität des neisserialen Kopplunsproteins zu 
charakterisieren.     
Das hypothetische Protein Yaf konnte erfolgreich in großen Mengen isoliert werden und bildet in 
Lösung ein Gleichgewicht zwischen verschiedenen oligomeren Stadien. Hauptsächlich werden jedoch 
Dimere gebildet. Das Gleichgewicht zwischen den verschiedenen Oligomeren wird deutlich von der 
Proteinkonzentration und den jeweiligen Pufferbedingungen beeinflusst. Die Umwandlung der 
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einzelnen Oligomerstadien ist ein langsam verlaufender Prozess. Die Anwesenheit eines 
N-terminalen His-tags hat einen stabilisierenden Effekt auf die tetramere Form. Limitierte Proteolyse 
mit Trypsin zeigte eine hohe Resistenz von Yaf gegenüber Trypsin, was auf eine hohe strukturelle 
Stabilität von Yaf hindeutet. Tetramere zeigten hierbei eine größere Resistenz gegenüber der 
proteolytischen Aktivität von Trypsin als Dimere. Erstaunlicherweise führten Punktmutationen 
innerhalb der Sequenze von Yaf zu einer Destabilisierung des Proteins und die Mengen an löslichem 
Protein waren stark reduziert. Mit Hilfer verschiedener Aktivitätsmessungen wurde die Funktion von 
Yaf untersucht. DNA-Bindungsversuche haben gezeigt, dass dimeres und tetrameres Yaf 
doppelsträngige DNA Substrate mit geringer Affinität (>5 µM) bindet. Desweiteren wurde in 
Elutionsfraktionen mit dimeren und tetrameren Yaf eine Metall-abhängige und 
Sequenz-unabhängige Nukleaseaktivität beobachtet. Diese Nukleaseaktivität war spezifisch für 
doppelsträngige DNA Fragmente und für Oligonukleotide mit Sekundärstrukturen. In der 
Anwesenheit von verschiedenen divalenten Metallionen konnte innerhalb der Elutionsfraktionen mit 
dimerem und tetramerem Yaf eine Relaxierungsaktivität auf superspiralisierte Plasmide beobachtet 
werden. Diese Reaktion war besonders verstärkt in Anwesenheit von Mn2+ und Co2+, konnte aber 
auch in Anwesenheit von Mg2+ beobachtet werden. Um Informationen über den strukturellen Aufbau 
und über die Funktion von Yaf zu erhalten, wurde die Kristallisation von Yaf in Zusammenarbeit mit 
Dr. S. Smits aus der Forschungsgruppe von Prof. L. Schmitt (Heinrich Heine Universität in Düsseldorf) 
begonnen. Kristalle, die aus Yaf mit einem N-terminalen His-tag bestehen, streuen zurzeit bis zu einer 
Auflösung von 3 Å. Zudem konnte kürzlich erstes Wachstum von Protein-Kristallen mit 
inkorporiertem Selenomethionin beobachtet werden. Natives Yaf kristallisiert jedoch nicht unter den 
gleichen Bedingungen wie Yaf mit einem N-terminalen His-tag. 
Um die MOBH Relaxase TraI funktionell zu charakterisieren wurden viele verschiedene 
Überexpressionsmethoden und Reinigungsprotokolle getestet. Schließlich konnten eine 
Überexpressionsmethode und ein Reinigungsprotokoll etabliert werden, mit denen erfolgreich 
lösliches TraI isoliert werden konnte. TraI bildet in Lösung stabile Dimere und limitierte Proteolyse 
zeigte, dass TraI aus mindestens drei unterschiedlichen Trypsin-resistenten Domänen besteht. 
DNA-Bindgungsversuche haben gezeit, dass TraI doppelsträngige und einzeilsträngige DNA mit hoher 
Affinität in einer Sequenz-unabhängigen Reaktion bindet. Die minimale Bindungslänge von 
einzelsträngigen DNA Substraten, die für eine Bindung mit TraI nötig ist wurde auf 9 Nukeotide 
bestimmt. Desweiteren wurde für TraI eine Metall-abhängige und Sequenz-unabhängige 
Relaxierungsaktivität auf superspiralisierte Plasmide beobachtet. In Anwesenheit von Mn2+ ist diese 
Aktivität deutlich gesteigert. Die Relaxierungsaktivität von TraI ist ähnlich zu der enzymatischen 
Aktivität von Topoisomerase I aus E. coli, unterscheidet sich aber von dieser bezüglich des 
bevorzugten Metall-Cofaktors und durch die tatsache, dass bei der Reaktion von TraI keine 
detektierbaren Topoisomerasen I-typischen Intermediate während der Reaktion beobachtet wurden. 
Experimente zur DNA-Strangspaltungsaktivität von TraI wurden mit unterschiedlichen einzel-
strängigen DNA Substraten durchgeführt. Dabei wurde ein TraI induzierte Strang-spezifische Spaltung 
bei zwei Oligonukleotiden beobachtet, die abhängig ist von Mn2+. TraI spaltet einzelsträngige DNA 
Substrate, die entweder die Sequenze der oriT Region des GGI enthalten oder die Sequenz der oriT 
Region des F-Plasmides aus E. coli. Dazu komplementäre Stränge und ein polyT Oligonukleotid 
wurden nicht von TraI gespalten. Ein Vergleich der beiden postulierten Spaltstellen in den 
Oligonukleotiden ergab keine Ähnlichkeiten zwischen den beiden Sequenzen. Um strukturelle 
Informationen über TraI zu erhalten, wurden die Kristallisation von TraI in Zusammenarbeit mit 
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Dr. S. Smits aus der Forschungsgruppe von Prof. L. Schmitt (Heinrich Heine Universität in Düsseldorf) 
initialisiert.  
Neben der Charakterisierung der enzymatischen Aktivität von TraI und Yaf wurde mit „pull-down“ 
Versuchen untersucht, ob beide Proteine miteinander oder ob sie mit mit der neisseriellen T4SS 
ATPase TraC interagieren. Die Ergebnisse zeigten jedoch keine Interaktion zwischen diesen drei 
Proteinen. 
Die Ergebnisse dieser Studie führen dazu, ein besseres Verständnis bezüglich des 
DNA-Prozessierungsmechanismus des einzigartigen T4SS von N. gonorrhoeae zu erhalten. 
Bedeutende Fortschritte wurden bei der funktionellen Überexpression und der Aufreinigung von TraI 
und Yaf erzielt. Die, in dieser Studie erzielten Ergebnisse der biochemischen Charakterisierung von 
TraI repräsentieren die ersten verfügbaren biochemischen Daten über diese neue Relaxase-Familie. 
Desweitern ermöglicht diese Studie erstmals Einblicke in die enzymatische Aktivität des nicht 
charakterisierten hypothetischen Proteins Yaf, obwohl die eigentliche Funktion dieses Proteins noch 
immer unbekannt ist.   
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1. Introduction 
1.1 Neisseria gonorrhoeae 
The genus Neisseria belongs to the family of Neisseriaceae which are classified into the group of 
Neisseriales and belong to the class of Gram-negative β-proteobacteria. These are mostly strict 
aerobic coccal or diplococcal bacteria (see Figure 1). Most members of this family are commensal 
bacteria colonizing human mucosal tissues. Two species within this genus, Neisseria gonorrhoeae and 
Neisseria meningitidis are serious human pathogens causing diseases like gonorrhea, bacterial 
meningitis, or septicemia. Both are non flagellated diplococci and are either termed gonococcus 
(N. gonorrhoeae) or meningococcus (N. meningitides) (1-4). Albert Neisser described N. gonorrhoeae 
as the causative agent for gonorrhea first in 1879.  
Gonorrhea is due to its rapid spread and serious symptoms, as well as often accompanying diseases 
(e.g. HIV), a very dangerous infection that fortunately still can be treated with antibiotics. In cases of 
co-infection with gonorrhea and HIV, N. gonorrhoeae is under suspicion to enhance the infection rate 
with HIV to the sexual partners and is therefore a potent amplifier of the spread of HIV (5). Globally 
more than 60 million new cases are recorded each year (WHO – World Health Organization), mostly 
appearing in less developed countries (6). High infection rates can be found within homosexually 
active men and women, as well as within indigenous populations and in poor areas (7).    
The infection of human urogenital tissues with N. gonorrhoeae causes urethritis in men and 
endocervicitis in women. However, N. gonorrhoeae is also able to infect other mucosal tissues, 
mostly resulting in more difficult diagnosis and treatments of the diseases (e.g. anorectal or 
pharyngeal infections). One complicating aspect in diagnosing gonorrhea is the fact that most 
endocervical, anorectal and pharyngeal infection are asymptomatic and therefore difficult to realize. 
In case of an infection spreading to adjacent tissues, men can develop an epididymoorchitis, and in 
women it can result in pelivic inflammatory disease (PID) or in few cases in gonococcemia which 
could lead to tenosynovitis, septic arthritis, endocarditis, or meningitis. Within women even more 
dangerous complication are possible since a salpingitis can cause PID and infertility, or can lead to an 
infection of a newborn during delivery. Gonorrhea is also accountable for first-trimester abortion and 
complications in ectopic pregnancies (8).  
The effective treatment of gonorrhea with antibiotics has become increasingly difficult since 
antibiotic resistances are mounting fast. Classical antibiotics like penicillins, tetracyclines, macrolides, 
spectinomycine, and even quinolones are already ineffective for use. In many industrial countries the 
recommended antibiotics for treatment of gonorrhea are therefore third-generation cephalosporins 
and ceftriaxone (8). The antibiotic resistance pattern within gonorrhea varies strongly in different 
countries, e.g. west pacific regions show resistance to penicillin, tetracyclines and quinolones, 
whereas in the Australian outback many strains are not resistant to penicillin (WHO). The spread of 
antibiotic resistances is caused by the natural competence of N. gonorrhoeae during all phases of 
growth, leading to a very efficient intra- and interspecies DNA transfer (9). In principle, DNA can be 
bound unspecific to the neisserial cell surface, but for effective DNA uptake and recombination the 
DNA needs to have a 10 bp conserved DUS sequence (DNA uptake sequence) (10). DUS sequences 
are accumulated in certain chromosomal areas, like e.g. regions encoding genes responsible for DNA 
maintenance and a few regions encoding other essential genes, implicating a potential function in 
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chromosome stability (11, 12). Besides this, it is in discussion whether or not recombination is a DNA 
repair mechanism in Neisseria since many typical DNA repair genes are lacking in this species (13). A 
comparison of genomes of three different Neisseria species revealed a clear differentiation between 
the species leading to the conclusion that interspecies recombination is an infrequent event (4). The 
DNA for transformation is released by autolysis, T4SS mediated secretion or blebbing (10, 14). The 
extraordinary T4SS of N. gonorrhoeae is located in the gonococcal genetic island (GGI) and will be 
described in more detail in Chapter 1.6. Blebbing occurs very frequently in Neisseria and seems to be 
an important mechanism to defend against the human immune system and to spread genetic 
information (15, 16). Blebs are detached membrane vesicles containing immunodominant cell 
surface antigens, as well as associated DNA and other attached proteins (14, 17). Dorward et al. 
showed the association of plasmid DNA to neisserial blebs and proposed the possibility of a new 
mechanism of interspecific plasmid transfer comparing the neisserial blebs with the 
transformasomes of Haemophilus (14, 18, 19). A large proportion of transformable DNA is supplied 
by the high incidence of autolysis within Neisseria. The mechanism of autolysis in Neisseria is up to 
now only poorly understood. The increasing antibiotic resistance and the resulting danger of 
incurability of gonorrhea make the understanding of the mechanism of intra- and interspecific DNA 
transfer an outstanding task. Recently, the N. gonorrhoeae strain H041 was listed as the first 
untreatable ‘Superbug’ of gonorrhoeae, since it is resistant to the commonly used antibiotics and 
even to Ceftriaxone (20, 21). 
  
 
 
 
 
 
 
1.2 Bacterial secretion systems 
Prokaryotes use secretion systems to secrete a broad range of substrates and have developed a huge 
set of different secretion systems. Up to now seven different secretion systems (type I-VII) are 
identified in Gram-negative and Gram-positive bacteria, as well as in archaea (22). Secretion systems 
are involved in versatile functions like e.g. intercellular signaling (23), bacterial movement (24, 25), 
effector protein transfer (26), symbiosis (27), regulation of metabolic pathways (27, 28), or DNA 
transfer (29, 30). Some of the systems are cell-contact dependent and transfer DNA and proteins into 
recipient cells (T3SS, T4SS, T5SS, T6SS), whereas other systems are not dependent on cell-contact 
and secrete surface molecules or effector proteins to the outer cell-surface and into the environment 
(T1SS, T2SS) (22, 31). Since T7SSs are the latest identified secretion systems, it is currently not known 
if their secretion mechanism is cell-contact dependent or not. So far T7SSs have only been identified 
in Mycobacteria and a few other Gram-negative bacteria and seem to be unique for this group (32), 
whereas other secretion systems (type I-VI) are widely spread among bacteria and archaea. A general 
1 µM
Figure 1: SEM picture of N. gonorrhoeae wild type strain MS11 with 20,000x 
magnitude. Cells were chemically fixed with glutaraldehyde and osmium 
tetroxide. The picture shows the typical diplococcal shape of N. gonorrhoeae. 
The micrograph was taken by T. Bender and A. Wagner (our group) with a 
Hitachi S-530 Scanning Electron Microscope with kind support of the group of 
Prof. Kost. 
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overview on the basic composition and organization of the prokaryotic secretion systems is given in 
Figure 2.  
Figure 2: General overview of current models of the basic organization of bacterial secretion systems. Omp: outer 
membrane protein; MFP: membrane fusionprotein; OM: outer membrane; IM: inner membrane; MM: mycobacterial 
membrane; HM: host membrane. The scheme is adapted from (22).  
 
Often several types of secretion systems are encoded within the genome of a species, 
e.g. Pseudomonas aeruginosa encodes five different secretion systems that are used for a broad set 
of functions (33). Each secretion system can also vary in its abundance and therefore several 
secretion systems of one type can be used for different functions within one organism. The secretion 
mechanisms of different secretion systems are either 1-step mechanisms (T1SS, T3SS, T4SS, and 
T6SS) in which the substrate is secreted in one step across the cell-envelope to the environment or 
into the host cell, or 2-step mechanisms (T2SS and T5SS) using the Sec- or Tat-translocation pathway 
prior secretion to deliver substrates into the periplasm followed by their translocation through the 
outer membrane via the secretion system (22, 31, 34). 
The Sec-translocation pathway is commonly used by bacteria to transfer proteins across the 
cytoplasmic membrane, either into the periplasm in Gram-negative bacteria or to the cell-surface 
and environment in Gram-positive bacteria and archaea (22, 35). The translocation system consists of 
an inner-membrane-pore made of the three proteins SecY, SecE and SecG, as well as a cytoplasmic 
ATPase (SecA) which energizes besides the proton motive force (PMF) the translocation of unfolded 
proteins across the cytoplasmic membrane (36-38). The proteins are triggered to the translocation 
pore via an N-terminal signal sequence and translocation occurs either co-translationally (for 
membrane proteins or proteins with a very hydrophobic signal sequences) with the translating 
ribosome targeted and localized to the translocation pore, or the SecB chaperon targets the proteins 
after translation to the SecYEG pore via binding to SecA (22, 36, 38). 
The Tat-translocation pathway is very similar to the SecYEG system. Bacteria and archaea use the 
Tat-system (twin-arginine-transporter) as an alternative translocation system to transfer folded 
proteins across the cytoplasmic membrane, contrary to the secretion of unfolded proteins in the 
SecYEG system (22, 39, 40). The Tat-system consists of three essential membrane proteins 
Introduction 
 
 
 
Page | 9  
 
(TatA, TatB and TatC). The translocation pore is made of the major pore-forming subunit TatA and 
PMF energizes the translocation process (39). Proteins for translocation contain a typical N-terminal 
recognition sequence (twin-arginine-motif: S-R-R-x-F-L-K) and are bound to a co-factor. They are 
recognized and targeted to the translocation-pore via TatC (39, 41, 42). 
Type I secretion systems (T1SS) can be found in Gram-negative and Gram-positive bacteria and are 
relatively simple secretion systems with regard to their architecture and their secretion mechanism 
(43, 44). The substrates of T1SSs are often virulence factors like toxins or could be 
exopolysaccharides which are important for biofilm formation (45, 46). The secretion of the 
substrates into the environment is an ATP dependent mechanism in which the substrate is targeted 
to the secretion system via a C-terminal secretion signal that cannot be cleaved from the protein (47, 
48). T1SSs consist of three different components which are an ABC-transporter (ATP binding 
cassette), an outer membrane factor, and a membrane fusionprotein that connects both membrane 
components (48). During T1S the proteins are secreted in an inactive unfolded state and are 
activated by changing their folding state at the outside of the cell (49). Some examples for T1SSs are 
the TolC-HlyB-HlyD system of E. coli (45), the Apr- and the Has-systems in P. aeruginosa (50, 51), or 
plant-pathogens like Xanthomonas oryzae pv. oryzae (52), Agrobacterium tumefaciens (53), 
Pseudomonas syringae pv. tomato (43), and Ralstonia solanacearum (43).  
Type II secretion systems (T2SS), also known as secretons, are used by Gram-negative proteobacteria 
and have highly adopted secretion functions specific to the abiotic and biotic environment of the cell 
(33, 54). Often T2SSs are involved in the secretion of toxins and other virulence factors (22). These 
systems are unique in their ability to secrete large multimeric proteins in an ATP and 
Sec-translocation dependent 2-step-mechanism, which involves at least 11-16 different proteins (55-
57). After the transfer via SecYEG the substrates are folded in the periplasm prior to secretion 
through the outer membrane. T2SSs are organized in three components with an integral inner 
membrane protein acting as a pore-anchor, a large outer membrane spanning channel formed of 
secretin subunits, and a type IV pilus like pseudopilus which has been proposed to act as a piston 
that pushes the substrates across the outer membrane (54-57). A cytosolic ATPase regulates the 
opening and closing of the pore. T2SSs can be found in many Gram-negative pathogens like e.g. the 
Xcp- and Hxc-systems of P. aeruginosa (58, 59), the StcE metalloprotease secretion system and the 
ADP-ribosylating toxin secretion system of E. coli (54), the cholera toxin of Vibrio cholera (54), or 
different substrates in R. solanacearum, Legionella pneumophila, Klebsiella oxytoca, or Aeromonas 
hydrophila (54).  
The injectisome of type III secretion systems (T3SS) is evolutionary related to the bacterial flagellum 
and is used by Gram-negative pathogens or mutualists to deliver effector proteins into host cells (31, 
60, 61). T3SSs can be separated in seven subfamilies and are often encoded in pathogenic islands or 
plasmids (60). They are large multiprotein systems with approximately 25 proteins involved in 
assembly and secretion. 9 of these 25 proteins are conserved in all subfamilies and 8 of these 9 
proteins are also conserved in bacterial flagella systems (60, 62). T3S is a SecYEG independent 1-step-
mechanism comparable to the injection with a syringe (60). The secretion system consists of an inner 
membrane embedded base structure with an inner and an outer ring and a cup-like structure at the 
cytosolic side, a needle-like filament mediating the contact with the host cell and the injection of 
virulence factors, and a pore which is assembled in the host membrane after cell-cell contact (31, 60, 
63). The length of the needle can vary between different species and is very important for virulence, 
Introduction 
 
 
 
Page | 10 
 
e.g. the needles of Shigella sp. or Yersinia sp. are 50-60 nm in length, whereas the needle of 
pathogenic E. coli is 600 nm in length (31, 64). Signaling from the host membrane pore via the needle 
to the base structure after cell-cell contact triggers the secretion mechanism, which is energized by 
ATP hydrolysis and the PMF (65-67). The substrate is targeted via an N-terminal secretion signal 
together with a chaperon in a chaperon-effector-complex to the secretion system. The chaperone-
effector-complex is then bound by an ATPase which unfolds the effector protein and triggers it to the 
cup-like structure at the inner membrane (68). The function of the chaperone is still not fully 
understood and it is assumed that it could be involved in several functions: i) keeping the effector in 
an unfolded inactive state, ii) triggering the secretion process, or iii) preventing an association of the 
effector with the membrane (33, 60). T3SSs are present in a broad range of pathogens like Yersinia 
enterolytica, Salmonella enterica, Salmonella typhimurium, Shigella flexneri, Burkholderia 
pseudomallei or E. coli (60).  
Type V secretion systems (T5SS) are the simplest secretion systems within bacteria and are widely 
spread among the group of Gram-negative bacteria (33). Secretion in T5SSs occurs in a cell-cell 
contact dependent manner and enables the transfer of large proteins (31). The secreted proteins, 
which are often virulence factors, either remain bound to the cell surface (e.g. adhesins) or are 
cleaved by an extracellular protease (e.g. toxins) (69). To date two different types of T5SSs are 
described in detail; autotransporters and 2-partner secretion systems (69, 70). Autotransporters are 
mostly used for the secretion of toxins or adhesins, whereas 2-partner secretion systems are used to 
co-ordinate the formation of biofilms or to compete on environmental resources (e.g. via growth 
inhibition) (71-73). The secretion mechanism is a SecYEG dependent 2-step mechanism. 
Autotransporters are targeted with a signal peptide to the inner membrane and are secreted into the 
periplasm via the Sec-translocase. The C-terminal domains of autotransporters integrate into the 
outer membrane forming β-barrels to enable the secretion of their own N-terminal domains. 
Therefore, autotransporters consist of three different domains: a C-terminal domain for β-barrel 
assembly, an N-terminal domain with a signal peptide, and a passenger domain in between (69, 74, 
75). The 2-partner secretion systems are very similar to autotransporter systems but consist of two 
proteins. One protein is forms the outer membrane β-barrel and the other protein is secreted across 
the membrane. The translocation of both proteins into the periplasm is SecYEG dependent. The 
effector protein is first secreted as a pre-pro-protein into the periplasm where it is cleaved into a pro-
protein prior transfer through the outer membrane. Outside the cell the pro-protein is then cleaved 
to the active protein (76-78). Often 2-partner systems are involved in contact dependent growth 
inhibition (CDI) in which the secreted effector protein leads to cell-death of the recipient by inhibiting 
the PMF (e.g. E. coli, B. pseudomallei, or Yersinia pestis) (79, 80). Another example for T5S is the 
secretion of the IgA protease in N. gonorrhoeae and N. meningitides (81).  
Type VI secretion systems (T6SS) are evolutionary related to the DNA injection systems of 
bacteriophages and share several proteins with high sequence identity and structural similarities 
with them (82). Many Gram-negative bacteria encode T6SSs involved in virulence or self-recognition 
within the same species (e.g. V. cholera, P. aeruginosa, A. tumefaciens, Edwardsiella tarda, 
Burkholderia mallei, or Proteus mirabilis) (83-86). T6SSs consist of multiple proteins and assemble to 
a basal plate located in the cytoplasmic membrane, an injection-tube that is pushed outside the cell 
and initiates the cell-contact, and a hexameric AAA+ ATPase (87). The detailed mechanism of T6S is 
still not fully understood and needs to be elucidated further. Up to now it is not clear if T6SSs have 
additional proteins with lysozyme-like activity at the tip of the tube to achieve penetration of the 
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host membrane (31). At present the proposed mechanism of T6S seems to be in a way similar to that 
of T3SSs.  
The most recently identified class of type VII secretion systems (T7SS) can be found in Mycobacteria, 
as well as in several other Gram-positive bacteria. Many pathogenic Mycobacteria use T7SSs to 
secret virulence factors (e.g. Mycobacterium marinum, Mycobacterium tuberculosis, or 
Mycobacterium leprae), but within Mycobacterium smegmatis T7SSs are also used for conjugation 
(88-91). Conserved gene clusters related to T7SSs (WXG100 family or ESX-4 homologues) were also 
identified in other Gram-positive bacteria like Bacillus anthracis, Bacillus subtilis, Staphylococcus 
aureus, Streptococcus agalactiae, Streptomycetes, Corynebacteria, and Nocardia (32, 92-97). The first 
T7SS was identified in a Mycobacterium bovis BCG vaccine strain, which is used in the production of 
tuberculosis vaccine. While generating a non-virulent strain for vaccination a conserved ESX-1 gene 
cluster has been identified and demonstrated to be important for virulence of M. bovis (32). Up to 
now five ESX clusters are identified and known to be involved in T7S within Mycobacteria. The ESX-1 
and ESX-5 clusters are important for virulence, and in M. smegmatis ESX-1 is involved in conjugation. 
The functions of ESX-2 and ESX-4 are still not known and the ESX-3 cluster is involved in iron and zinc 
homeostasis (94). To date the mechanism of T7S is only poorly understood and a first model for the 
assembly of the secretion system and the secretion process is based on bioinformatical predictions 
and a few protein-protein interaction studies. T7SSs are multiprotein systems (ESX-1 encodes already 
14 proteins) with an inner membrane channel associated with an inactive chaperone-like ATPase that 
interacts with the C-terminus of the effector proteins to form an active ATPase for secretion (32). It is 
assumed that the mycomembrane is crossed via a channel-like structure similar to other secretion 
systems, but so far no mycomembrane-channel components could be identified (32). Interestingly, 
the effector proteins of T7SSs dimerize prior secretion and are transferred as dimer-complexes (98, 
99). Within these dimeric effector-protein-complexes one of the two proteins carries a C-terminal 
signal sequence (100). This signal sequence can be used for the secretion of other soluble proteins. 
Therefore, it is assumed that T7SSs secret multimeric complexes (101). Since no structural data is 
available and only a few proteins within T7SSs are characterized in detail, it is up to now not known 
how these complexes pass the inner membrane channel. However, T7SSs show some similarities to 
T4SSs (102, 103).  
 
1.3 Multifunctional type IV secretion systems 
The versatile and widespread group of type IV secretion systems (T4SS) can be separated into three 
subfamilies: i) the large group of conjugative systems, ii) the pathogenic relevant effector 
translocator systems, and iii) the small group of DNA uptake and release systems (104). Generally, 
T4SSs are large macromolecular machineries consisting of 11-15 different proteins (102, 104). These 
complex secretion machineries span both cell membranes in Gram-nagative bacteria and enable the 
secretion of single stranded transfer DNA and/or effector molecules to a host organism or into the 
environment, often in a cell contact dependent mechanism (104, 105). T4SSs are ubiquitous 
distributed among bacteria and archaea. Especially the large family of conjugative T4SSs is widely 
spread and can be found in Gram-negative, Gram-positive, and wall-less bacteria, as well as in 
Crenarchaeota (105). However, the subfamilies of effector translocator systems and DNA 
uptake/release systems can only be found in Gram-negative bacteria (104, 105). The rife of T4SSs 
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results in considerable genome plasticity, which has a strong impact on the rapid evolution of 
bacterial genomes (105). The presence of a T4SS is often coupled with the acquisition of different 
environmental or metabolic advantages to its host. For instance, T4SSs are major initiators for 
increasing antibiotic resistances or enhance the virulence and colonization skills of pathogenic 
bacteria (106-108).  
The broad variety of T4SSs hampers a general classification of these systems. Up to now, three 
different classification methods are commonly used and are currently under discussion. The simplest 
and most limited method is the classification of T4SSs into the three previously mentioned 
subfamilies (104). Considering the diversity of conjugative plasmids grouped together within the 
family of conjugative systems, a detailed sub-grouping of the different conjugative plasmids was 
established with the classification method based on the incompatibility groups of the plasmids (30, 
109). A new T4SS classification method based on sequence similarities and biochemical data 
obtained from relaxases was established by Garcillán-Barcia et al. (110), and represents in 
combination with the other two classification methods a logical and reasonable approach for the 
difficult classification and grouping of T4SSs. Recently, this classification system was extended to a 
separation system based on the differentiation of eight relaxase families and eight mating pair 
formation (MPF) families (111, 112). 
The conjugative systems are the best studied subfamily of T4SSs and are distributed among 
self-transmissible plasmids, ICEs and GIs (30, 113-115). The E. coli F-plasmid and the A. tumefaciens 
Ti-plasmid T4SSs represent only two well characterized prototypes of this large subfamily (30, 102, 
116). Functionally, conjugative T4SSs transfer ssDNA form one organism to another in a cell contact 
dependent mechanism (102). Thereby, the conjugative DNA transfer is not limited to one species and 
can occur within and between kingdoms (104, 107). The mechanism can be divided into three 
reactions types: i) the initial DNA processing reaction, ii) the recruitment of the substrate to the 
secretion complex, and iii) the translocation process (102, 117, 118). The initial DNA processing 
reaction is of major interest within this study and will be described in detail in Chapters 1.7 – 1.9. The 
substrate recruitment is often mediated by positively charged C-terminal signal-sequences and is 
covered in Chapters 1.7 and 1.8. The translocation process of T4SSs still includes many unknown 
variables and different translocation models are currently under discussion. Recently, Fronzes et al. 
solved the structure of an assembled and functional purified secretion complex, which represents a 
milestone in understanding the translocation process in T4SSs (119, 120). Detailed information about 
the assembly of this representative secretion complex will be given later within this Chapter in 
context with the functional mechanism of T4SSs.  
The family of effector translocator systems is functionally closely related to the conjugative systems. 
In addition to the often coupled conjugative DNA transfer, these systems transfer effector proteins 
(e.g. virulence factors, toxins, or metabolically active substrates) into host cells in a cell contact 
dependent mechanism, similar to that of conjugative systems (102, 104, 121-123). The transferred 
effector proteins and the T-DNA play an important role in infection processes, colonization 
processes, and the survival of bacteria within the host cell or on tissues (102, 104). These systems 
often lack dtr proteins and the coupling protein, indicating their high specialization on effector 
proteins transfer (105, 122, 124). The substrate recruitment is often mediated by Chaperones or 
C-terminal recognition signals, similar to conjugative systems (105). The mechanism of the effector 
translocation through the secretion complex still remains unknown and is topic of current research.  
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The small subfamily of DNA uptake and release systems resembles up to now only three known 
examples, which are the DNA uptake systems of Campylobacter jejuni (Cjp/VirB) and Helicobacter 
pylori (ComB), and the DNA release system encoded in a genomic island of N. gonorrhoeae (GGI) 
which is in the major focus of this study (113, 125, 126). The remarkable and novel cell contact 
independent T4SS of N. gonorrhoeae will be described in detail in Chapter 1.6.  
To enable the transfer of DNA and effector proteins from one organism to another, T4SSs have to 
pass the barrier of the inner and the outer cell membrane and the border of the host cell membrane. 
Therefore, T4SSs resemble a huge macromolecular complex spanning both membranes. The coupling 
protein (e.g. VirD4AT, TraDF, TrwBR388), which mediates the contact between the substrate and the 
secretion complex is integrated into the inner membrane and localize in close proximity to the 
secretion complex (detailed information on T4SS coupling proteins is given in Chapter 1.10). Besides 
the secretion channel and the coupling protein, T4SSs encode one or two additional ATPases thought 
to energize the assembly of the secretion complex, the pilus assembly and disassembly, and/or the 
substrate transfer (102, 105). VirB4AT like ATPases (e.g. TrwKR388, TraCF, TrhCR27) can be found in all 
T4SSs and have been reported to be involved in pilus assembly (TraCF) (127). It has been proposed 
that these proteins assemble into an active homohexameric state and are involved in substrate 
docking (105, 128). Recently the structure of the ATPase domain of the VirB4 homologue of 
Thermoanaerobacter pseudethanolicus has been solved and has been modeled into the structure of 
the T4SS core complex (129). This protein forms an equilibrium of monomers and dimers in solution. 
Walldén et al. also demonstrated that the VirB4 homologue of plasmid pKM101 binds to the core 
complex as a monomer (129). 
VirB11AT like ATPases (e.g. TrbBRP4, TrwCR388) have been reported to assemble as homohexameric 
rings and associate with the cytoplasmic membrane (105). The activity of these proteins seems to be 
enhanced in vitro in the presence of lipids (130, 131). Homologues of VirB11AT like ATPases are often 
found in type IV pilus systems, type II secretion systems and archaealla (105, 132). In T4SSs these 
proteins are essential for the assembly of the pilus and the secretion complex (105). Remarkably, no 
VirB11 homologues can be found in T4SSs that resemble the F-plasmid. The membrane spanning 
secretion complex consists of an inner membrane channel and an outer membrane channel that are 
connected in the periplasmic space. The inner channel is made of VirB3AT, VirB6AT, VirB8AT, and 
VirB10AT like proteins, which tightly interacts with each other to form a stable channel complex (102, 
105, 119). VirB3AT like proteins are integral inner membrane proteins and have been reported to be 
involved in pilus assembly and substrate translocation, even though the specific function of these 
proteins is still unknown (105, 133, 134). VirB6AT like proteins (e.g. TraGF) are polytopic membrane 
proteins that stabilize the mpf complex and mediate the transfer of the ssDNA via direct DNA-protein 
interactions (135-138). VirB8AT like proteins are responsible for the spatial positioning of the 
secretion complex at the cell pole and have been reported to form dimers (105, 139, 140). VirB10AT 
homologues are bitopic inner membrane proteins with a structurally dynamic character (141). These 
proteins are structural scaffold proteins and bridge the inner and outer channel components in a 
structural dynamic mechanism, including conformational changes due to energizing via ATP-
hydrolysis (119, 120, 142). The periplasmic connection and the outer membrane channel consist of 
VirB1AT, VirB2AT, VirB5AT, VirB7AT, and VirB9AT like proteins (102, 105, 119). VirB1AT like proteins are 
transglycosylases and do not directly interact and associate with the secretion complex, but are 
essential to facilitate the assembly of the secretion channel via local degradation of peptidoglycan 
(143). The outer membrane channel is mostly assembled of VirB7AT like proteins (e.g. TraOpKM101), 
Introduction 
 
 
 
Page | 14 
 
which are small lipoproteins that stabilize VirB9AT like proteins (105, 144). VirB7AT like proteins form 
together with VirB9AT and VirB10AT like proteins the central membrane spanning channel (105, 119, 
120). The VirB9AT like proteins (e.g. TraNpKM101) are part of the outer membrane channel and are 
hydrophilic proteins that localize in the periplasm and the outer membrane (105, 145). The cell 
contact and substrate transfer in T4SSs is facilitated by the formation of a dynamic pilus structure at 
the outside of the cell, which is formed by VirB2AT and VirB5AT like pilin subunits. VirB2AT like proteins 
are small hydrophobic channel components that could not be readily identified in Gram-positive 
bacteria and archaea (105). VirB5AT like proteins are transferred into the periplasmic space and 
facilitate the transfer of the substrate and the assembly of the pilus (105). VirB5AT like proteins have 
been reported to mediate the cell contact with the host (105). 
The number of available structures of T4SS components is strongly increasing within the last years, 
giving more and more insight into the complex mechanism of substrate transfer and complex 
assembly. Up to now, structures of VirB5AT like pilin subunits, VirB11AT like ATPases, VirB7AT – 
VirB10AT like channel components, and VirD4AT like coupling proteins are known (119, 120, 146). 
These structures allow in combination with biochemical data limited conclusions about a common 
architecture model of T4SSs. Recently, the first multi-protein structure of the 1 MDa T4SS core 
complex from plasmid pKM101 was solved with a resolution of 15 Å, using cryo electron microscopy 
and 3D crystallography (119, 120). This remarkable breakthrough allowed for the first time structural 
insights into the assembly and functionality of a membrane spanning multi-protein complex. The 
secretion complex of pKM101 has an overall height of 185 Å and consists of an inner layer (I-layer), 
an outer layer (O-layer) and a cap like structure (119). The I-layer forms a double-walled ring-like 
chamber with a 55 Å central opening at the cytoplasmic site and is made of the N-terminal domains 
of TraOpKM101 (VirB9AT) and TraFpKM101 (VirB10AT) (119). The O-layer resembles together with the cap 
the main body of the secretion complex and is formed by TraNpKM101 (VirB7AT) and the C-terminal 
domains of TraOpKM101 (VirB9AT) and TraFpKM101 (VirB10AT) (119). The cap has a central constriction of 
10 Å in diameter, representing the outer membrane opening of the secretion channel (119, 120). The 
constriction can be extended to a diameter of 20 Å via conformational rearrangements and allows a 
controlled opening and closing of the secretion channel (119, 120).  
However, the exact mechanism of substrate transfer through the secretion channel (especially the 
transfer of large proteins) still remains largely unknown. Two different models for the substrate 
transfer mechanism in T4SSs have been proposed. In the channel model the pilus is supposed to 
form a channel connecting the host cell with the recipient cell (104). The extension of the pilus 
mediates the initial cell contact and the followed retraction of the pilus brings both cells into close 
proximity to each other, allowing an efficient substrate transfer through the secretion channel (104). 
In the piston model the substrate is loaded on top of the pilus and is transferred to the recipient cell 
during the extension of the pilus. The secretion channel acts thereby like a piston motor and pushes 
the substrate to the outside (104). Nevertheless, both models still raise the question of how the 
substrate enters the secretion channel. Especially the mechanism of the exceptional secretion 
mechanism of the pertussis toxin from Bordetella pertussis, which is mediated by the sec pathway 
and the T4SS, represents an interesting model to study the substrate entrance into the secretion 
complexes of T4SSs.  
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1.4 Secretion Systems of Neisseria sp. 
Genome analyses of different N. meningitides strains, N. gonorrhoeae strain FA1090, and a strain of 
the commensal Neisseria lactamica revealed that Neisseriacea contain at least three different types 
of secretion systems (T1SS, T4SS and T5SS) and uncovered a strongly degenerated secretome in 
N. gonorrhoeae in comparison with N. meningitides and N. lactamica. Many of the pseudogenes and 
disrupted ORFs in N. gonorrhoeae encode genes of different secretion systems (147). The 
degenerated secretom of N. gonorrhoeae should be considered with caution since only the genome 
sequence of strain FA1090 was available by the time of the analysis (147). Especially due to the 
adaptation to the specific niche N. gonorrhoeae is inhabiting it is reasonable, that the number of 
secretion systems within this species is reduced. In this comparative genome analysis no homologous 
genes for T2SS, T3SS, T6SS, and T7SS were identified (147). However, it cannot be excluded that still 
unknown or alternative secretion mechanisms like e.g. the transport via outer membrane vesicles in 
E. coli (148) are present in N. gonorrhoeae. The latter option is particularly noteworthy since 
Neisseria are known for an intense blebbing activity (14). Homologues for T1SS genes can be found in 
N. meningitides, but not in N. gonorrhoeae and N. lactamica. N. meningitides encodes three RXT 
homologous islands (RTX I-III) encoding frp (Fe-regulated proteins) genes, which are expressed under 
iron starvation (149). The exact function of these proteins still needs to be investigated. 
N. meningitides encodes besides the frp gene cluster two other T1SSs (natC and mtrE), which show 
similarity with multidrug efflux systems (147). Some strains of pathogenic Neisseria contain contrary 
to commensal Neisseria a T4SS, which is remarkable in its ability to secret DNA into the environment. 
At first this T4SS was only identified in N. gonorrhoeae strains, but recently it was also identified in a 
few N. meningitides strains (113, 150). A detailed description of the neisserial T4SS is given in 
Chapter 1.6. The most abundant secretion systems in Neisseriaceae are T5SSs with a broad range of 
versatility (e.g. autA/B, ata1/2/3, iga, app, nhhA, ihhA/B, nalP, nadA, aus1). At least three of these 
autotransporter gene clusters (iga, app, and nalP) seem to be highly conserved among Neisseriaceae 
(147). The IgA protease is absent in commensal Neisseria but is very important for the virulence of 
pathogenic Neisseria, as it cleaves human IgA, Lamp1 and chorionic gonadotropin (151-153). The 
adhesion and penetration protein App is conserved in N. meningitides, N. gonorrhoeae, and 
N. lactamica and is involved in the adhesion to distinct epithelial surfaces (154, 155). The NalP 
protein contains an uncommon C-terminal lipoprotein motif. The lipidation of NalP is important for 
the positioning of the protease near the cell surface to enable a proper access to the proteolytic sites 
of secreted proteins (156).  
 
1.5 Mobile genetic elements 
The spread of genetic information via horizontal gene transfer is one of most important forces of 
bacterial evolution. Three different mechanisms are known to be used for DNA transfer in bacteria: 
i) transduction via phage infection, ii) natural transformation via competence systems, and iii) T4SS 
mediated conjugation (111, 157). Since conjugation can result in the transfer of whole genomes it 
has the highest impact on DNA transfer in bacteria (158). T4SSs are not only located in conjugative 
plasmids, besides they can be also found within bacterial genomes located in or next to 
self-transmissible conjugative elements, or as T4SSs that are no longer involved in DNA transfer but 
in secretion of effector proteins (159).  
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Within bacterial genomes several genetic elements are self-transmissible and are classified as ICEs 
(integrative conjugative elements). This includes also conjugative transposons and integrated 
conjugative plasmids (e.g. Tn916 or CTnDOT with low sequence specificity or more sequence 
restricted ICEs like ICE-SXT) (160-162), or GIs (genetic islands) containing a compatible oriT sequence, 
or GIs that are integrated into a conjugative element (e.g. ICEclc or ICEM1Sym) (159). It is assumed 
that non mobile GIs are evolutionary related to ICEs but underwent a genetic degradation resulting in 
a loss of mobility (159). Besides ICEs, also integrative mobilizable elements (IMEs) are present in 
bacterial genomes. Theses genetic elements need the presence of other integrated T4SSs to be 
mobilized, and differ in this point from ICEs, conjugative transposons and GIs (163, 164). 
ICEs are wide spread within bacterial genomes and an extensive bioinformatical analysis to classify 
and identify different groups of ICEs by the use of chromosomally integrated T4SSs was done in 2011 
by Guglielmini et al.(111). The classification followed from this analysis is based on the comparison of 
the different relaxases families (MOBB, MOBT, MOBV, MOBQ, MOBP, MOBH, MOBF, MOBC), coupling 
proteins, conserved VirB4 like ATPases, and eight different MPF groups (MPFT, MPFF, MPFG, MPFI, 
MPFB, MPFC, MPFFA and MPFFATA) (111, 112). The analysis revealed that all glades of bacteria with 
sequenced genomes contain at least 86% more ICEs than conjugative plasmids. The distribution of 
ICEs and conjugative plasmids can vary strongly within different glades and both systems can 
co-occur sometimes in the same organism in large numbers. This implies that different T4SSs can 
co-exist in a functional state within one host. Several ICEs combining different MOB and MPF systems 
were identified in the analysis of Guglielmini et al., indicating an evolutionary shuttle within these 
systems (e.g. MPFT + MOBP, MPFG + MOBF or MPFG + MOBH) (111). 
Three different modules enable DNA transfer in ICEs: i) an integration and excision module, ii) a 
conjugation module, and iii) a regulatory module. In addition to these modules ICEs contain a broad 
range of extra functions like antibiotic resistances, heavy metal resistances, nitrogen fixation, 
degradation of aromatic compounds, virulence, and biofilm formation. Due to the spread of 
antibiotic resistance and the high number of mobile pathogenicity islands (e.g. 89K from 
Streptococcus suis) ICEs are of important clinical relevance (165-171).  
Before ICEs can be transferred via T4SSs to a recipient cell, the integrated element needs to be 
excised from the chromosome to form a circular extra-chromosomal intermediate. These 
intermediates are normally not auto-replicative and cannot be maintained in an extra-chromosomal 
stage. The excision within ICEs is mediated by integrases (often phage-like integrases), which are 
proteins mostly belonging to the family of tyrosine recombinases (e.g. Int from phage λ (172), 
SXT-R391 (162), ICEclc or ICEM1Sym (173, 174)), but also serine recombinases (e.g. Tn5397 (175)), 
DDE transposases (e.g. CTnGBS2 (176)), or XerCD like integrases (e.g. PAPI-1 or ICEHin1056 (177, 
178)) can be found. The mechanism of excision is comparable to the mechanism of integration (site-
directed recombination) and the integrase is forced to excise the ICEs via additional recombination 
directionality factors (RDFs). RDFs (excisionases) are small DNA-binding proteins that interfere with 
the DNA or perform protein-protein interaction and are very difficult to identify with bioinformatical 
approaches (179). Up to now, only a few RDFs are known and have been functionally characterized 
(e.g. Exc from CTnDOT or Xis from 89K (180, 181)). It is demonstrated that RDFs can show 
Topoisomerase I like DNA processing activity in vitro (180). Both proteins, the integrase and the RDF, 
are mostly not co-regulated since the frequency of excision and integration needs to be controlled 
separately due to environmental influences. An excellent review on the regulation of ICEs is given by 
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Wozniak et al. (159). The excision of ICEs can lead to the loss of the genetic elements. Up to now two 
mechanisms are known to prevent the loss of the excised ICEs. One, still uncharacterized mechanism 
is the stabilization of the excised ICEs with the help of additional proteins involved in chromosome 
partitioning and plasmid maintenance (e.g. Soj from PAPI-1 (182)), the second mechanism is the 
stabilization of excised ICEs via toxin-antitoxin systems (e.g. ICE-SXT (183)).  
For conjugational DNA transfer ICEs need at least a minimal set of T4SS components, which are a 
relaxase for the processing of single stranded transfer DNA, a coupling protein to mediate the 
contact between the DNA and the secretion channel, and components of the mating pair formation 
complex (MPF) (111). For many ICEs a relaxase and an oriT sequence are identified and are located in 
close proximity to each other. One exception is given by the relaxase TraI of ICE-SXT that has a 
distance of 40 kb to its oriT sequence (184). Recently, the bioinformatical analysis of Guglielmini et al. 
revealed several T4SSs within ICEs lacking the relaxase protein. The authors explained this result with 
a high number of potentially unknown relaxases that are not recognized within the analysis and a 
high number of genomic T4SSs that are not involved in conjugation, but might be involved in transfer 
of other substrates (111). Besides the use of T4SSs for DNA transfer a few ICEs mediate the DNA 
transfer via DNA translocases similar to the mechanism of SpoIIIE or FtsK (185).  
Likewise conjugative plasmids, ICEs also show in part exclusion groups to prevent the acquisition of 
closely related elements in one host (186, 187). To prevent a double-integration of the same ICE in 
the chromosome bacteria use a similar mechanism for entry exclusion like it is used for conjugative 
plasmids. The entry exclusion is mediated via the coupling protein of the T4SS and an additional 
entry exclusion protein. After the successful transfer of an ICE to the recipient cell it is integrated into 
the recipient chromosomes on integrase-dependent integration sites (e.g. dif-sites or attR- and 
attL-sites (159, 188, 189)). Many integrases use a mechanism similar to Topoisomerase I activity and 
do not require additional energy from ATP hydrolysis (172). The site-specific recombination 
mechanism of integrases is comparable with the mechanism of DNA integration of phages 
(e.g. phage φ80 and phage P4 (190, 191)). If the primary insertion site is not present in the 
chromosome ICEs can often also integrate on a second, partly imperfect insertion site (192).  
 
1.6 Gonococcal Genetic Island 
The Gonococcal genetic island (GGI) is a horizontally acquired genetic island with a size of 57 kb and 
takes its name from gonococci since it was first identified in the chromosome of N. gonorrhoeae 
(113). It is present in 80% of N. gonorrhoeae strains and in 17.5% of N. meningitides strains (only in 
serogroups H, W-135, Z and strain α275), and so far it could not be detected in commensal Neisseria 
species (e.g. N. lactamica) (113, 150, 193, 194). Within different neisserial strains the genetic 
organization and the integrity of the GGI can vary and five different GGI classes can be distinguished 
(150, 194). An overview of the different GGI classes is given in Table 1. Some variants of the GGI can 
be linked with the incidence of disseminated gonococcal infections (DGIs), but the presence of the 
GGI is in general not necessarily required for pathogenicity within Neisseria (113). The GGI variants 
isolated from DGI patients mostly contain an additional serum-resistence allele (sac-4) located within 
the traG gene and the lytic transglycosylase atlA (113, 195). However, it is not known if the product 
of the expressed sac-4 allele is surface exposed, resulting in a serum-resistance (113). In 
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N. meningitides no correlation between the presence of the GGI and the invasive form of the disease 
could be shown (150). Zola et al. showed recently a coherency of the GGI encoded T4SS with the 
ability for intracellular survival of N. gonorrhoeae in absence of the TonB dependent iron acquisition 
complex (196). 
 
Table 1: Overview of different GGI classes found in N. gonorrhoeae and N. meningitides strains. The data is summarized 
from Woodhams et al. (150). 
Class I lacks atlA and exp1 
deletion of 11 kb between yecB and parB 
encodes eppA  
long traA allele 
46 kb in size 
Class II lacks atlA and exp1 
deletion of 8.2 kb between yeb and ssb but integrated IS1301 element 
encodes eppA  
insertion of IS1301 element in traD with second copy in yaa 
long traA allele 
51 kb in size 
Class III lacks atlA and exp1 
deletion of 300 bps in traD and deletion of yaa 
insertion of IS1665 element in traK (no TraK production possible) 
56 kb in size 
Class IV highly similar to Class III within difA and ydbA 
numerous insertions within ybdB and parA 
deletions of 56 bps in yeh, 80 bps in topB, 30 bps in parB 
unique for N. meningitides strain α275 
64 kb in size 
Class V deletion of 22 kb between traE and yda (replaced with IS1301 insertions) 
deletion of 11 kb between yecB and parB 
contain ssbB and a homolog of topB 
24 kb in size 
 
Based on several differences between the neisserial chromosome and the GGI it was proposed that 
the GGI was horizontally acquired. These differences are a variation within the GC content (44% in 
GGI vs. 51% in chromosome in N. gonorrhoeae), as well as differing dinucleotide frequencies 
between the GGI and the chromosome, and diverging quantities of DUS sequences which are 
necessary for successful transformation of Neisseria species (in the chromosome 1.1 DUS/1kb vs. 9.5 
DUS/1kb in the GGI of N. gonorrhoeae) (197-199). Besides the already referred evidences for a 
putative horizontal acquisition of the GGI, it is bordered by two dif sites (difA and difB) which are 
recognized by the genome integrated XerCD recombinase (189, 198). The integration of the GGI into 
the chromosome could be facilitated via a XerCD dependent site-directed recombination mechanism 
(189, 200). The excision frequency of the GGI is very low due to a stabilizing effect of the imperfect 
difB site (189). DifB contains four mismatches compared to the consensus sequence of the intact difA 
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site and reduce therefore the excision efficiency of XerCD (189, 200). The circular form of the GGI 
cannot be maintained sufficiently in the cell, which could lead to the loss of the GGI since it seems 
not to be self replicative (189, 198, 200). All sequenced gonococcal GGIs contain the same four 
mismatches in the difB site, whereas in meningococci the mismatches in difB differ, which explains 
the chromosomal maintenance of incomplete GGI versions in meningococci (189). All these findings 
lead to the conclusion that the GGI was horizontally acquired from an up to now unknown ancestral 
species (200, 201). Most likely the GGI is an ICE that underwent genetic degradation over time, 
resulting in becoming a stabilized genomic island (198, 200). This assumption is consistent with the 
finding that the GGI encodes a T4SS with a large set of IncF and IncH homologous genes (110, 113, 
198, 202).  
The GGI of N. gonorrhoeae strain MS11 contains in total 62 open reading frames (ORFs) organized in 
at least five different operons ((113, 198, 203), K. Siewering unpublished data). The first 27.5 kb of 
the GGI encode a unique T4SS that enables gonococci to secrete ssDNA directly into the environment 
in a cell-contact independent manner (198). The secreted DNA is 5’ protected against DNAses and 
can be used for natural transformation by other gonococci and, therefore, is a potent factor for the 
spread of genetic information (202). It is unclear whether or not the secreted DNA also has an 
immunoregulatory function within the immune defense of gonococci (113, 204). Within 
meningococci the T4SS neither is involved in DNA secretion nor in a Ton-independent iron uptake for 
intracellular survival like it has been reported for N. gonorrhoeae (150, 196).  
The T4SS is encoded within the first three operons of the GGI and consists of 23 proteins ((198), 
K. Siewering unpublished data). 18 genes are homologous to the E. coli F-plasmid (IncF) (e.g. traGNG 
and traGEC have 22% identity and 40% similarity; traHNG and traHEC have 24% identity and 42% 
similarity; traFNG and traFEC have 29% identity and 45% similarity) (113, 205, 206). Most of the 
proteins are involved in the formation and stabilization of the secretion complex. 15 of the genes are 
ordered in the same orientation like the E. coli F-plasmid (198). The genes for the assembly and the 
stabilization of the secretion complex are located within the second and the third operon ((198), 
K. Siewering unpublished data). A few genes of the T4SS differ from those of the F-plasmid, e.g. the 
peptidoglycan transgylcosylase LtgX, the relaxase TraI, the coupling protein TraD, as well as the small 
proteins Yaf and Yaa (198, 202). However, the DNA processing and transferring proteins (TraI and 
TraD) of the neisserial T4SS seem to be phylogenetically more related to those of the IncH group and 
are located together in the first operon with the small proteins Yaa and Yaf ((110, 198, 202), PhD 
thesis of E. Pachulec 2010). The relaxase TraI belongs to the family of MOBH relaxases typically 
associated with ICEs and GIs, as well as conjugative plasmids (110). The coupling protein TraD 
clusters in phylogenetic analyses together with this group of relaxases and homologous proteins to 
Yaa. A predicted origin of transfer (oriT) is located within an inverted repeat in an AT-rich region 
between the coding sequences of yaf and ltgX in close proximity to the relaxase traI (150, 202). More 
detailed information considering the DNA processing proteins of the T4SS of N. gonorrhoeae are 
given in the Chapters 1.7 – 1.9. In addition to the genes of the T4SS the GGI encodes 39 ORFs with 
conserved hypothetical genes with up to now unknown function and some with putative DNA 
binding and processing function (e.g. the chromosome partitioning proteins ParA and ParB, the 
putative helicase Yea, Ssb, TopB and the DNA methylases Ydg and YdhA) (198). For most of the GGI 
encoded T4SS genes, DNA secretion assays were performed to test whether they are essential for 
DNA secretion or not ((113, 198, 202, 205), PhD thesis of E. Pachulec 2010). A scheme of the genetic 
organization of the GGI and an overview about the essential genes for DNA secretion is given in 
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Figure 3. Nearly all genes involved in assembly and stabilization of the secretion complex have been 
shown to be essential for DNA secretion. In particular, mutations within TraD do not result in a 
complete prevention of DNA secretion, but led to a significantly decreased level of secretion (198). 
Currently the small protein Yaa within the neisserial GGI is not tested in secretion assays, but a 
homologous protein within SXT/R391 S043 has been shown to be essential for DNA transfer (207).  
 
 
 
 
 
 
 
 
Figure 3: Genetic organization of the GGI from N. gonorrhoeae strain MS11. Genes shown to be essential for DNA 
secretion are colored in blue, genes shown to be not essential for DNA secretion are colored in cyan. Genes that have not 
yet been proven to be essential for DNA secretion are white colored. The oriT is located between yaf and ltgX. The six 
DUS sequences present in the GGI are labeled with red triangles. The picture is adopted and changed according to the 
PhD thesis of E. Pachulec 2010, the master thesis of K. Siewering 2010, and (200, 203).  
 
At present, there is not much known about the regulation of DNA secretion in the neisserial T4SS or 
the excision and integration of the GGI. So far, no homologues of regulatory factors could be 
identified in the GGI. Recently, Salgado-Pabòn et al. showed that the DNA secretion is increased in 
pilliated N. gonorrhoeae cells, resulting from an upregulation of the expression levels of traI and traD 
(208). This is the first indication of a regulatory mechanism within the T4SS of N. gonorrhoeae. Most 
likely the system is also regulated on other levels which have not yet been identified, e.g. regulatory 
mechanisms for the excision and integration of the GGI might exist. As discussed previously in 
Chapter 1.5, the excision of ICEs and GIs is often triggered by small proteins functioning as RDFs. 
Since RDFs are difficult to identify, it could be possible that within the hypothetical genes of the GGI 
putative RDFs are encoded. The control on excision and integration of the GGI would enable the cell 
to distinguish between the secretion of the excised GGI (similar to conjugative plasmids) and the 
secretion of the whole chromosome (like Hfr-strains in E. coli) under certain conditions. 
 
1.7 DNA processing within type IV secretion 
The DNA processing mechanism is one of the most important steps within bacterial conjugation and 
DNA secretion. The initial processing of double stranded supercoiled DNA into single stranded 
transfer DNA is a cascade like, highly structured mechanism and is essential to enable DNA transfer 
(209, 210). 
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Mostly, the DNA processing in T4SSs is mediated by a nucleo-protein-complex termed “relaxosome”, 
which consists of several proteins involved in DNA processing and the covalently bound transfer-DNA 
(209, 211, 212). The most important component of the relaxosome is the relaxase protein, which is 
responsible for the DNA cleavage and the processing of the transfer DNA (212-214). The sequence 
specificity and an optimal cleavage activity of the relaxase are mediated by additional nicking 
accessory proteins like NikAR64, TraJRP4, TraHRP4, TraYF, TraMF, or TrwAR388, as well as the integration 
host factor (IHF) (209, 215-219). Some of them function as spatial positioning factors and trigger the 
relaxosome to the secretion complex (220), other NAPs introduce topological changes into the 
supercoiled DNA and enable access for the large relaxase protein (221). 
The DNA processing mechanism is initialized by the binding of the NAPs and the IHF to distinct 
binding sites near the origin of transfer region (oriT) (214, 219, 222-224). The oriT sequence forms a 
stem-loop like structure resulting from an inverted repeat in an AT-rich region, which is recognized 
by the relaxase and other relaxosome components (225, 226). The inverted repeat is surrounded by 
various binding sites for NAPs, the IHF, and the relaxase, and could comprise sequence regions of 
several hundred bps (226). Generally, the oriT region of a T4SS is localized in close proximity to the 
dtr genes. The different NAP binding sites, as well as the binding site of the relaxase (nic site) in the 
oriT region are important triggering factors for the high sequence specificity of conjugative DNA 
processing (209, 219, 223, 227). The binding of dimeric NAPs to their distinct recognitions site 
enables a tetramerization of two NAP dimers, which leads to a bending of the supercoiled dsDNA 
(215). Detailed information about the functional mechanism of NAPs is given in Chapter 1.9. The 
heterodimeric IHF acts in a similar mechanism like other NAPs and bends the dsDNA helix around 
160°, resulting together with other NAPs in a DNA bend that enables the relaxase binding-access to 
the dsDNA at the nic site (210, 228). Additionally to their DNA bending activity, NAPs interact directly 
with their cognate relaxase via protein-protein interactions and trigger the relaxase to its specific 
binding site (214, 218). Well studied systems for the relaxosome formation are the T4SSs of plasmid 
RP4 and of the F-plasmid (209, 211, 212, 214). For instance, the NAP TraJRP4 binds to its palindromic 
recognition site srJ forming a nucleo-protein complex, which interacts via protein-protein 
interactions with TraIRP4, triggering the relaxase to its binding site srI near nic (214). It has been 
reported that the accessory protein TraHRP4 stabilizes the TraJRP4-TraIRP4-DNA complex, even though it 
does not directly bind to DNA (209). This sequential assembly of a relaxosome exemplifies the highly 
regulated initial process within conjugation and DNA secretion.  
The mechanism of DNA processing and transfer in T4SSs is still under discussion and needs to be 
elucidated further. It is hypothesized that the relaxase protein binds in an inactive mode to the 
dsDNA and changes after a stimulus from other relaxosome and T4SSs components to its active 
mode (229). The assembled relaxosome is triggered to the coupling protein (CP) by spatial 
positioning factors (e.g. TraMF) and is anchored to it via protein-protein interactions (220, 223). The 
CP oligomerizes to its active hexameric state after receiving an initiating signal, which comes most 
likely from the cell-cell contact with the recipient (229). This “pre-initiation” complex is connected to 
the secretion complex via the CP (229). A signal transduction cascade indicates the completed 
assembly of the secretion system and leads to a change in the binding mode of the relaxase, resulting 
in an activation of the DNA processing reaction (229). The nucleophilic attack of the active site 
tyrosine of the relaxase leads to a covalent phosphodiester-bond between the relaxase and the 
phosphate-backbone of the transfer DNA (212). More detailed information about the reaction 
mechanism of relaxases is given in Chapter 1.8. After the initial cleavage reaction of the relaxase 
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domain, the helicase domain of the relaxase starts to unwind the dsDNA in an ATP dependent 
mechanism. The single stranded transfer DNA stays covalently bound to the relaxase at its 5’ end 
(212, 227). The CP starts to hydrolyze ATP and functions as a DNA pump, forcing the transfer of the 
DNA through the secretion complex (229, 230). The remaining uncleaved DNA strand is replicated by 
DNA polymerases via the rolling cycle replication mechanism (214). The DNA processing reaction is 
terminated by a second cleavage reaction at the nic site in the oriT region (212, 214, 231).  
The DNA secretion system of N. gonorrhoeae represents an interesting exception of the common 
T4SSs since it secrets the DNA directly into the environment. The DNA processing mechanism of this 
T4SS is still unknown and the relaxase TraING belongs to a novel and uncharacterized relaxase family 
(MOBH) (110). Besides the relaxase, no additional relaxosome components could be identified in 
Neisseria, even though a gene for the IHF is encoded within the chromosome. A possible role of the 
IHF in the formation of a putative relaxosome in Neisseria has not yet been investigated. A putative 
oriT region, which is located between the genes yaf and ltgX has been predicted in N. gonorrhoeae 
and mutagenesis studies in combination with complementation assays have shown that this region is 
essential for DNA secretion (202). Furthermore, the localization of the neisserial oriT is similar to that 
of E. coli F-plasmid, which is located between the relaxase gene traI and geneX (similar to the 
neisseria ltgX) (202). A possible role of the two small proteins Yaf and Yaa in the DNA processing 
mechanism in the neisserial T4SSs still need to be investigated. Considering the close proximity of 
both genes to the other dtr genes and their location within the same operon, both are important 
potential candidates for possible relaxosome components in Neisseria. 
 
1.8 Relaxases 
The most important step in conjugative DNA transfer is the processing of a single stranded transfer 
DNA. This crucial process is catalyzed by a single protein belonging to the diverse class of relaxases, 
which introduces a nick on the dsDNA in the oriT region (nic site) and unwinds the cleaved dsDNA to 
produce a single stranded transfer DNA (105, 212, 232, 233). This essential protein is part of the dtr 
machinery of T4SSs and its gene is located in close proximity to other dtr genes encoding additional 
relaxosome components and the CP (105). 
The ubiquitous distribution and essential role of relaxases in conjugative DNA processing make these 
proteins an interesting target to develop a classification system for T4SSs. Based on sequence 
identities and biochemical data, Garcillán-Barcia et al. performed an extensive bioinformatical 
analysis and grouped the diverse class of relaxases into eight families (MOBQ, MOBP, MOBV, MOBF, 
MOBH, MOBC, MOBHEN and Tn916 like relaxases) (110, 234). Considering the catalytic tyrosine(s) within 
the active site of the relaxases, the eight families can be divided into three categories. Relaxases with 
one catalytic tyrosine belong to the MOBQ, MOBP, and MOBV families and can be clustered together 
into one major group (110). Relaxases with two catalytic tyrosines belong to the MOBF family and 
differ in their enzymatic mechanism from the other relaxase families (110). The third group of 
relaxase families is made of MOBH and MOBC relaxases. For both families no biochemical data is 
available and their catalytic mechanisms are still unknown (110). An overview on the general 
characteristics of the six largest relaxase families is summarized from Garcillán-Barcia et al. in 
Table 2. 
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Relaxases fulfill several functions simultaneously to enable the conjugative DNA processing and 
transfer in T4SSs (212). Therefore, these proteins usually consist of at least two different domains, 
which are an N-terminal relaxase domain responsible for the DNA cleavage, a helicase domain that 
unwinds in an ATP dependent reaction the cleaved DNA strand from the 5’ to the 3’ direction, and 
sometimes an additional C-terminal domain (e.g. DUF1528) for protein-protein interactions that 
contains also a signal sequence to trigger the nucleo-protein complex to the secretion pore (103, 
105, 212, 235). The composition of the distinct domains varies within different relaxases and strongly 
influences the mechanism of DNA processing. Biochemical data has revealed that the enzymatic 
activity of the helicase domain provides the required force that is necessary for a sufficient strand 
transfer (e.g. TraIF) (212). However, not all relaxases contain a helicase domain (e.g. TraIRP4) and use 
external replicative helicases to unwind the DNA (212). The relaxase domain is the only domain 
which is present in all relaxases and catalyzes the cleavage of the dsDNA at the nic site in the oriT 
region. The nicking reaction of relaxases is a site- and strand-specific transesterification reaction 
(212). The free energy released from the broken phosphoester-bond is restored in the covalent 
attachment of the 5’ end of the DNA to the relaxase via a phosphotyrosyl-linkage. The resulting 
nucleo-protein complex forms a stable long-term intermediate (209, 236-238). The 3’ end of the 
nicked transfer DNA strand remains bound to the relaxase during the unwinding process, keeping the 
superhelical topology of the DNA, but does not form a covalent bond with the protein (209, 236, 
238). This bond is released after terminating the unwinding of the DNA and the single stranded 
T-DNA is further transferred via the secretion complex. The nicking reaction is terminated by a 
second cleavage event at the nic site (212, 214). Depending on the presence of one or two catalytic 
tyrosines, different possibilities for the termination of the reaction are in discussion. Relaxases with 
one catalytic tyrosine need a second relaxase for the termination of the reaction since the active 
tyrosine is blocked by the covalent phosphotyrosyl-linkage (212, 214). Structural data from TraIF 
indicate a dimerization of the protein supporting the hypothesis of a second relaxase for the 
termination, even though it is not clear whether this dimer formation is an artificial event during 
crystallization or the active oligomeric state of the protein (232). Biochemical and structural data 
tend to suppose a crystallization effect and not a natural dimer formation of TraIF (232). 
Nevertheless, dimerization has been reported for several other relaxases and strengthens the model 
for a possible termination reaction by a second relaxase (239, 240). Besides the dimerization model 
for relaxases with one catalytic tyrosine, the possibility of altered termination mechanisms need to 
be considered, since relaxases without a covalent intermediate have been reported (e.g. MobCColDF13) 
(241). These relaxases could terminate the DNA processing reaction by a second cleavage event 
performed at the same active tyrosine catalyzing already the first nicking reaction, implicating that 
these relaxases do not obligatory need a second protein. Generally, relaxases with two conserved 
tyrosines do not necessarily need a second protein for the termination reaction, although it is still 
unknown for many of them whether both tyrosines have a catalytic activity (212).  
The reversible and isoenergetic nicking reaction of relaxases is enabled by three distinct sequence 
motifs, which are highly conserved in almost all relaxase families (110, 212). However, some relaxase 
families have altered sequence motifs. The influence of these changes on the DNA processing 
reaction still remains unknown. The first motif (Motif I) consists of one or two conserved tyrosines, 
with one of them acting with its hydroxyl-group as a nucleophil on the phosphate-backbone of the 
DNA (242). The catalytic tyrosine attacks the phosphate-backbone at a distinct scissile phosphate at 
the nic site and forms a covalent phosphodiester-bond with the cleaved transfer DNA strand 
(Y-O-P-O-X) (212). The remaining strand contains an OH-group at its 3’ end. The second motif 
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(Motif II) contains a conserved aspartate or glutamate and is thought to maintain the protein-DNA 
contact at the 3’ site of the nick at oriT and enhances the nucleophilic attack of the catalytic tyrosine 
(110, 242, 243). The third sequence motif (Motif III) contains several conserved histidines involved in 
the coordination of a divalent metal ion, which is in the main Mg2+ (110, 242, 243). The coordinated 
metal ion is in close proximity to the catalytic tyrosine and enables the nucleophilic attack of the 
hydroxyl-group of the tyrosine by pulling electrons from the oxygen and forcing the OH-group to act 
as a nucleophil (212, 232, 244). This highly conserved motif is altered within the MOBH family and 
seems to be a special characteristic for these relaxases (110). The altered histidine triad and 
conserved HD domains in MOBH relaxases suggest a different metal ion coordination mechanism of 
this relaxase family (110). How the metal ion is coordinated in MOBH relaxases and how this changed 
mechanism influences the cleavage mechanism remains unknown, since no biochemical data of this 
novel relaxase family is available. 
 
Table 2: General characteristics and properties of six main relaxase families summarized from Garcillán-Barcia et al. 
(110).  
Family Sub-
families 
Size Structure Conserved 
motifs 
Active 
tyrosine 
Special characteristics 
MOBF 2 
MOBF1+F2 
very 
huge 
TrwCR388 
TraIF 
I 
II 
III 
1 large/complex oriT 
region; clusters with 
IS91 relaxases 
MOBQ 3 
MOBQ1-Q3 
huge MobARSF1010 I 
II 
III 
1 clusters in part with 
MOBP and MOBHEN 
relaxases 
MOBP 7 
MOBP1-P7 
largest 
family 
- I 
II 
III 
1 well characterized; 
includes MOBHEN family; 
clusters with MOBQ 
MOBV 5 
MOBV1-V5 
small - I 
III 
no 
essential 
tyrosine 
identified 
only few biochemical 
data available; possibly 
new mechanism; 
ancestrally related to 
MOBP relaxases 
MOBC 3 
MOBC1-C3 
small - no I +III 
equivalents 
(alternative 
DEE motif 
for metal 
binding) 
sometimes 
substituted 
with Phe 
unrelated to other 
relaxases; no covalent 
bond with DNA; 
mechanism unknown; 
also present in GIs; very 
few biochemical data  
MOBH 3 
MOBH1-H3 
small - alternative 
3H motif; 
conserved 
HD 
domains 
rarely 
conserved 
tyrosin 
very new family; 
present in plasmids, 
ICEs and GIs; unrelated 
to other relaxases; no 
biochemical data; 
mechanism unknown 
 
To date, only little structural data of T4SS relaxases is available. The structures of the relaxase 
domains from TraIF, TrwCR388, and MobARSF1010 have been solved and shed light on the DNA binding 
and processing mechanism of these enzymes (227, 245, 246). In general all three structures share a 
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highly similar fold, even though the sequence identity between the different relaxases is relatively 
low (sequence identities: MobARSF1010 and TraIF → 12%; MobARSF1010 and TrwCR388 → 10%; TraIF and 
TrwCR388 → 42%) (232). The overall structure obtained from the relaxase domains of TraIF, TrwCR388 
and MobARSF1010 has a hand like shape, formed by a 5-stranded anti-parallel β-sheet flanked by 
α-helices (232, 245). The active site is located within a binding cleft, which is formed by the anti-
parallel β-sheet (232). The binding cleft contains three pockets with a diameter of 7-10 Å and a depth 
of 4-8 Å, which recognize certain bases with a “knob-into-hole”-like mechanism, enabeling the high 
sequence specificity of these enzymes (232). The size of the binding cleft is between 11-15 Å (232). 
The complete cleft is lined with neutral, nonaromatic residues resembling the ssDNA binding site 
(232, 245). The amino acid composition of the DNA binding site is a unique feature of relaxases and 
differs from other well-characterized ssDNA binding proteins (232). Only a few charged amino acids 
located in the binding cleft are sufficient to generate an electrostatic potential that positions with the 
help of a metal cofactor the scissile phosphate near the catalytic tyrosine (232). The metal binding 
site is located at the edge of the cleft in close proximity to the catalytic tyrosine (232). Relaxases are 
structurally and functionally related to virus replicases, rolling cycle transposases, replication initiator 
proteins and type IA topoisomerases (212, 247, 248).  
The relaxase TraI of the novel T4SS of N. gonorrhoeae represents the prototype of the 
uncharacterized relaxase family MOBH (110). Up to now, only little is known about the biochemical 
properties of TraI and its role in the DNA processing mechanism. TraI combines classical relaxase 
features with unique MOBH characteristics that could not be found in the other relaxase families 
(110, 202). Like other relaxases contains the neisserial TraI an N-terminal relaxase domain, but does 
not share commonly conserved sequence motifs, except two conserved tyrosines (Y93 and Y201) that 
have been reported to be important for DNA secretion (202). Instead of the classical metal binding 
site contains the neisserial TraI an altered histidine triad (H106 – H108) as well as additional conserved 
HD domains, which are typically found in metal dependent phosphohydrolases (e.g. involved in the 
DNA metabolism) (202, 249). The HD domains of phosphohydrolases are involved in the coordination 
of metal ions, similar to the conserved histidine motif of relaxases (249). Both sequence motifs 
suggest a different metal binding mechanism within MOBH relaxases. Mutagenesis studies and DNA 
secretion assays have shown that the conserved histidine triad of TraI does not have a significant 
influence on the level of DNA secretion (202). However, the mutation of the HD I domain (D120) led to 
significantly reduced secretion levels (202). The relaxase domain is N-terminally flanked by a 
hydrophobic amphipathic α-helix that most likely acts as a membrane anchor to facilitate a close 
contact of TraI with the cytoplasmic membrane in close proximity to the secretion complex (202). 
This hydrophobic N-terminus is an uncommon and special feature of TraI and could not be found in 
other relaxases, even though different relaxases have been reported to attach to the cytoplasmic 
membrane (214). At its C-termius TraI contains a conserved DUF1528 domain, which is most likely 
responsible for protein-protein interactions (202). The precise function of this domain still remains 
unknown. Besides commonly shared protein characteristics also the genetic organization of the 
neisserial dtr genes corresponds to the typical organization of dtr genes in T4SSs. The neisserial traI 
gene is encoded together with yaa, traD and yaf in the same operon (the first operon of the GGI) and 
is in close proximity to the predicted oriT region (between yaf and ltgX) (202). Furthermore, initial 
evidence for a possible secretion of TraI has been reported by Salgado-Pabòn et al., based on the 
detection of 5’ protected DNA in the external environment of the cells (202). It is not yet completely 
known, whether TraI is secreted to the outside of the cell or if the detected DNA results from 
external binding of TraI, which is transported via membrane blebs or delivered from autolysis.  
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1.9 Nicking accessory proteins  
As a part of the relaxosome, nicking accessory proteins (NAPs) play an important role in the DNA 
processing mechanism of T4SSs. They are mostly rather small proteins with an average length of 200 
amino acids (250). Genes encoding for NAPs are generally localized in close proximity to the relaxase 
and other dtr genes (219, 250, 251). In particular, NAPs fulfill several functions in the DNA processing 
mechanism comprising the transcriptional regulation of dtr genes (219, 252, 253), the spatial 
positioning of the relaxosome – DNA complex near the secretion channel (254-256), the recruitment 
of the relaxase (222, 254), and the enhancement of the endonucleic DNA processing activity of the 
relaxase (217-219). Considering the multi-tasking character of these proteins NAPs are of exceptional 
importance in regulating and specifying the DNA transfer within T4S. Well-studies examples of this 
protein group include e.g. NikAR64, TraJRP4, MobCRSF1010, PcfFpCF10, MbeCColE1, TraYF, TraMF, TrwAR388, 
VirC2AT and VirC1AT (215, 216, 218, 250, 254, 257-260).  
The DNA binding of NAPs is often related to distinct binding sites, but is usually sequence unspecific. 
However, it has been reported that NAPs bind specifically dsDNA near the oriT sequence, in close 
proximity to the nic site and the binding sites of the IHF (218, 223, 259-262). A common ribbon-helix-
helix domain structure (RHH) mediates the DNA binding and has been reported to be important for 
the recruitment of the relaxase (215, 250, 259, 260). The RHH binding fold of NAPs is structurally 
related to the phage p22 transcriptional regulators Arc and MetJ and to members of the CopG, Mnt 
and ParA family (215, 250, 263, 264). The sequence homology within different NAPs and RHH 
proteins is only poorly conserved with 15.4% similarity (265), which hampers the bioinformatical 
characterization and identification of these proteins. A conserved hydrophobic core in the RHH 
domain facilitates the DNA binding via polar amino acids localized in the β-sheet (260). Besides the 
conserved core of the RHH domain, only one conserved glycine can be identified connecting both 
α-helices (260).  
Currently, two structures of NAPs are available, which are the crystal structure of VirC2AT at 1.7 Å 
resolution and the NMR structure of NikAR64 (215, 260). Both resemble the RHH binding fold with two 
anti-parallel oriented β-sheets, which are characteristic for Arc/MetJ related RHH proteins. The anti-
parallel β-sheets coordinate a group of polar amino acids that facilitate the DNA binding (260). The 
α-helices are most likely involved in the oligomerization of the proteins. The domain organization of 
several NAPs was analyzed with limited proteolysis and confirmed the presence of two different 
domains (250, 259, 260). The N-terminal domain represents the DNA binding domain, whereas the 
C-terminal domain is involved in protein-protein interactions mediating the tetramerization of 
DNA-bound proteins, as shown for TrwAR388 and MbeCColE1 (250, 259). Actually, the C-terminal 
domain of VirC2AT is reported to be trypsin resistant, indicating the stable fold of this domain (260).  
A common model of the functional mechanism of NAPs in T4SSs is based on the structural similarity 
to the Arc/MetJ transcription regulators and biochemical data obtained from several NAPs. Most of 
the NAPs bind DNA as homodimers and oligomerize to tetrameric states in their active conformation, 
similar to the mechanisms of Arc and MetJ (215, 250, 260). In solution most NAPs dimerize, with 
reported exceptions like TraYF which stays monomeric or TrwAR388 forming stable tetramers (215, 
250, 258-260). In general, the dsDNA is bound by two dimeric NAPs at specific binding sites within 
the oriT region (218, 259, 260). The conserved polar residues in the anti-parallel β-sheets facilitate a 
positively charged surface on one site of the dimer, enabeling the DNA binding (260). The close 
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proximity of the C-termini of both homodimers leads to a tetramerization via protein-protein 
interactions (259). The conformational changes during the tetramerization result in a bending of the 
dsDNA and enable an optimized binding and processing of the large relaxase at the nic site (215). 
Interactions of the NAPs with their cognate relaxase ensure the proper recruitment of the relaxase 
and the formation of the relaxosome complex (210, 218).  
A well-studied example for the numerous protein-protein interactions of NAPs is the T4SS of 
A. tumefaciens. Biochemical data has shown that the spatial positioning protein VirC1AT binds to the 
“overdrive” sequence in the oriT region and interacts with VirC2AT forming a VirC1AT/VirC2AT complex, 
which interact with the VirD1AT/VirD2AT relaxase complex to recruit the relaxase to the nic site. The 
binding of VirC1AT to the “overdrive” sequence stimulates the DNA processing reaction and mediates 
the contact of the T-DNA with the VirB/D4AT secretion complex. The importance of the RHH domain 
for the DNA binding and the sequence specificity of the cleavage reaction has been studied in detail 
with DNA binding assays and mutagenesis studies for VirC2AT (102, 222, 260). Several other NAPs 
were studied with regard to their influence on the conjugative DNA transfer. The relaxosome of the 
E. coli F-plasmid is besides the Ti-plasmid of A. tumefaciens one of the best studied examples in 
conjugative DNA transfer. Both relaxosome complexes function in a similar mechanism. The 
F-plasmid relaxosome consists of several components necessary for a sufficient DNA processing, 
which are the relaxase TraIF, the IHFF, and TraYF (NAP), as well as the additional spatial positioning 
protein TraMF (210, 217, 218). TraMF exemplifies with its various protein interactions the importance 
of NAPs for the specificity of the DNA transfer reaction. The extensive interactions of TraMF with the 
coupling protein TraDF and the relaxase TraIF enable a highly specific DNA transfer during conjugation 
(256, 266). More detailed information on the interactions of TraMF with TraDF is given in Chapter 
1.10. It has been reported that TraMF enhances the relaxation activity of TraIF up to 5-fold in 
presence of the other relaxosome components TraIF, IHFF, and TraYF (218).  
The transcriptional regulation of dtr gene expression in T4SSs is a precisely controlled mechanism, 
which is important to allow a controlled conjugative DNA transfer. To ensure the sufficient 
processing and transfer of DNA during conjugation, the different relaxosome components need a 
distinct protein ratio for their proper interaction, which is often triggered by transcriptional 
regulation of the dtr operon, mediated by NAPs. For instance, TraYF binds to a sequence near its own 
promoter and up-regulates the transcription of TraYF (258). A down-regulation of the transcription of 
the complete dtr operon of the R388-plasmid encoded T4SS (trwABC) has been reported for TrwAR388 
(219). Both examples represent in part the versatile transcriptional regulation during DNA processing 
in T4SSs. 
The DNA processing mechanism of the remarkable T4SS of N. gonorrhoeae is up to now unknown 
and needs to be studied in detail. Information about the relaxase TraI and the coupling protein TraD 
are given in Chapter 1.8 and 1.10. However, no further components of a putative relaxosome of 
N. gonorrhoeae were identified up to now. Since only little is known about the DNA processing 
mechanism of the T4SS of N. gonorrhoeae, it is most likely that additional relaxosome components 
have not been detected yet. 
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1.10 Coupling proteins 
Coupling proteins (CPs) are essential for the function of T4SSs and are present in almost all known 
T4SSs, with one exception, the secretion system of the B. pertussis (230, 267, 268). CPs are of special 
importance in T4SSs since they mediate the interaction of the transferring substrate with the 
secretion complex (230). The sequence homology within different CPs is very low (15 – 20%) and only 
a few motifs are conserved (105). Based on conserved nucleotide binding domains and the number 
of transmembrane domains, up to six different classes of CPs can be distinguished (105). The main 
characteristics of these different classes are summarized in Table 3, according to the review of 
Alvarez-Martinez and Christie (105).  
A well studied paradigm of Gram-negative coupling proteins is TrwBR388. The crystal structure of the 
soluble C-terminus of TrwBR388 shed light on possible mechanisms for the substrate translocation 
within T4SSs and was an important milestone within the research of T4SSs. The structural 
organization of TrwBR388 revealed a strong similarity of TrwBR388 to F1F0-ATPases, to the 
Cag525/HP0525 traffic ATPase, and to the T7 gene 4 DNA ring helicase (269, 270). The cytoplasmic 
C-terminal part of TrwBR388 consist of two different domains, a nucleotide binding domain (NBD) and 
an all-α domain (AAD), whereas the N-terminal part contains the transmembrane domains (TM) and 
is integrated into the inner membrane (269, 270). The C-terminus of CPs is unstructured and contains 
the AAD, which shows similarity to the XerD recombinase and is involved in the binding of DNA 
substrates and protein-protein interactions (269, 270). The NBD is localized between the AAD and 
the TM domain and is structurally related to RecA and the T7 gene 4 ring helicase (269). The Walker 
A and B motifs for ATP binding and hydrolysis are the most conserved motifs within CPs and are both 
localized in the NBD (105). Mutations in the Walker motifs lead to conjugation deficient phenotypes 
and demonstrate the importance of ATP hydrolysis and the NBD for the proper function of CPs (271-
273). The TM domains are responsible for the integration of the CPs into the cytoplasmic membrane, 
similar to F1F0-ATPase (270, 274-276). The holoenzyme assembles as a homohexamer in presence of 
the relaxosome complex (277, 278). The assembled hexameric CP is located in close proximity to the 
secretion complex and is supposed to energize the translocation process by ATP hydrolysis (230, 272, 
273). The homohexameric structure of TrwB has an orange like shape with a diameter of 110 Å and a 
central channel in the middle with 20 Å in diameter. The central channel is constricted to 7-8 Å, 
which is supposed to prevent a leakage of the cytoplasmic membrane and could most likely be 
opened and closed by conformational changes e.g. during ATP hydrolysis. The height of the 
hexameric complex is 90 Å (270).  
The interaction of CPs with processed DNA substrates and proteins of the relaxosome complex could 
be shown in vitro for several CPs. In most cases the initial substrate interaction with the CP starts via 
a protein-protein interaction at the C-terminus of the CP and only in a few exceptions the CP 
interacts directly with the processed DNA. Protein-protein interactions with CPs have been shown for 
different relaxases and nicking accessory proteins. For instance, VirD4AT needs for the binding of 
ssDNA the enzymatic activity of the relaxase VirD2AT (137). The interaction of CPs with their cognate 
relaxases could be also shown for Gram-positive T4SSs, exemplified with the interactions of PcfCpCF10 
and the relaxase PcfGpCF10 and Orf10pIP501 and TraA (254, 279). Intensive interactions of the hexameric 
CP with nicking accessory proteins of the relaxosome are often the key for the highly specific 
substrate transfer in T4SSs. This has been shown for TraDF, which interacts extensively with the 
nicking accessory protein TraMF (220, 256, 266). Interestingly, it has been shown that CPs can 
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substitute each other within different T4SSs, but the interchangeability seems to be restricted to the 
different classes of CPs (105). It has been reported that TraGRP4 can substitute TrwBR388, and TraGpTic58 
can be exchanged with VirD4AT (268, 280). The compatibility of CPs from different T4SSs among each 
other indicates the possibility of different ancestral origins of the dtr proteins and the mpf proteins, 
which is in accordance to bioinformatical data discussed in the context of integrative and conjugative 
elements in Chapter 1.5. 
 
Table 3: Overview on the classification of CPs summarized from Alvarez-Martinez and Christie, 2009 (105). 
Class Characteristics Examples 
VirD4 like CPs well characterized class of CPs 
at least 2 TM-domains 
structure of TrwBR388 available 
huge sequence heterogeneity  
large proteins with 600 – 750 AS 
VirD4AT; TrwBR388 (2 TM-domains) 
YdcQICEBs1; Orf14pSKU146 (2 TM-domains) 
HP0524Hyp; TraGpSymA (4 TM-domains) 
TraGB9 (4 TM-domains) 
TraDF; TraGRIc  
(2 TM-domains; C-terminal extension) 
TraDNG  
(no TM-domain; C-terminal extension) 
FtsK/SpoIIIE like CPs variability in length 
differ in TM-domain number 
function independent from 
other T4SS components 
TraGpKLC102; Orf16pAB559 (3 TM-domains) 
TraBpSGs (1 TM-domain) 
TcpApCW3  
(2 TM-domains; C-terminal extension) 
TraGR27 + TraJ like CPs short TM-domains 
need additional TraJ  
(with 4 TM-domains) 
TraGR27; TraGR478; p081pWWO 
CPs without TM-domain + 
small membrane protein 
no TM-domains 
linked with small predicted 
membrane protein  
(2TM-domains) 
TraGBC; Orf10pIP501; pPSR1p49pPSR1 
CPs without TM-domain - BACCAP01795Bca; 
CLOL250_01204Clo 
Archaeal CPs archaeal specific sequences 
no TM-domains 
TraGpKEF9; Orf1023pAH1 
 
Currently, three different models for the DNA translocation mechanism mediated by CPs have been 
proposed. One model postulates the CP functioning as a connector between the secretion complex 
and the relaxosome-DNA complex. The recognition of the secretion substrate and the secretion 
complex on both sites of the CP does not require ATP hydrolysis, but it is assumed that 
conformational changes due to ATP hydrolysis could act as a molecular switch in the CP to trigger the 
secretion process (230). Both of the other discussed models require for their postulated 
translocation mechanisms rotational force generated by ATP hydrolysis and are due to the ATPase 
activity of CPs commonly the more preferred models. One model proposes the CP acting as a DNA 
pumping motor with the processed ssDNA wrapped around the cytosolic part of the protein. The 
binding of ssDNA and dsDNA is enabled by a positively charged belt at the external surface of the CP. 
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The hydrolysis of ATP leads to the rotation of the CP and triggers the bound relaxosome complex to 
the secretion pore (230). Since only very few biochemical data supports this model it is one of the 
less preferred mechanisms. The up to now most preferred model for the DNA translocation via CPs is 
similar to the mechanism of SpoIIIE and FtsK. In this model the processed ssDNA substrates pass 
through the central channel of the CP, which is acting like a DNA pump. The inner surface of the 
channel is negatively charged, which would at first instance hinder the translocation of negatively 
charged DNA, but similar to the external surface of the CPs a positively charged belt enables the 
translocation of the DNA. ATP hydrolysis will force the pumping of the DNA and it is supposed that 
conformational changes in CPs trigger the opening and closing of the central channel (230).  
The CP TraD of N. gonorrhoeae is essential for the DNA secretion (198), but so far no biochemical 
data of this protein is available. Interestingly, TraD is classified to the VirD4 like CPs (105), but seems 
to lack the TM domains typically found within this class, and is in one operon with the small 
membrane protein Yaa that contains at least four predicted TM domains. This clustering may result 
from the classification based on the conserved Walker A and B motifs, but considering the predicted 
TM domain topology and the genetically close proximity to yaa it is more likely that the neisserial 
TraD clusters into the class of TraGR27 like CPs or the class of TM domain-less CPs associated with 
small predicted membrane proteins. A phylogenetic analysis of different CPs performed by 
E. Pachulec, a former PhD student of our group, revealed that the neisserial TraD clusters not as 
expected to TraDF, but seems to be closer related to TraGR27, TraDR391 and TraDSXT (PhD thesis 
E. Pachulec, 2010). This strengthens the hypothesis that TraD belongs to the class of TraGR27 like CPs 
and the function of Yaa is may be similar to that of TraJ. However, the biochemical characterization 
of TraD is of oustanding importance to shed light on the DNA translocation mechanism of the novel 
T4SS of N. gonorrhoeae, which is in the focus of this study.  
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2. Objectives of the study 
The current study focuses on the understanding of the DNA secretion mechanism of the remarkable 
T4SS of N. gonorrhoeae, which is the only known T4SS that secretes DNA directly into the 
environment, without a previous cell-cell contact. This novel T4SS encodes an mpf complex which is 
highly similar to the T4SS of the E. coli F-plasmid, but the dtr genes seem to be relatated to another 
system since phylogenetic studies with related T4SSs revealed a different clustering of the neisserial 
and the E. coli dtr genes.  
The key enzyme for the DNA processing in T4SSs is the relaxase, which introduces a nick into the 
dsDNA and unwinds the DNA to generate a single stranded transfer DNA. The neisserial relaxase TraI 
represents a prototype of the novel relaxase family MOBH and up to now, no biochemical data of this 
relaxase family is available. Since TraI contains several sequence motifs (e.g. a hydrophobic 
N-terminus, conserved HD domains, an altered histidine motif, and a conserved C-terminal DUF1528 
domain) that could not be found in other relaxases, it is assumed that TraI (representative for MOBH 
relaxases) has most likely a different enzymatic mechanism. To shed light on the unknown DNA 
processing mechanism of MOBH relaxases and to understand the mechanism of DNA transfer within 
the novel T4SS of N. gonorrhoeae, it is of outstanding importance to characterize the biochemical 
properties of the key enzyme TraI, which is in the major focus of the current study.  
In T4SSs, the contact of the processed transfer DNA with the secretion complex is mediated via a 
coupling protein (TraD), which is an integral inner membrane ATPase localized in close proximity to 
the secretion channel. The mechanism of how coupling proteins transfer the ssDNA to the secretion 
channel is still under discussion. To elucidate the DNA transfer mechanism of the remarkable T4SS of 
N. gonorrhoeae, it is necessary to understand the enzymatic activity and functional properties of the 
neisserial coupling protein TraD. Therefore, the biochemical characterization of TraD is besides the 
characterization of the relaxase TraI another aspect of the current study.  
The DNA cleavage reaction of the relaxase is often initiated through the presence of additional 
nicking accessory proteins that form together with the relaxase and the DNA the “relaxosome” 
complex. Up to now, no additional relaxosome components have been identified in the T4SS of 
N. gonorrhoeae. However, the possibility of the formation of a relaxosome in N. gonorrhoeae cannot 
be absolutely excluded. One subject within the current study is the identification of a possible nicking 
accessory protein within the T4SS of N. gonorrhoeae that is involved in the DNA processing 
mechanism and possibly in the formation of a neisserial relaxosome. In addition to the relaxase gene 
the dtr operon contains two hypothetical genes (yaa and yaf) encoding for proteins with up to now 
unknown function. Considering bioinformatical evidences, Yaf seems to be a promising candidate for 
a nicking accessory protein, and the functional and biochemical characterization of this hypothetical 
protein in context with a possible relaxosome formation in N. gonorrhoeae is within the focus of the 
current study.  
The current study should provide information about the enzymatic function of three up to now 
uncharacterized key proteins in the DNA processing mechanism of N. gonorrhoeae, and should 
improve the understanding of the novel DNA secretion mechanism of the neisserial T4SS.  
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3. Material and Methods 
3.1 Material 
3.1.1 Chemicals and enzymes 
All chemicals were purchased from Carl Roth, Sigma-Aldrich, Merck, Jena Bioscience and Hartmann 
Analytics. Enzymes were purchased from New England Biolabs, Roche or Fermentas.  
 
3.1.2 Media 
LB medium 
LB media (Luria/Miller) and LB agar (Luria/Miller) were purchased from Roth. The composition of LB 
medium and LB agar is given in Table 4 and 5. The media were autoclaved for 20 min at 120°C.  
 
Table 4: Components for liquid LB medium 
Concentration Component 
10 g/L Tryptone 
5 g/L Yeast extract 
10 g/L NaCl 
 
Table 5: Components for LB agar medium 
Concentration Component 
10 g/L Tryptone 
5 g/L Yeast extract 
10 g/L NaCl 
15 g/L Agar-Agar 
 
 
SOC medium 
SOC medium was used for the initial growth of transformed E. coli cells. The composition for SOC 
medium is given in Table 6. All components except glucose were mixed and autoclaved. A 50% (w/v) 
glucose solution was autoclaved separately and was added to the medium to its final concentration 
afterwards. 
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Table 6: Components for SOC medium 
Concentration Component 
2% (w/v) Tryptone 
0.5% (w/v) Yeast extract 
8.6 mM NaCl 
10 mM MgCl2 
10 mM MgSO4 
2.5 mM KCl 
 filled up to 1 L and autoclaved 
0.36% (v/v) Glucose 
 
Autoinduction medium 
The method of autoinduction was used for the overproduction of full-length TraD and N-terminal 
truncated TraD. The composition of the medium was in accordance to Studier et al. (281). The sugar 
and salt solutions, as well as the basic media components, were autoclaved separately from each 
other. The trace element solution was filtered with a 0.22 µm sterile syringe filter. The components 
were mixed under sterile conditions shortly before the inoculation with E.coli cells. 
 
3.1.3 Buffer and solution list 
 
Isolation of TraD 
Denaturing buffer  Purification buffer 
50 mM HEPES/NaOH pH 7.5 50 mM HEPES/NaOH pH 7.5 
6 M Guanidine/HCl 6 M Guanidine/HCl 
  1% (v/v) TritonX-100 
   
   
Isolation of MBP-TraI fusionprotein   
His-tag MBP-TraI A  His-tag MBP-TraI B 
30 mM Tris/HCl pH 8.0  30 mM Tris/HCl pH 8 
150 mM NaCl  150 mM NaCl 
5 mM Imidazole  400 mM Imidazole 
5% (v/v) Glycerol  5% (v/v) Glycerol 
 
Gelfiltration MBP-TraI   
30 mM Tris/HCl pH 8.0   
150 mM NaCl   
5% (v/v) Glycerol   
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Isolation of native TraI without detergent   
Q Sepharose TraI A  Q sepharose TraI B 
50 mM Tris/HCl pH 7.6  50 mM Tris/HCl pH 7.6 
   1 M NaCl 
 
Phenyl-Sepharose TraI A  Phenyl-Sepharose TraI B 
50 mM Tris/HCl pH 7.6  50 mM Tris/HCl pH 7.6 
40 mM (NH4)2SO4  2 M (NH4)2SO4 
 
Buffer gelfiltration native TraI Phen   
50 mM Tris/HCl pH 7.6    
150 mM NaCl    
 
 
Isolation of native TraI with detergent 
Ion exchange TraI detergent A  Ion exchange TraI detergent B 
50 mM Tris/HCl pH 7.6  50 mM Tris/HCl pH 7.6 
25 mM NaCl  1 M NaCl 
10 % (v/v) Glycerol  10 % (v/v) Glycerol 
0.05% (v/v) DDM  0.05% (v/v) DDM 
 
Gelfiltration TraI detergent   
50 mM Tris/HCl pH 7.6    
150 mM NaCl    
10% (v/v) Glycerol    
0.05% (v/v) DDM    
 
 
Isolation of His-tagged yaf 
His-tag Yaf A  His-tag Yaf B 
50 mM HEPES/NaOH pH 7.0  50 mM HEPES/NaOH pH 7.0 
500 mM NaCl  500 mM NaCl 
10 mM Imidazole  400 mM Imidazole 
10% (v/v) Glycerol   10% (v/v) Glycerol  
 
Gelfiltration Yaf (His-tag)    
50 mM HEPES/NaOH pH 7.0    
250 mM NaCl    
10% (v/v) Glycerol     
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Isolation of native Yaf 
Ion exchange Yaf A  Ion exchange Yaf B 
50 mM HEPES/NaOH pH 7.0  50 mM HEPES/NaOH pH 7.0 
50 mM NaCl  1 M NaCl 
10% (v/v) Glycerol  10% (v/v) Glycerol 
 
Gelfiltration native Yaf    
50 mM HEPES/NaOH pH 7.0    
150 mM NaCl    
10% (v/v) Glycerol    
 
 
Electrophoresis buffer 
10x TB buffer  10x TGS buffer 
108 g/L Tris base  30.3 g/L Tris base 
55 g/L Boric acid  144 g/L Glycine 
 adjust to pH 8.0 with HCl  10 g/L SDS 
 
Stacking buffer (SDS-PAGE)  Separation buffer (SDS-PAGE) 
0.5 M Tris base  1.5 M Tris base 
0.4% (w/v) SDS  0.4% (w/v) SDS 
 adjust to pH 6.8   adjust to pH 8.8 
 
Cathode buffer A (BN)  Cathode buffer B (BN) 
50 mM Tricine  50 mM Tricine 
7.5 mM Imidazole  7.5 mM Imidazole 
0.02% (w/v) SERVA Blue G  0.002% (w/v) SERVA Blue G 
 
Anode buffer (BN)  BN Gelbuffer 3x 
25 mM Imidazole/HCl  75 mM Imidazole/HCl pH 7.0 
 adjust to pH 7.0  1.5 M 6-aminocaproic acid 
 
5x SDS-PAGE loading dye  Coomassie staining solution 
10% (w/v) SDS  0.1% (w/v) Coomassie R 
50% (v/v) Glycerol  0.1% (w/v) CuSO4 
0.04%(w/v) Bromophenol blue  25% (v/v) Ethanol 
500 mM DTT  20% (v/v) Acetic acid 
300 mM Tris/HCl pH 6.8    
 
Destaining solution    
0.5% (w/v) CuSO4    
7% (v/v) Acetic acid    
12% (v/v) 2-Propanol    
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DNA processing assays 
6x DNA loading dye  5x Colorless loading dye 
50% (w/v) Sucrose  150 mM Tris/HCl pH 7.5 
0.1% (w/v) Bromophenol blue  60% (v/v) Glycerol 
 
2x Stop solution  5x Native loading dye 
80% (v/v) Formamide  150 mM Tris/HCl pH 7.5 
1% (v/v) SDS  60% (v/v) Glycerol 
40 mM Na2EDTA * 2 H2O  0.1% (w/v) Bromophenol blue 
 
10x TE buffer   
100 mM Tris base    
10 mM Na2EDTA * 2 H2O    
 adjust to pH 8.0 with HCl    
 
3.2 Strains, oligonucleotides and plasmids 
3.2.1 Strains 
 
Table 7: Strains used for cloning and protein overexpression 
Strain Genotype Reference Source 
E. coli DH5α fhuA2 Δ(argF-lacZ)U169 phoA glnV44 Φ80 
Δ(lacZ) M15 gyrA96 recA1 relA1 endA1 thi-1 
hsdR17  
(282) Invitrogen 
E. coli BL21 (DE3) F- ompT hsdSB(rB
- mB
-) gal dcm (DE3) (283) 
 
NEB 
E. coli Tuner (DE3)  F– ompT hsdSB (rB
– mB
–) gal dcm lacY1(DE3) (284) 
 
Novagen 
E. coli C43 (DE3) 
pRARE 
F– ompT gal dcm hsdSB(rB
- mB
-)(DE3) pRARE 
(CamR)  
(285) Lucigen 
E. coli Arctic 
Express (DE3) 
E. coli B F– ompT hsdS (rB–mB–) dcm+ Tetr gal 
λ(DE3) endA Hte [cpn10 cpn60 Gentr] 
(286) 
(287) 
Stratagene 
E. coli LEMO21 
(DE3) 
fhuA2 [lon] ompT gal (λ DE3) [dcm] ∆hsdS/ 
pLemo((CamR)(pACYC184-PrhaBAD-lysY)) 
(288) NEB 
E. coli BL21 (DE3) 
Star 
F- ompT hsdSB (rB
-, mB
-) gal dcm rne131 (DE3) (289) 
(290) 
Invitrogen 
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3.2.2 Oligonucleotides 
 
Table 8: Oligonucleotides used for cloning and mutagenesis. Oligonucleotides are shown from 5’ to 3’. 
Name Sequence Description 
native traI F ACTAGTAAAAATCGGCATCATGAAAACAAGCCTTCTCAC 
 
SpeI site; start 
native traI R TCAGGGAAGCGGCCGCTCATTTTTGTTCCATTACTAATAAG 
 
NotI site; end 
eXact-tag traI F GCGCGGACTAGTATGAAAACAAGCCTTCTCAC 
 
SpeI site; start 
native yaf F GGCCGCGCATATGAATGAAACAGATCTTCCCAAGCTTCTTAGTG 
 
NdeI site; start  
native yaf R GCGGCGCTCGAGTCATGATGATTTAAGCAAAGATTTTAG 
 
XhoI site; end 
traI Y93F F GCCCTTCCCTTTTTGGAAAAATTCATAGCC 
 
Y93F mutation 
traI Y93F R CAAAGGCTATGAATTTTTCCAAAAAGG 
 
Y93F mutation 
MBP-His-tag XhoI CGCATCTCGAGTGGTCCTTGTTGGTGAAGTG  
 
N-term. His-tag; XhoI site 
MBP-TEV XbaI GCGGCTCTAGATCCTTGGAAGTACAGGTTCTCGGATCCGAATTCCGGTACC
TTG 
C-term. TEV site; XbaI site 
Vector XhoI CGCGGCTCGAGATGCTATGGTCCTTGTTGGTGAAGTG 
 
Vectoramplification; XhoI site 
Vector XbaI CGGAATTCGGATCCTCTAGAGTC 
 
Vectoramplification; XbaI site 
XhoI removal F GGACCATAGCATATGCACCACCATCATCACCATC 
 
Removes XhoI site 
XhoI removal R GATGGTGGTGCATATGCTATGGTCCTTGTTGGTGAAGTG 
 
Removes XhoI site 
His-tag yaf F GACGCGCATATGCACCATCACCACCATCATCACCATCACCACAATGAAACA
GATCTTCCCAAGCTTCTTAGTG 
NdeI site; start 
MBP-TEV-TraI F CGCAGTCTAGAATGAAAACAAGCCTTCTCAC 
 
XbaI site; start 
MBP-TEV-TraI R GCGATCCTGCAGGTCATTTTTGTTCCATTACTAATAAG 
 
SbfI site; end 
yaf Y47F F CGTCATCATTTCCAGAAAACCGCTAGCACGCTGTATCC 
 
Y47F mutation 
yaf Y47F R GCGTGCTAGCGGTTTTCTGGAAATGATGACGCTGGATGAC 
 
Y47F mutation 
yaf Y100F/Y104F F CTTCAAGTGAATTCCAGGCTTCAGAACCGGCTTGGGCCATTAG 
 
Y100F/Y104F mut 
yaf Y100F/Y104F R ATCTTATTTCTAATGGCCCAAGCCGGTTCTGAAGCCTGGAATTCAC 
 
Y100F/Y104F mut 
yaf D89A F TTTGCAGAAGCACTTGCCGCTGACTTTGAAATC 
 
D89A mutation 
yaf D89A R GATTTCAAAGTCAGCGGCAAGTGCTTCTGCAAAAGTCG 
 
D89A mutation 
yaf D90A F GCAGAAGCACTTGCCGATGCCTTTGAAATCTTATTTCTAATGG 
 
D90A mutation 
yaf D90A R GATTTCAAAGGCATCGGCAAGTGCTTCTGC 
 
D90A mutation 
yaf E57A F GGTTGCCGTATTAGCATCGTCATCCAGCGTC 
 
E57A mutation 
yaf E57A R CTGGATGACGATGCTAATACGGCAACCTTC 
 
E57A mutation 
yaf F91A F GATTTCAGCGTCATCGGCAAGTGCTTCTG 
 
F91A mutation 
yaf F91A R CTTGCCGATGACGCTGAAATCTTATTTCTAATGG 
 
F91A mutation 
yaf F115A F GTCTAATACAAGCTTCCTCAAAGCTTTCTTCAAG 
 
F115A mutation 
yaf F115A R GAGGAAGCTTGTATTAGACATACTACGCTACC 
 
F115A mutation 
yaf S107A F GCTTTCTTCAAGAGCATTCCAGTATTCAGAACCG 
 
S107A mutation 
yaf S107A R GAATACTGGAATGCTCTTGAAGAAAGCTTTGAGG S107A mutation 
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Table 9: Oligonucleotides used for enzymatic activity assays 
Name Sequence Description 
GGI oriT 75bp F AATGCTGCCCCTTTTAATAGGCAAAGGCCTGCATTTTTACATGCAGGCCTTTGTTTT
ACCTTTAACTTTTACCCT 
 
ssDNA 75 bp long; 
contain GGI oriT 
GGI oriT 75bp R AGGGTAAAAGTTAAAGGTAAAACAAAGGCCTGCATGTAAAAATGCAGGCCTTTGC
CTATTAAAAGGGGCAGCATT 
 
ssDNA 75 bp long; 
contain GGI oriT 
GGI oriT 120bp F CAGAATAAGATTTATAAGGTATAATGCTGCCCCTTTTAATAGGCAAAGGCCTGCAT
TTTTACATGCAGGCCTTTGTTTTACCTTTAACTTTTACCCTTTTTCCCTTGAACCCTTC
CTTTA 
ssDNA 120 bp 
long; GGI oriT 
GGI oriT 120bp R TAAAGGAAGGGTTCAAGGGAAAAAGGGTAAAAGTTAAAGGTAAAACAAAGGCCT
GCATGTAAAAATGCAGGCCTTTGCCTATTAAAAGGGGCAGCATTATACCTTA 
TAAATCTTATTCTG 
ssDNA 120 bp 
long; GGI oriT 
F oriT 76bp F GTTCTCACCACCAAAAGCACCACACCCCACGCAAAAACAAGTTTTTGCTGATTTTTC
TTTATAAATAGAGTGTTAT 
 
ssDNA 76 bp long; 
contain F oriT 
F oriT 76bp R ATAACACTCTATTTATAAAGAAAAATCAGCAAAAACTTGTTTTTGCGTGGGGTGTG
GTGCTTTTGGTGGTGAGAAC 
 
ssDNA 76 bp long; 
contain F oriT 
F oriT 120bp F CTCAACAGGTTGGTGGTTCTCACCACCAAAAGCACCACACCCCACGCAAAAACAAG
TTTTTGCTGATTTTTCTTTATAAATAGAGTGTTATGAAAAATTAGTTTCTCTTACTCT
CTTTAT 
ssDNA 120 bp 
long; F oriT 
F oriT 120bp R ATAAAGAGAGTAAGAGAAACTAATTTTTCATAACACTCTATTTATAAAGAAAAATC
AGCAAAAACTTGTTTTTGCGTGGGGTGTGGTGCTTTTGGTGGTGAGAACCACCAAC
CTGTTGAG 
ssDNA 120 bp 
long; F oriT 
GGI oriT F GAAGCTTGGGAAGATCTG 
 
 
used for GGI oriT 
PCR product 
GGI oriT R GGGTAAAGGCTCTTATCC 
 
 
used for GGI oriT 
PCR product (short) 
GGI oriT ltgX R ATGGCCCTTAATCTCATGTC 
 
 
used for GGI oriT 
PCR product (long) 
914 ACCGGCTACACGTACAACTG 
 
 
used for dif-site  
PCR product 
yaa-sequence GAGTGCAGGCATTTATCACC 
 
 
used for dif-site  
PCR product 
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3.2.3 Plasmids 
 
Table 10: Plasmids used for protein overproduction and enzymatic activity assays 
Plasmid Vector Gene Res. Source Oligonucleotide Method 
pMW001 pET15b TraD  
(C-teminal His-tag) 
Amp M. Wiezes  
(AG Does) 
  
pMW002 pET15b TraD  
(N-terminal His-tag) 
Amp M. Wiezes  
(AG Does) 
  
pMW003 pET15b TraD  
(∆ TM; C-term. His-tag) 
Amp M. Wiezes  
(AG Does) 
  
pMW004 pET15b TraD  
(∆ TM; N-term. His-tag) 
Amp M. Wiezes  
(AG Does) 
  
pEP073 pCDFDuet 390 bp oriT of  
F-plasmid 
Strep E. Pachulec  
(AG Does) 
  
pEP074 pCDFDuet 468 bp oriT of GGI 
 
Strep E. Pachulec  
(AG Does) 
  
-pJK001 pPAL7 traI (native) 
 
Amp E.-M. Heller  
J. Koch 
native traI F: 
native traI R 
cloning with 
ligation 
pJK002 pPAL7 traI  
(N-terminal eXact-tag) 
Amp E.-M. Heller 
J. Koch 
eXact-tag traI F;  
native traI R 
cloning with 
ligation 
pKS008 pET20b(+) yaf (native) 
 
Amp E.-M. Heller 
K. Siewering 
native yaf F; 
native yaf R 
cloning with 
ligation 
pSJ007 pKH184 traI  
(N-terminal His-tag) 
Kan S. Jain  
(AG Does) 
  
pSJ011 pKH184 traI  
(C-terminal His-tag) 
Kan S. Jain  
(AG Does) 
  
pSJ017 IBA-101 traI  
(C-terminal Strep-tag) 
Amp S. Jain  
(AG Does) 
  
pSJ018 IBA-102 traI  
(N-terminal Strep-tag) 
Amp S. Jain  
(AG Does) 
  
pSJ024 pTE088 traI  
(N-term. MBP fusion) 
Amp S. Jain  
(AG Does) 
  
pEMH004 pJK001 traI (native);  
Y93F mutant 
Amp E.-M. Heller traI Y93F R; 
traI Y93F F 
mutagenesis 
pEMH007 pMALc2E introduced TEV  
cleavage site 
Amp E.-M. Heller MBP-His-tag XhoI; MBP-TEV 
XbaI; Vector XhoI; Vector 
XbaI; XhoI rem. F; XhoI rem. R 
cloning with 
ligation and 
mutagenesis 
pEMH008 pET20b(+) yaf  
(N-terminal His-tag) 
Amp E.-M. Heller His-tag yaf F; 
native yaf R 
cloning with 
ligation 
pEMH010 pEMH007 traI (N- term. His-
MBP-TEV fusion) 
Amp E.-M. Heller  MBP-TEV-TraI F; 
MBP-TEV-TraI R 
cloning with 
ligation 
pEMH017 pEMH010 traI (N-MBP fusion);  
Y93F mutant 
Amp E.-M. Heller traI Y93F R: 
traI Y93F F 
mutagenesis 
pEMH021 pEMH008 yaf (N-His-tag);  
Y47F mutant 
Amp E.-M. Heller yaf Y47F R; 
yaf Y47F F 
mutagenesis 
pEMH022 pEMH008 yaf (N-His-tag);  
Y100F/Y104F mut. 
Amp E.-M. Heller yaf Y100F/Y104F F; 
yaf Y100F/Y104F R 
mutagenesis 
pEMH023 pEMH008 yaf (N-His-tag);  
D89A mutant 
Amp E.-M. Heller yaf D89A F; 
yaf D89A R 
mutagenesis 
pEMH024 pEMH008 yaf (N-His-tag);  
D90A mutant 
Amp E.-M. Heller yaf D90A F; 
yaf D90A R 
mutagenesis 
pEMH025 pEMH008 yaf (N-His-tag);  
D89A/D90A mut. 
Amp E.-M. Heller yaf D89A F; yaf D89A R 
yaf D90A F; yaf D90A R 
double 
mutagenesis 
pEMH038 pEMH008 yaf (N-His-tag);  
E57A mutant 
Amp E.-M. Heller yaf E57A F; 
yaf E57A R 
mutagenesis 
pEMH041 pEMH008 yaf (N-His-tag);  
F91A mutant 
Amp E.-M. Heller yaf F91A F; 
yaf F91A R 
mutagenesis 
pEMH043 pEMH008 yaf (N-His-tag);  
F115A mutant 
Amp E.-M. Heller yaf F115A F; 
yaf F115A R 
mutagenesis 
pEMH045 pEMH008 yaf (N-His-tag);  
S107A mutant 
Amp E.-M. Heller yaf S107A F; 
yaf S107A R 
mutagenesis 
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3.3 Cloning and mutagenesis 
3.3.1 PCR for cloning 
The genes of interest were fused 5’ and 3’ with recognition sites for the corresponding restriction 
enzymes and were amplified with PCR. The restriction enzyme recognition sites were introduced 
with the corresponding primer pair and are given in Table 8. The PCRs were performed with Phusion 
polymerase (Finnzymes) as described in Table 11 and 12. In case of the amplification of neisserial 
genes N. gonorrhoeae MS11 chromosomal DNA was used as template DNA. The annealing 
temperature varied corresponding to the used primer pairs and was calculated for each PCR with the 
Clone Manager Professional 9.0 (Sci-ed Software). The elongation time of the product was changed 
corresponding the length of the gene of interst and was calculated with 30 sec/kb. The PCR products 
were purified with the PCR clean up kit (Zymo) as described in the manual and were analyzed on 
agarose gels. The concentration of the PCR product was measured with the Nanodrop.  
 
Table 11: PCR reaction-mix for cloning 
Volume Components 
10 µl 10x HF-buffer (or GC-buffer) 
1 µl dNTP-mix (10 µM) 
0.25 µl Oligonucleotide 1 (0.5 µM) 
0.25 µl Oligonucleotide 2 (0.5 µM) 
0.75 µl Template DNA (< 250 ng) 
37.5 µl deionized autocalved H2O 
0.25 µl Phusion 
 
Table 12: PCR program for cloning 
Temperature Time Cycles 
98°C 2 min 1x 
98°C 10 sec  
35x X°C 30 sec 
72°C 30 sec/kb 
72°C 10 min 1x 
4°C ∞ - 
 
3.3.2 Restriction digests for cloning 
The purified PCR products were mixed with the corresponding restriction enzymes and were digested 
as recommended by the manufacturer. In most cases the reaction mix was incubated in a double 
digest reaction for 1 h at 37°C. The restriction enzymes were inactivated as recommended by the 
manufacturer and the digested DNA was purified with the Clean & Concentrator kit (Zymo) as 
described in the manual. The DNA concentration was measured with Nanodrop.  
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Table 13: Reaction-mix for restriction digests 
Volume Component 
25 µl Purified PCR product 
5 µl 10x reaction buffer (NEB1-4) 
0.5 µl Restriction enzyme 1 and 2 
0.5 µl 100x BSA (optional) 
18.5 µl deionized autoclaved H2O 
 
3.3.3 Ligation of DNA fragments 
The vectors were digested as described above and were additionally incubated with alkaline 
phosphatase as recommended by the manufacturer, to avoid religation of the original vector. The 
amounts of insert and vector were calculated as following: 
Insert mass (ng) = 6* ((Insert length (bp) / Vector length (bp)) * Vector mass (ng)) 
The ligation reaction was prepared as described in Table 14 and was incubated for 1 h at 22°C. 15 µl 
of the reaction were transformed into chemical competent E. coli DH5α cells. The transformed cells 
were plated on LB plates with the corresponding antibiotic and single colonies were picked and used 
for the isolation of the generated construct.  
 
Table 14: Reaction-mix for ligation reaction 
Volume Component 
X µl Insert gene 
X µl Vector 
4 µl 5x rapid ligation buffer 
1 µl T4 ligase 
X µl deionized autoclaved H2O 
 total reaction volume: 20 µl  
 
3.3.4 Transformation of E. coli 
Unless otherwise noted, chemical competent E. coli cells were transformed as described following. 
200 µl of frozen competent cells were thawed on ice and 0.25 µl of plasmid DNA was added. The cells 
were incubated together with the DNA for 5 min on ice prior a 45 sec heat-shock at 42°C. Afterwards 
the cells were incubated on ice for 10 min before the addition of 800 µl LB medium. Subsequently 
the cells were incubated in a shaking incubator for 1 h at 37°C and were either plated on antibiotic 
containing LB plates or were directly inoculated with 50 ml LB medium with antibiotic in case of 
pre-cultures for the overproduction of the protein. 
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3.3.5 Amplification and isolation of plasmids 
Plasmids were transformed into chemical competent E. coli DH5α cells as described in Chapter 3.3.4. 
A 50 ml over night culture with the corresponding antibiotic was incubated in a shaking incubator at 
37°C. 3-5 ml of the overnight culture was centrifuged (Eppendorf Fresco Table centrifuge; 3.500 rmp; 
4°C; 4 min) and the pellet was used for plasmid isolation. Plasmids were isolated with the Classic 
Miniprep Kit (Zymo) as described in the manual. The DNA concentration was determined with 
Nanodrop (Peqlab) and the plasmids were stored at -20°C until further use. 
Plasmids used in DNA relaxtion assays described in Chapter 3.8.6 were isolated with the Midiprep-Kit 
(Quiagen) as described in the manual. DNA coiling was analyzed with agarose gel electrophoresis as 
described in Chapter 3.7.2. The concentration of the isolated plasmids was determined with 
Nanodrop (Peqlab) and the plasmids were stored at 4°C. 
The cloned and mutagenized constructs were analyzed for theire correct sequence by sequencing the 
distinct gene of interest. The sequencing reaction was performed by the company “Eurofins MWG 
Operon”. The data was analyzed with Clone Manager Professional 9.0 (Sci-ed Software). 
 
3.3.6 Site-directed mutagenesis 
Site-directed mutagenesis was performed to generate point mutations in accordance with the 
protocol of the QuickChange site-directed mutagenesis kit from Stratagene. A list of used 
oligonucleotides is given in Chapter 3.2.2. The PCR-program and the reaction-mix are given in Table 
15 and 16. Yaf mutants were generated using plasmid pEMH008 (WT-Yaf with N-terminal 10x His-
tag) as template, whereas TraI mutants were generated using pEMH010 (MBP-TraI fusion) and 
pJK001 (native TraI) as templates. The PCR products were digested with DpnI for at least for 4 h at 
37°C. The reaction mix for the DpnI digest is given in Table 17. The digested PCR product was purified 
with the DNA Clean & Concentrator Kit 25 (Zymo) following the manufacturer’s protocol. 5-10 µl of 
the purified PCR products were transformed as described in Chapter 3.3.4 into chemical competent 
E. coli DH5α cells. Single colonies were picked from plates and plasmids were amplified as described 
in Chapter 3.3.5. 
 
Table 15: PCR reaction-mix for site-directed mutagenesis 
Volume Component 
10 µl 5x KapaHIFI GC buffer high fidelity 
1 µl Oligonucleotide fwrd (1:10 dilution) 
1 µl Oligonucleotide rev (1:10 dilution) 
1 µl dNTPs 
0.5 µl Template DNA 
0.25 µl KapaHIFI-polymerase 
36.25 µl H2O 
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Table 16: PCR program used for site-directed mutagenesis 
Temperature Time Cycles 
95°C 5 min 1x 
98°C 20 sec  
34x 54°C 15 sec 
72°C 30 sec/kb  
72°C 10 min 1x 
4°C ∞ 1x 
 
 
Table 17: Reaction-mix for DpnI digest 
Volume Component 
50 µl PCR product 
40 µl H2O 
10 µl 10x NEB4 buffer 
2 µl DpnI enzyme 
 
3.4 Isolation of TraD 
3.4.1 Overproduction of TraD 
Overproduction in LB medium 
Plasmids were transformed as described in Chapter 3.3.4. The transformed cells were inoculated in 
liquid LB medium with the corresponding antibiotic. The pre-cultures were incubated at 37°C over 
night in a shaking incubator. 2 L LB medium was inoculated 1:100 with the overnight pre-cultures in 
5 L Erlenmeyer flasks. The main-cultures were incubated at 37°C in a shaking incubator at 140 rpm. 
The growth was monitored by measuring the optical density of the cultures at 600 nm (OD600). At an 
OD600 of 0.6-0.8 the cells were induced with 0.5 mM IPTG and further incubated for 2.5 h with 
140 rpm. The cells were harvested by centrifugation (4,500 rpm; 20 min; 4°C; Sorvall F10S rotor; 
Sorvall RC6+ centrifuge) and the cell-pellets were washed with 10 mM Tris/HCl pH 8.0. After a second 
centrifugation (same as first centrifugation) the cell-pellets were frozen in liquid nitrogen and stored 
at -80°C until further use. 
 
Overproduction in autoinduction medium 
The transformation and the pre-culture were performed as described in Chapter 3.3.4 and in the 
previous passage. The overnight pre-culture was inoculated with fresh LB medium with antibiotics 
and was incubated in a shaking incubator at 30°C or 37°C for 10 h. The main-cultures (1 or 2 L 
autoinduction medium in 5 L Erlenmeyer flaks) were inoculated 1:100 with the second pre-culture 
and were incubated while shaking (140 rpm) at 30°C or 37°C for different time periods between 4 h 
and 16 h. The OD600 was measured at different time points to monitor the growth of the cultures. 
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The cells were harvested by centrifugation (6,000 rpm; 4°C; 20 min; Sorvall F10S rotor; Sorvall RC6+ 
centrifuge) and the pellets were washed with 10 mM Tris/HCl pH 8.0. The cells were frozen as pellets 
in liquid nitrogen and were stored at -80°C. 
 
Overproduction with Rifampicin 
The transformation and the overnight pre-culture were performed as described previously. The 2 L 
main-culture (LB medium with the corresponding antibiotic) was inoculated 1:100 with the pre-
culture in a 5 L Erlenmeyer flask and was incubated in a shaking incubator at 30°C. At an OD600 of 0.6 
the cells were induced with 0.5 mM IPTG and were incubated for 30 min at 30°C before Rifampicin 
(200 µg/ml) was added. Since Rifampicin was solved in DMSO the final concentration of DMSO in the 
culture was 0.5% (v/v). The cultures were further incubated for 1.5 h at 30°C. The cells were 
harvested with centrifugation (6,000 rpm; 4°C; 20 min; Sorvall F10S rotor; Sorvall RC6+ centrifuge) 
and the pellets were washed with 50 mM Tris/HCl pH 8.0 and 150 mM NaCl. After a second 
centrifugation the cells were frozen as pellets and were stored at -80°C.  
 
3.4.2 Isolation of TraD from inclusion bodies 
Cell breakage 
Frozen cell pellets were resuspended in 10 mM Tris/HCl pH 8.0 (10 ml buffer/ 1 g cells) and 1 mg 
DNAseI was added together with 1 mM PMSF. The cells were broken with the cell disruptor 
(Constant Systems) with a pressure of 2.4 kBar. The breakage was repeated twice. The broken cells 
were centrifuged for 20 min at 4°C (6,000 rpm; Sorvall F10S rotor; Sorvall RC6+ centrifuge). The 
supernatants were analyzed by 11% SDS-PAGEs and the pellets were used for the further isolation of 
TraD from inclusion bodies. 
 
Isolation of inclusion bodies 
Pellets from the broken cells were resuspended in 10 mM Tris/HCl pH 8 and were centrifuged again 
(6,000 rpm; Sorvall F10S rotor; Sorvall RC6+ centrifuge). The wash steps of the inclusion body pellets 
were repeated three times. Finally the pellets were resuspended in 3 ml of ‘Denaturing buffer’. To 
completely solve the resuspended inclusion bodies the samples were incubated at 37°C for 8 min and 
vortexed vigourosly. The samples were again incubated for 5 min at 37°C and were vortexed shortly. 
The denatured protein solutions were centrifuged for 30 min at 4°C (85,000 rpm; Beckman&Coulter 
TLA 110 rotor; Beckman&Coulter Optima Max-XP Ultracentrifuge). The isolated inclusion bodies were 
analyzed by 11% SDS-PAGEs and were further purified. 
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Purification of denatured TraD  
Denatured TraD protein was purified with Ni-affinity chromatography via gravity flow. Ni-NTA-
agarose from Sigma-Aldrich was used as column material and was activated as described in the 
manual. The column was equilibrated with 5 CV of ‘Purification buffer’. The purification was 
performed at room temperature. The denatured TraD was bound to the column and the purification 
was performed with the protocol given in Table 18. The different fractions were analyzed with 11% 
SDS-PAGEs. The samples were precipitated with TCA before loading onto the gel. 
 
Table 18: Buffer conditions used for the purification of denatured TraD 
Buffer CImidazole CV Step 
Purification buffer 5 mM 2 wash 
Purification buffer 10 mM 2 wash 
Purification buffer 20 mM 2 wash 
Purification buffer 30 mM 2 wash 
Purification buffer 40 mM 2 wash 
Purification buffer 50 mM 2 wash 
Purification buffer 60 mM 2 wash 
Purification buffer 70 mM 2 wash 
Purification buffer 80 mM 2 wash 
Purification buffer 90 mM 2 wash 
Purification buffer 100 mM 2 wash 
Purification buffer 200 mM ½ elution 
Purification buffer 400 mM 1 ½  elution 
 
3.4.3 Refolding of denatured TraD 
A screen for refolding conditions of TraD was performed with purified denatured protein. The 
conditions which were tested are summarized in Table 19. The protein was mixed in different buffers 
in a 1:20 ratio. The samples were vigourosly vortexed for a few seconds after mixing and were 
incubated for at least 1 h or over night at 4°C. After incubation the samples were centrifuged 
(15 min; 4°C; 13,300 rpm; Heraeus Fresco 17 centrifuge). The supernatant was removed carefully and 
the pellet was resuspended in 40 µl 1x SDS-PAGE loading dye. 250 µl of the supernatant were 
precipitated with 10% (v/v) TCA (final concentration) and resuspended in 10 µl 2x SDS-PAGE loading 
dye. After neutralization the precipitated samples of the supernatant and 10 µl of the corresponding 
pellet suspension were analyzed by 11% SDS-PAGEs. The samples were incubated at 99°C for 5 min 
before loading on the gel.  
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Table 19: Condition screening for the refolding of purified denatured TraD  
Buffer 
 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 
Tris  
pH 8.5 
- 50 
mM 
50 
mM 
50 
mM 
50 
mM 
50 
mM 
50 
mM 
50 
mM 
50 
mM 
- 50 
mM 
50 
mM 
50 
mM 
50 
mM 
50 
mM 
50 
mM 
50 
mM 
MES 
pH 6.0 
50 
mM 
- - - - - - - - 50 
mM 
- - - - - - - 
NaCl 
 
240 
mM 
240 
mM 
9.6 
mM 
9.6  
mM 
9.6 
mM 
9.6 
mM 
9.6 
mM 
9.6 
mM 
240 
mM 
9.6 
mM 
9.6 
mM 
9.6 
mM 
9.6 
mM 
9.6 
mM 
9.6 
mM 
9.6 
mM 
9.6 
mM 
KCl 
 
10 
mM 
10 
mM 
0.4 
mM 
0.4  
mM 
0.4 
mM 
0.4 
mM 
0.4 
mM 
10 
mM 
0.4 
mM 
0.4 
mM 
0.4 
mM 
0.4 
mM 
0.4 
mM 
0.4 
mM 
0.4 
mM 
0.4 
mM 
0.4 
mM 
MgCl2 
 
2 
mM 
2 
mM 
- - - - - - - - - - - - - - - 
CaCl2 
 
- 2 
mM 
- - - - - - - - - - - - - - - 
Arginine 
 
0.5 
M 
0.5 
M 
- - - - - - - - - - - - - - - 
EDTA 
 
- - 1 
mM 
- - - - - - - - - - - - - - 
Glutathione 
reduced 
1 
mM 
1 
mM 
- - - - - - - - - - - - - - - 
Glutathione 
oxidized 
0.1 
mM 
0.1 
mM 
- - - - - - - - - - - - - - - 
DTT 
 
- - 1 
mM 
1 
mM 
1 
mM 
1 
mM 
1 
mM 
1  
mM 
1 
mM 
1 
mM 
1 
mM 
1 
mM 
1 
mM 
1 
mM 
1 
mM 
1 
mM 
1 
mM 
TritonX-100 
 
0.5 
% 
0.5 
% 
0.5 
% 
0.5 
% 
- - 0.1 
% 
0.5 
% 
0.5 
% 
0.5 
% 
- - - - - - - 
DDM 
 
- - - - 0.1 
% 
- - - - - - - - - - - - 
Zwittergent 
3-14 
- - - - - - - - - - 0.1 
% 
- - - - - - 
DM 
 
- - - - - - - - - - - 0.1 
% 
- - - - - 
UDM 
 
- - - - - - - - - - - - 0.1 
% 
- - - - 
Chaps 
 
- - - - - - - - - - - - - 0.7 
% 
- - - 
ASB-14 
 
- - - - - - - - - - - - - - 0.5 
% 
- - 
LDAO 
 
- - - - - - - - - - - - - - - 0.1 
% 
- 
Sodium-
deoxycholate 
- - - - - - - - - - - - - - - - 0.3 
% 
 
3.4.4 Separation of inner and outer cell membranes from E. coli  
Total cell membrans were isolated from broken cells by ultracentrifugation. Therefore, the broken 
cells were first centrifuged with low spin to remove unbroken cells and inclusion bodies (6,000 rpm; 
Sorvall F10S rotor; Sorvall RC6+ centrifuge; 15 min; 4°C) followed by a high spin centrifugation step 
(1 h; 4°C; 40,000 rpm; Sorvall T647.5 rotor; Beckman&Coulter Optima L-90K Ultracentrifuge). The 
isolated total membrane pellets were resuspended in 25 mM Tris/HCl pH 8.0 (0.3 ml/OD600 1/LCulture) 
and 0.3 ml resuspended membranes were loaded on a sucrose gradient with 55%, 51%, 45% and 36% 
steps. The samples and the sucrose solutions were always handled on ice. The sucrose was solved in 
25 mM Tris/HCl pH 8.0. The volume of the 55%, 51% and 45% steps was 0.9 ml, whereas the volume 
of the 36% step was only 0.5 ml. The gradient was centrifuged for 30 min at 4°C (100,000 rpm; 
Beckman&Coulter TLA 110 rotor; Optima Max-XP Ultracentrifuge). The separated inner and outer 
membranes were collected and diluted 3-fold with 25 mM Tris/HCl pH 8.0. The diluted membranes 
were centrifuged for 45 min at 4°C (40,000 rpm; Sorvall T647.5 rotor; Beckman&Coulter Optima L90K 
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Ultracentrifuge). The pellet was resuspended in 25 mM Tris/HCL pH 8.0 with 10% (v/v) glycerol. The 
samples were analyzed by 11% SDS-PAGEs and were frozen in liquid nitrogen and stored at -80°C. 
 
3.4.5 Solubilization screen of TraD with isolated cell membranes from E. coli 
The resuspended membranes were diluted 1:50 with the corresponding buffer and were rotated for 
1 h at 4°C. The solubilized samples were afterwards centrifuged for 25 min at 4°C (80,000 rpm; 
Beckmann&Coulter TLA120.1 rotor; Optima Max-XP Ultracentrifuge). The supernatants were 
carefully removed and the pellets were resuspended in 25 mM Tris/HCl pH 8.0. The supernatant and 
the pellet fractions were analyzed by 11% SDS-PAGEs. The tested solubilization conditions are 
summarized in Table 20 and 21. 
 
Table 20: Buffer condition screening for the solubilization of TraD  
Buffer 1 Buffer 2 Buffer 3 Buffer 4 
50 mM Tris/HCl pH8 50 mM Tris/HCl pH8 50 mM Tris/HCl pH8 50 mM Tris/HCl pH8 
10% (v/v) Glycerol 10% (v/v) Glycerol 10% (v/v) Glycerol 10% (v/v) Glycerol 
150 mM NaCl 150 mM NaCl 150 mM NaCl 150 mM NaCl 
1 mM DTT 1 mM DTT 1 mM DTT 1 mM DTT 
 + 1x Complete EDTA free + 1 mM EDTA + 1 mM PMSF 
+ detergent 
 
Table 21: Detergent screening used in combination with the buffer condition screening for the solubilization and the 
membrane detachment of TraD  
Concentration Detergent/Additives  Concentration Detergent/Additives 
1% (v/v) DM 1% (v/v) Aminosulfobetain-14 
1% (v/v) UDM 1% (v/v) Chaps 
1% (v/v) DDM 2% (v/v) Sodium-laurylsarcosine 
1% (v/v) LDAO   
1% (v/v) Triton X-100 100 mM Na2CO3 
1% (v/v) Zwittergent 3-14 1 M NaCl 
1% (v/v) Sodium-deoxycholate   
 
3.5 Isolation of TraI 
The overproduction and isolation of TraI was done with support of J. Koch (technical staff).  
3.5.1 Overproduction of MBP-TraI fusionprotein 
Plasmid pEMH010 was transformed into E. coli BL21 Star cells as described in Chapter 3.3.4. 
Ampicillin was used at a final concentration of 100 µg/ml and 0.5% glucose was added to the liquid 
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cultures. The transformed cells were plated on LB-Ampicillin-plates and incubated overnight at 37°C. 
A 50 ml pre-culture was inoculated from colonies from plates and incubated in a shaking incubator at 
37°C over night.  
2 L LB-medium containing Ampicillin and glucose were inoculated with 20 ml pre-culture in 5 L 
Erlenmeyer flasks and were incubated in a shaking incubator (140 rpm) at 37°C. The growth was 
monitored by measuring the OD600. At OD600 = 0.5 the overexpression was induced with the addition 
of IPTG to a final concentration of 0.1 mM. After induction the cells were grown for 3 h before 
harvesting. Alternatively a similar protocol was used, but the cells were grown at 30°C till an OD600 of 
0.6, and then overexpression was induced by the addition of IPTG to a final concentration of 0.1 mM 
IPTG. After induction the cells were further shaking incubated overnigth at 18°C.  
The cells were harvested by centrifugation (6,000 rpm; 4°C; 10 min; Sorvall RC6+ centrifuge; Sorvall 
F10S rotor), the cell-pellets were resuspended in 50 mM Tris/HCl pH 7.5 and centrifuged again 
(4.200 rpm; 15 min; 4°C; Heraeus Multifuge 1 s-R). The pellets were frozen in liquid nitrogen and 
stored at -80°C until further use. 
 
3.5.2 Overproduction of native TraI 
Plasmid pJK001 was transformed into E. coli BL21 Star cells as described in Chapter 3.3.4. The 
transformed cells were directly inoculated in 50 ml pre-cultures (LB-medium) with 100 µg/ml 
Ampicillin and 0.5% glucose. The pre-cultures were incubated in a shaking incubator over night at 
30°C. 2 L main-cultures (LB-medium + ampicillin + glucose) were inoculated with 20 ml of the over 
night pre-cultures and were incubated in a shaking incubater at 30°C. At an OD600 of 0.6 the cells 
were induced with 0.5 mM IPTG and further incubated for 2.5 h at 30°C. The cells were harvested by 
centrifugation (6,000 rpm; 4°C; 10 min; Sorvall RC6+ centrifuge; Sorvall F10S rotor), the cell-pellets 
were resuspended in 50 mM Tris/HCl pH 7.5 and centrifuged (4.200 rpm; 15 min; 4°C; Heraeus 
Multifuge 1 s-R). The cell-pellets were frozen in liquid nitrogen and stored at -80°C. 
 
3.5.3 Isolation of MBP-TraI  
Cell breakage 
Frozen cell-pellets were resuspended in ‘His-tag MBP-TraI A’ buffer (5 ml buffer/1 g cell-pellet) and 
protease inhibitor (Complete EDTA free; Roche) was added to a concentration recommended by the 
manufacturer. All steps were performed on ice. The resuspended cells were disrupted with a French 
Press Cell (SLM Instruments) with a pressure of 1,100 PSI. The breakage was repeated at least 3 times 
until the suspension changed slightly in color and started to clarify. The broken cells were centrifuged 
for 5 min at 4°C (8,000 rpm; Sorvall F10S rotor; Sorvall RC6+ centrifuge). The supernatant was 
centrifuged again (30 min; 4°C; 40,000 rpm; Sorvall T647.5 rotor; Beckman&Coulter Optima L-90K 
Ultracentrifuge). The cytosol was used for the further isolation of MBP-TraI. 
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Ni-affinity chromatography 
The purification of the MBP-TraI fusionprotein was performed using a 5 ml HiTrap Chelating HP 
column (GE Healthcare) on an ÄKTA purifier system. The column was loaded with NiSO4 as described 
in the manual. The column was equilibrated with 5 CV ‘His-tag MBP-TraI A’ buffer before the cytosol 
was loaded at a flowrate of 0.5-1 ml/min. The flowthrough was collected separately. The purification 
program is given in Table 22. Eluting proteins were detected at 280 nm. The protein containing 
elution fractions were analyzed by 11% SDS-PAGEs and used for further purification. 
 
Table 22: Protocol for the isolation of MBP-TraI fusionprotein with Ni-affinity chromatography  
Step Volume  Flowrate  Program Buffer 
loading - 1-2 ml/min external sample pump isolated cytosol 
 
elution 70 ml 4 ml/min gradientInc 100% B; 
fractionation (4 ml/tube) 
His-tag MBP-TraI A; 
His-tag MBP-TraI B 
 maximum pressure: 0.3 MPa 
 
 
Size exclusion chromatography 
The MBP-TraI containing samples were further purified with a SD200 16/60 HiLoad gelfiltration 
column (GE Healthcare). The column was equilibrated with 1-2 CV filtered and degased ‘Gelfiltration 
MBP-TraI’ buffer before the samples were injected. The samples were centrifuged (13,300 rpm; 
15 min; 4°C; Heraeus Fresco 17 centrifuge) prior the injection and were either injected 
unconcentrated or after concentration with Amicon filtration-units (70,000 Da cut-off; Millipore) as 
described in the manual. The column was loaded with 2 ml sample-volume and was run at a flowrate 
of 1 ml/min. Fractions with a volume of 2 ml were collected after an elution volume of 40 ml. Eluting 
proteins were detected at 280 nm. The protein containing fractions were analyzed by 11% SDS-
PAGEs. For storage the proteins were mixed with glycerol to a final concentration of 10% (v/v) before 
freezing in liquid nitrogen and were stored at -80°C. 
 
TEV cleavage 
The MBP-TraI fusionprotein containing fractions from the size exclusion chromatography were 
incubated with TEV protease to yield native non-fused TraI. MBP-TraI was mixed with TEV protease in 
gelfiltration buffer with ratios of 100:1, 50:1, 10:1, and 5:1. The samples were incubated at 4°C, at 
room temperature and at 30°C for 16 h. The same experiment was performed in the presence of 
0.5 mM EDTA and 1 mM DTT. The digested samples were analyzed by 11% SDS-PAGEs. Samples 
incubated at 4°C and at room temperature were pooled together and were tried in a further 
purification with Ni-affinity chromatography as described previously. The elution fractions from the 
purification were analyzed by 11% SDS-PAGEs. The cleavage protocol is adopted with changes from 
Waugh et al.(291). 
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3.5.4 Isolation of native TraI without detergents 
Cell breakage 
Frozen cell-pellets were resuspended in 50 mM Tris/HCl pH 7.6 (5 ml buffer/ 1 g cells) and protease 
inhibitor (Complete EDTA free; Roche) was added together with a small spatula tip of DNAseI 
(Roche). The cells were broken with a pre-cooled (4°C) cell disruptor (Constant Systems; IUL) at a 
pressure of 2.4 kbar. The breakage was repeated 3 times until the suspension turned clearer. The 
cells were always handled on ice. The broken cells were centrifuged for 20 min at 8,000 rpm at 4°C 
(Sorvall RC6+ centrifuge; Sorvall F10S rotor). A second centrifugation was performed with the 
supernatant for 1 h with 40,000 rpm at 4°C (Beckman&Coulter Optima L-90K Ultracentrifuge; 
Sorvall T647.5 rotor). The isolated cytosol was used for the purification of native TraI. 
 
Anion exchange chromatography 
The anion exchange chromatography was performed with a self-made 75 ml Q-Sepharose HP column 
(GE Healthcare) used on an ÄKTA purifier system. The column was equilibrated with 3-4 CV of 50 mM 
Tris/HCl pH 7.6. The sample was loaded at a flowrate of 2-4 ml/min and the flowthrough was 
collected separately. The purification-program is given in Table 23. The second buffer used within the 
protocol contains 50 mM Tris/HCl pH 7.6 and 1 M NaCl. Eluting proteins were detected with UV light 
at a wavelength of 280 nm. Protein containing fractions were analyzed by 11% SDS-PAGEs and TraI 
containing fractions were used for further purification. 
 
Table 23: Protocol for the isolation of native TraI with anion exchange chromatography 
Step Volume Flowrate Program Buffer 
loading - 2-4 ml/min external pump isolated cytosol 
 
wash 40 ml 4 ml/min 0% B 50 mM Tris/HCl pH 7.0 
 
elution 360 ml 4 ml/min gradientInc 100 B; 
fractionation (8 ml/tube) 
50 mM Tris/HCl pH 7.0; 
50 mM Tris/HCl pH 7.6 + 1 M NaCl 
 maximum pressure: 0.3 MPa 
 
Hydrophobic interaction chromatography  
The further purification of the TraI containing samples from the previous performed anion exchange 
chromatography was done with a self-made 16 ml Phenyl-Sepharose column (GE Healthcare) used on 
an ÄKTA purifier system. The column was equilibrated with 5 CV of ‘Phenyl-Sepharose TraI A’ buffer. 
The samples were adjusted to a final (NH4)2SO4 concentration of 40 mM and were loaded at a 
flowrate of 1-2 ml/min. The flowthrough was collected separately. The purification-program is given 
in Table 24. Protein containing elution fractions were precipitated with TCA and analyzed by 11% 
SDS-PAGEs.  
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Table 24: Protocol for the isolation of native TraI with hydrophobic interaction chromatography 
Step Volume Flowrate Program Buffer 
loading - 1-2 ml/min external pump elution fraction from anion 
exchange chromatography 
wash 16 ml 4 ml/min 40% B Phenyl-Sepharose TraI A; 
Phenyl-Sepharose TraI B 
elution 160 ml 4 ml/min gradientDec 40% B; 
fractionation (4 ml/tube) 
Phenyl-Sepharose TraI A; 
Phenyl-Sepharose TraI B 
 maximum pressure: 0.5 MPa 
 
Hydroxyapatite chromatography 
TraI containing elution fractions from the hydrophobic interaction chromatography were adjusted to 
30 mM potassium-phosphate buffer pH 7.6 before they were further purified with hydroxyapatite 
chromatography, which was performed with an 18 ml self-made column (Type I ceramic 
Hydroxyapatite 20 µm; Biorad) with an ÄKTA purifier system. The column was equilibrated with 5 CV 
of 30 mM potassium-phosphate-buffer pH 7.6. The samples were loaded at a flowrate of 1-2 ml/min 
and the flowthrough was collected separately. The protocol of the program is given in Table 25. 
Protein containing elution fractions were TCA precipitated and analyzed by 11% SDS-PAGEs. The TraI 
containing samples were further purified by size exclusion chromatography. 
 
Table 25: Protocol for the isolation of native TraI with hydroxyapatite chromatography 
Step Volume Flowrate Program Buffer 
loading - 1-2 ml/min external pump elution fractions from 
hydrophobic interaction chrom. 
elution 1 20 ml 4 ml/min 5% B; 
fractionation (4 ml/tube) 
30 mM KPi buffer pH 7.6; 
500 mM KPi buffer pH 7.6 
elution 2 90 ml 4 ml/min gradientInc 20% B 30 mM KPi buffer pH 7.6; 
500 mM KPi buffer pH 7.6 
elution 3 30 ml 4 ml/min gradientInc 100% B 500 mM KPi buffer pH 7.6 
 maximum pressure: 0.4 MPa 
 
Size exclusion chromatography 
Size exclusion chromatography was performed by loading the samples on an SD 200 16/60 HiLoad 
gelfiltration column (GE Healthcare) on an ÄKTA purifier system as described in Chapter 3.5.3. The 
column was equilibrated with 2 CV of 50 mM Tris/HCl pH 7.6 and 150 mM NaCl. TraI containing 
elution fractions from the hydrophobic interaction chromatography were pooled together and 
concentrated with Amicons (70,000 Da cut-off; Millipore) as described in the manual. The samples 
were centrifuged (13,300 rpm; 15 min; 4°C; Heraeus Fresco 17 centrifuge) before injection to the 
column. Protein containing samples were analyzed by 11% SDS-PAGEs. For storage the proteins were 
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mixed with glycerol to a final concentration of 10% (v/v) and frozen in liquid nitrogen. The samples 
were stored at -80°C. 
 
3.5.6 Isolation of native TraI with detergents 
Cell breakage 
Frozen E. coli Bl21 Star cells with overproduced native TraI were resuspended in 5 ml ‘Ion exchange 
TraI detergent A’ buffer without DDM per 1 g cell-pellet. Protease inhibitor (Complete EDTA free; 
Roche) was added to the concentration recommended by the manufacturer. The resuspended cells 
were broken with a French Press Cell (SLM Instruments) as described in Chapter 3.5.3. The broken 
cells were centrifuged for 1 h at 4°C (15,000 rpm; Sorvall SS34 rotor; Sorvall RC6+ centrifuge). The 
supernatant was mixed with DDM to a final concentration of 1% (v/v) and solubilized for 2 h on ice 
before a second centrifugation was performed (40,000 rpm; 4°C; 45 min; Sorvall T647.5 rotor; 
Beckman&Coulter Optima L-90K Ultracentrifuge). The supernatant was used for further isolation of 
native TraI. 
 
Anion exchange chromatography 
A 5 ml HiTrapQ HP column (GE Healthcare) was equilibrated with 5 CV of ‘Ion exchange TraI 
detergent A’ buffer before the supernatant was loaded at a flowrate of 1 ml/min. The flowthrough 
was collected separately. The protocol of the purification program is given in Table 26. The protein 
containing elution samples and the flowthrough were analyzed by 11% SDS-PAGEs. The flowthrough 
was used for further purification steps since TraI could not be detected in the elution fractions and 
remains completely in the flowthrough.  
 
Table 26: Protocol for the isolation of native TraI in the presence of detergent with anion exchange chromatography  
Step Volume Flowrate Program Buffer 
loading - 1-2 ml/min external pump isolated cytosol 
elution 1 16 ml 4 ml/min 0%B;  
fraction (4ml/tube) 
ion exchange TraI detergent A 
elution 2 100 ml 4 ml/min increasing gradient  
till 100%B 
ion exchange TraI detergent A; 
ion exchange TraI detergent B 
 maximum pressure: 0.3 MPa 
 
1. Cation exchange chromatography 
The TraI containing flowthrough from the anion exchange chromatography was further purified with 
a cation exchange chromatography with a 5 ml HiTrapSP HP column (GE Healthcare). The column was 
equilibrated with 5 CV of ‘Ion exchange TraI detergent A’ buffer before the flowthrough was loaded 
at a flowrate of 1-2 ml/min. The protocol of the program is equal to the anion exchange 
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chromatography and is given in Table 26. The protein containing samples were analyzed by 11% SDS-
PAGEs. 
 
2. Cation exchange chromatography 
The protein containing fractions from the first cation exchange chromatography were pooled 
together and diluted 3 times with ‘Ion exchange TraI detergent A’ buffer, before the samples were 
loaded on the equilibrated column. The protocol for the program is similar to the program of the 
anion exchange chromatography given in Table 26 with the exception that the first elution gradient is 
performed in a volume of 4 ml and the second elution step is performed in a volume of 16 ml, to 
elute a higher concentrated protein. The elution fractions were analyzed by 11% SDS-PAGEs and TraI 
containing samples were further concentrated (2x) with Amicons (70,000 Da cut-off; Millipore) as 
described in the manual.  
 
Size exclusion chromatography 
The size exclusion chromatography was performed as described in Chapter 3.5.3. The SD200 16/60 
HiLoad column (GE Healthcare) was equilibrated with 2 CV ‘Gelfiltration TraI detergent’ buffer. The 
sample was centrifuged before the injection to remove possible aggregates. The protein containing 
elution fractions were analyzed by 11% SDS-PAGEs. The TraI samples were frozen in liquid nitrogen 
and stored at -80°C.  
 
3.6 Isolation of Yaf 
3.6.1 Over-production of His-tagged Yaf and native Yaf 
Plasmids encoding the respective yaf gene were transformed into E. coli BL21 Star cells as described 
in Chapter 3.3.4. The transformed cells were inoculated in 50 ml pre-cultures (LB-medium; 100 µg/ml 
Ampicillin; 0.5% glucose) and incubated over night in a shaking incubator (200 rpm/37°C). 2 L 
LB medium (100 µg/ml Ampicillin; 0.5% glucose) were inoculated in 5 L Erlenmeyer flasks with 20 ml 
of the over night pre-cultures and incubated in a shaking incubator (140 rpm) at 37°C. The growth of 
the cells was monitored by measuring the OD600. At an OD600 = 0.5-0.8 the overexpression of yaf was 
induced by adding IPTG to a final concentration of 0.5 mM. After induction the cells were further 
incubated for 2.5 h (37°C; 140 rpm). The cells were harvested by centrifugation (15 min; 6,000 rpm; 
4°C; Sorvall RC6+ centrifuge; F10S rotor) and were resuspended in 50 mM Tris/HCl pH 7.5. The 
resuspended cells were centrifuged again (15 min; 4,200 rpm; 4°C; Heraeus Multiguge 1 s-R) and the 
cell-pellets were frozen in liquid nitrogen and stored at -80°C. 
 
3.6.2 Overproduction of His-tagged Yaf mutants 
The overproduction of Yaf mutants was performed as described in Chapter 3.6.1 with changed 
growth-temperatures and different induction time points. The pre-cultures were grown at 37°C, 
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whereas the main-cultures were grown at 30°C until an OD600 of 0.5-0.8. The cells were induced at 
OD600 = 0.5-0.8 with 0.1 mM IPTG and were shaking (140 rpm) incubated at 18°C over night. Cell-
harvesting and storage was performed as described previously. 
 
3.6.3 Overproduction of Yaf with incorporated selenomethionine 
The overproduction of N-terminal His-tagged Yaf with incorporated selenomethionine was 
performed in E. coli B834(DE3) cells transformed with the plasmid pEMH008, as described in 
Chapter 3.3.4. The cells were grown in M9 minimal medium in the presence of L-selenomethionine 
(50 µg/Lculture). The cells were incubated in a shaking incubator at 37°C. The growth was monitored by 
measuring the optical density (OD600). At an OD600 of 0.5 the cells were induced with 0.5 mM IPTG 
and were further incubated for 3 h at 37°C. The cells were harvested with centrifugation (15 min; 
4°C; Sorvall RC6+ centrifuge; Sorvall F10S rotor) and resuspended in 50 mM Tris/HCL pH 7.0. The cells 
were centrifuged again (same as first centrifugation) and the cell-pellets were frozen in liquid 
nitrogen and stored at -80°C.  
 
3.6.4 Isolation of His-tagged Yaf  
Cell breakage 
Frozen E. coli BL21 Star cells with overproduced His-tagged Yaf were resuspended in 10 ml ‘His-tag 
Yaf A’ buffer per 1 g cell-pellet. Protease inhibitor was added as recommended by the manufacturer 
(Complete EDTA free; Roche) together with a small spatula tip of DNAseI (Roche) prior resuspension. 
The cells were always kept on ice and were broken by sonication (5x 4 min; 2 min break; 50% duty; 
stage 5-6) until the color of the cells turned slightly darker and the suspension starts to clarify. A low 
spin centrifugation (Sorvall RC6+ centrifuge; Sorvall F10S rotor; 6000 rpm; 10 min; 4°C) was 
performed to remove the unbroken cells, followed by an ultracentrifugation step (Beckman&Coulter 
Optima L-90K Ultracentrifuge; Sorvall T647.5 rotor; 35,000 rpm; 1 h; 4°C). The isolated cytosol was 
used for the purification of His-tagged Yaf. 
 
Ni-affinity chromatography 
His-tagged Yaf was purified by Ni-affinity chromatography using the ÄKTA purifier system 
(GE Healthcare). A 5 ml HiTrap Chelating HP column (GE Healthcare) was loaded with NiSO4 as 
described in the manual. The column was equilibrated with 5 CV of ‘His-tag Yaf A’ buffer prior to 
protein purification. The isolated cytosol was loaded on the column at a flowrate of 0.5-1 ml/min 
depending on the amount of cytosol. The flowthrough was collected separately. The purification-
program is given in Table 27. The pressure limit was 0.3 MPa. The protein containing elution samples 
were analyzed by 15% SDS-PAGEs and samples with purified Yaf were pooled together and either 
directly used for further purification with gelfiltration or frozen in liquid nitrogen and stored at -80°C. 
Material and Methods 
 
 
 
Page | 55  
 
The column was regenerated and stored as described in the manual. For the purification of the 
different mutants the column was stripped and recharged for each mutant. 
 
Table 27: Protocol for the isolation of His-tagged Yaf with Ni-affinity chromatography 
Step Volume Flowrate Program Buffer 
loading - 1 ml/min external pump isolated cytosol 
wash 1 10 ml 4 ml/min 5% B; increasing gradient His-tag Yaf A; His-tag Yaf B 
wash 2 10 ml 4 ml/min 10% B; increasing gradient His-tag Yaf A; His-tag Yaf B 
wash 3 10 ml 4 ml/min 12.5% B; increasing gradient His-tag Yaf A; His-tag Yaf B 
elution 15 ml 2 ml/min gradient 100% B; frac. (2ml/tube) His-tag Yaf A; His-tag Yaf B 
 
Size exclusion chromatography  
The final purification step was performed with a size exclusion chromatography with a SD75 16/60 
HiLoad column (GE Healthcare). The column was equilibrated with 2 CV of ‘Gelfiltration Yaf (His-tag)’ 
buffer. The Yaf containing samples from the Ni-affinity chromatography were pooled together and 
were either injected without previous concentration or were first concentrated with Amicons 
(10,000 Da cut-off; Millipore). Before the injection the samples were filtered through a 0.2 µM PVDF 
syringe filter. The injection volume was 2 ml and the elution was done with a flowrate of 1 ml/min. 
After 40 ml fractions of 2 ml were collected. The total elution volume was 1 CV. A pressure limit of 
0.3 MPa was used as recommended by the manufacturer. The protein containing samples were 
analyzed by 15% SDS-PAGEs and were frozen in liquid nitrogen. The samples were stored at -80°C. 
 
3.6.5 Isolation of native Yaf 
The isolation of native Yaf was done with support of J. Koch (technical staff). 
 
Cell breakage 
Frozen cells with overproduced native Yaf were resuspended in ‘Ion exchange Yaf A’ buffer with 1x 
protease inhibitor (Complete EDTA free; Roche). The cell breakage and the isolation of the cytosol 
were performed as described in Chapter 3.6.4. The cytosol was used for the isolation of native Yaf. 
 
Anion exchange chromatography 
A 5 ml HiTrapQ HP column (GE Healthcare) was equilibrated with 5 CV of ‘Ion exchange Yaf A’ buffer 
before the isolated cytosol was loaded at a flowrate of 1 ml/min. The flowthrough was collected 
separately. The protocol for the program is given in Table 28. Protein was detected with UV light at 
280 nm. The protein containing samples were analyzed by 15% SDS-PAGEs. Samples with Yaf were 
used for further purification steps. 
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Table 28: Protocol for the isolation of native Yaf with anion exchange chromatography 
Step Volume Flowrate Program Buffer 
loading - 0.5-2 ml/min external pump isolated cytosol 
elution 100 ml 4 ml/min 100% B; 
Fraction (4 ml/tube) 
ion exchange Yaf A; 
ion exchange Yaf B 
 maximum pressure: 0.3 MPa 
 
1. Cation exchange chromatography 
Yaf containing samples were further purified by cation exchange chromatography. A 5 ml HiTrapSP 
column (GE Healthcare) was equilibrated with 5 CV of ‘Ion exchange Yaf A’ buffer. The samples were 
diluted 3x with ‘Ion exchange Yaf A’ buffer without NaCl before loading to the column with a flowrate 
of 1 ml/min. The purification-program is given in Table 29. The protein containing fractions were 
analyzed by 15% SDS-PAGEs.  
 
Table 29: Protocol for the isolation of native Yaf with cation exchange chromatography  
Step Volume Flowrate Program Buffer 
loading - 0.5 ml/min external pump elution from anion exchange 
elution 20 ml 4 ml/min 50% B; increasing grad.; 
Fraction (4 ml/min) 
ion exchange Yaf A; 
ion exchange Yaf B 
 maximum pressure: 0.3 MPa 
 
2. Cation exchange chromatography 
To concentrate the protein, a second cation exchange chromatography was performed with the 
same column and buffers as described above. Yaf containing samples were pooled together and 
diluted 2 times with ‘Ion exchange Yaf A’ buffer before they were loaded on the equilibrated column. 
The purification-program was similar to the protocol from the first cation exchange, except that the 
elution gradient was steeper. The eluted samples were analyzed by 15% SDS-PAGEs and further 
purified with size exclusion chromatography. 
 
Size exclusion chromatography 
Size exclusion chromatography was performed with an SD75 16/60 HiLoad gelfiltration column 
(GE Healthcare) as described in Chapter 3.6.4 using ‘Gelfiltration native Yaf’ buffer. 2 ml of the 
previous concentrated Yaf samples were loaded to the column. Protein containing samples were 
analyzed by 15% SDS-PAGEs and Yaf containing fractions were frozen in liquid nitrogen and stored at 
-80°C. 
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3.7 Analytical methods 
3.7.1 Determination of DNA concentration 
The concentration of double stranded DNA was determined with a NanoDrop Spectrophotometer 
(Peqlab) at a wavelength of 260 nm. Contaminations with RNA or proteins were estimated by the 
ratios of 260/230 nm for RNA and 260/280 nm for proteins. The system was blanked with the 
corresponding sample buffer prior the concentration determination. The measurements were 
performed with a sample volume of 1 µl.  
 
3.7.2 Agarose gel electrophoresis 
Agarose gel electrophoresis was either performed in SBA buffer for standard DNA analyses or in TB 
buffer for enzymatic activity assays. Depending on the size of the analyzed DNA, gels containing the 
corresponding buffer (SBA or TB) with 0.8 – 1% agarose were used. Samples for standard DNA 
analyses were mixed with 6x Orange DNA loading dye (Fermentas) and run with 140-160 V in SBA 
buffer. The run time varied with the DNA size, short fragments were run for 20 min whereas plasmids 
were run for 40 min. The 1 KBplus ladder (Fermentas) was used as size standard. Samples for 
enzymatic activity assays were treated as described in Chapter 3.8.6. Samples were run with variable 
time at 100 V in TB buffer in relation to the DNA size, short fragments were run for 30 min and 
plasmids were run for 1 h. 
 
3.7.3 Visualization of DNA  
Double stranded DNA was visualized by intercalation of ethidium bromide and detection of the 
fluorescence of ethidium bromide with UV-light. To visualize DNA used in cloning procedures the 
ethidium bromide was directly mixed in a final concentration of 0.01% with the warm agarose-
buffer-mix prior casting of the gel. To visualize DNA within enzymatic activity assays the agarose gels 
were stained afterwards for 15 min in a buffer solution containing 0.1% ethidium bromide. The DNA 
was visualized and data was documented with a 2UV Transilluminator gel documentation system 
(UVP). 
 
3.7.4 Determination of protein concentration 
The Bradford assay was used to determine the exact protein concentration. The assays were 
performed with Bradford ready-to-use reagent (Fermentas) as recommended by the manufacturer. 
Calibration curves were performed with BSA concentrations between 0-2 mg/ml. Each assay included 
besides a calibration curve a blank sample with the corresponding buffer of the protein. The assays 
were performed in 96 well-plates with a total reaction volume of 250 µl. The samples were mixed 
with the Bradford reagent and were incubated for 5 min at room temperature. Afterwards the 
samples were measured with a plate-reader-spectrophotometer (Infinite M200; Tecan) with a 
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wavelength of 595 nm. The protein concentrations were calculated by taking the sample volume and 
the calibration curve into account. 
For a fast determination of the protein concentration determination, the protein absorbance of the 
samples was measured with the NanoDrop Spectrophotometer (Peqlab) at a wavelength of 280 nm. 
The corresponding buffer was used for a blank sample. The protein concentration was determined 
based on the extinction coefficient based on the primary amino acid sequence of the protein. 
 
3.7.5 Protein precipitation with TCA 
Protein samples were mixed with pre-cooled TCA to a final TCA concentration of 10% (v/v). The 
samples were shortly vortexted and were incubated on ice for 15 min. After incubation the samples 
were centrifuged for 15 min at 4°C (13,300 rpm; Heraeus Fresco-17 centrifuge). The supernatants 
were carefully removed and the pellets were resuspended in 2x SDS-PAGE loading dye. The samples 
were neutralized with 1 M NaOH until the color of the pH indicator turned from yellow to blue and 
were then analyzed by SDS-PAGE. 
 
3.7.6 Polyacrylamide gel electrophoresis 
SDS-PAGE 
SDS-PAGE analyses were performed with the Minigel-system (Biorad) with 0.75 mm gels. The 
acrylamide content of the separation gels was either 11% for the separation of TraI and TraD or 15% 
for the separation of Yaf. The compositions of 11% and 15% separation gels are given in Table 30 and 
31. The stacking gels were prepared with 4% acrylamide; the composition for stacking gels is given in 
Table 32. Samples were mixed with 5x protein-loading dye (final concentration 1x) prior loading. TCA 
precipitated samples were pretreated as described in Chapter 3.7.5. The gels were run in 1x TGS 
buffer at 30 mA/gel until the blue loading dye front reached the bottom of the gel (~45 min). Gels 
were stained afterwards with coomassie or silver. 
 
Table 30: Buffer-mix of two 11% separating gels 
Volume Component 
2.5 ml  Separation buffer (see Chapter 3.1.3) 
3.67 ml Acrylamide (30%) 
3.75 ml deionized H2O 
60 µl APS (10% w/v) 
7 µl TEMED 
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Table 31: Buffer-mix of two 15% separating gels 
Volume Component 
2.5 ml Separation buffer (see Chapter 3.1.3) 
5 ml Acrylamide (30%) 
2.38 ml deionized H2O 
60 µl APS (10% w/v) 
7 µl TEMED 
 
Table 32: Buffer-mix of two 4% stacking gels  
Volume Component 
1.25 ml Stacking buffer (see Chapter 3.1.3) 
0.65 ml Acrylamide (30%) 
3.06 ml deionized H2O 
60 µl APS (10% w/v) 
7 µl TEMED 
 
Blue native PAGE 
Blue native PAGE analyses were performed with the Minigel-system from Biorad with 0.75 mm gels. 
Blue native gels were cast as gradient gels with 5-13% acrylamide. 4% stacking gels were layered on 
top of the native gel. The compositions for 4%, 5% and 13% gels are given in Table 33. The gels were 
cast at room temperature with a gradient-casting system. The cathode buffer A (high coomassie 
concentration) was stirred over night at room temperature to achieve complete solubility of the 
coomassie. The sample buffer was made of cathode buffer A and 10% glycerol (v/v). The size 
standards used are given in Table 34. The gels were run at 4-7°C. As long as the samples were in the 
stacking gel the gels were run with cathode buffer A at a constant voltage of 100 V. After entering 
the native gel the voltage was changed to 150 V. When 1/3 of the gels were reached the cathode 
buffer was changed to cathode buffer B (low coomassie concentration) and the voltage was changed 
to 200 V. The molecular masses of the protein samples were calculated based on the migration rates 
of the marker proteins and the sample. The Blue Native PAGE was performed with support of J. Koch 
(technical staff). 
 
Table 33: Buffer-mix for the preparation of Blue native PAGE gels 
Volume 4% gel Volume 5% gel Volume 13% gel Component 
0.6 ml 1.25 ml 3.25 ml Acrylamide 40% 
2 ml 3.33 ml 3.33 ml Gel buffer (3x) 
- - 2 ml Glycerol 
50 µl 60 µl 60 µl APS (10% w/v) 
5 µl 7 µl 7 µl TEMED 
6 ml 10 ml 10 ml add deionized H2O the 
corresponding volume 
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Table 34: Marker-proteins used to estimate molecular masses in Blue native PAGEs 
Protein Molecular mass (kDa) 
Thyroglobulin 669 
Ferritin 440 
Aldolase 158 
Conalbumin 75 
Ovalbumin 40 
Ribonuclease 13.7 
 
Denaturing Urea PAGE 
Denaturing urea polyacylamide gels were used with the XL gel system of Biorad. The composition for 
7.2% gels is given in Table 35. All components, except APS and TEMED, were mixed and heated for 
15-30 sec in a microwave to completely solve the urea. Afterwards the solution was filtered through 
a 0.2 µm sterile filter and was degased until no further air bubbles could be detected. After the 
addition of APS and TEMED the gels were immediately cast at room temperature. The denaturing 
urea gels only consist of the separation gel and do not contain a stacking gel. 
Prior running samples, the gels were pre-run in 1x TB buffer for 2 h at 300 V. Each pocket was 
washed with a glass syringe to remove diffusing urea before the samples were loaded. Sample 
containing gels were run for 1:45 h at 300 V.  
 
Table 35: Buffer-mix for the preparation of denaturing Urea PAGE gels 
 
 
 
 
 
 
Native TB PAGE 
Native TB PAGEs were performed with 0.75 mm Minigels. The composition of 7.5% gels is given in 
Table 36. After mixing all components the gels were cast at room temperature without stacking gels. 
Samples were run immediately without a pre-run of the gel. If not otherwise mentioned the gels 
were run in 1x TB buffer for 1 h at 100 V. 
 
 
 
Volume Component 
17.5 ml 10x TB buffer 
31.5 ml Acrylamide (40%) 
73.5 g Urea 
 fill up to 175 ml with deionized H2O 
 add prior to casting 52.5 µl TEMED 
 add prior to casting 525 µl APS (10% w/v) 
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Table 36: Buffer-mix for the preparation of native TB PAGE gels 
Volume Component 
9.55 ml deionized H2O 
1.5 ml 10x TB buffer 
3.75 ml Acrylamide (30%) 
105 µl APS (10% w/v) 
18 µl TEMED 
 
3.7.7 Staining of proteins 
Coomassie staining 
Polyacrylamide gels were heated in a microwave covered with coomassie staining solution until 
boiling. The gels were incubated in the hot coomassie staining solution for 5-10 min on a platform 
shaker and then washed twice in H2O. The gels were again heated in water and incubated for 5 min 
with constant shaking. A final destaining step was performed by incubating the gel in hot destaining 
solution until the background turned colorless. In a final step the gels were washed with H2O and 
scanned with an Epson Perfection V700 Photo scanner.  
 
Silver staining 
The protocol for silver staining of proteins is adopted from Nesterenko et al. (292) and is given in 
Table 37. All steps were performed at room temperature in petridishes while slowly shaking on a gel 
shaker (KS-130 basic; IKA). The incubation times in the protocol were used for 0.75 mm 
polyacrylamide minigels. 
 
Table 37: Protocol for silver staining of proteins in SDS-polyacrylamide gels, adopted from (292). 
Step Solution Time 
fixation 60 ml acetone (stock 50% v/v); 1.5 ml TCA (stock 50% v/v);  
25 µl formaldehyde (stock 37% v/v) 
5 min 
rinse deionized H2O 3x5 sec 
wash deionized H2O 5 min 
rinse deionized H2O 3x5 sec 
pretreat A 60 ml acetone (stock 50% v/v) 5 min 
pretreat B 100 µl Na2S2O3 · 5 H2O (stock 10% v/v) in 60 ml deionized H2O 1 min 
rinse deionized H2O 3x5 sec 
impregnation 0.8 ml AgNO3 (stock 20% v/v); 0.6 ml formaldehyde (stock 37% v/v); 60 ml 
deionized H2O 
8 min 
rinse deionized H2O 2x5 sec 
developer 1.2 g Na2CO3; 25 µl formaldehyde (stock 37% v/v);  
25 µl Na2S2O3 · 5 H2O (stock 10% v/v); 60 ml deionized H2O 
10-30 sec 
stop-solution 1% v/v glacial acetic acid in deionized H2O 30 sec 
wash deionized H2O 10 sec 
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3.7.8 MALDI-TOF mass-spectrometry and Nano-LC 
The identification of specific protein-bands in SDS polyacrylamide gels was done with MALDI-TOF 
peptide fingerpint analyses performed by J. Kahnt (department of ecophysiology; Max-Planck-
Institute for terrestrial microbiology). The samples were cut from the gels and trypsin digested to 
generate peptide fragments which were used for the identification with mass-spectrometry. Samples 
that were difficult to measure with MALDI-TOF mass-spectrometry were additionally analyzed with 
Nano-liquid-chromatography which was also performed by J. Kahnt.  
Samples from limited proteolysis experiments were first extracted with organic solvents to remove 
NaCl and DDM, which had a disturbing effect on the MALDI-TOF measurement. After extraction the 
samples were mixed and fixed on the corresponding matrix. The organic extraction and the 
measurements were performed by J. Kahnt.   
 
3.8 Biochemical methods for protein-characterization 
3.8.1 Labeling of oligonucleotides with γ-P32-ATP 
The reaction-mix for γ-P32-ATP labeling of oligonucleotides is given in Table 38. The reaction was 
incubated for 30 min at 37°C and inactivated for 20 min at 65°C. After inactivation the reaction-mix 
was shortly centrifuged (Heraeus Pico 17 centrifuge) and diluted with 36 µl 10 mM Tris/HCl pH 8.5 to 
a final concentration of oligonucleotides of 5 µM. The labeled oligonucleotides were stored at -20°C. 
 
Table 38: Reaction-mix for γ-P32-ATP labeling of oligonucleotides 
 
 
 
 
 
 
 
 
3.8.2 Construction of γ-P32-ATP labeled PCR products 
PCRs with γ-P32-ATP labeled oligonucleotides were performed to obtain γ-P32-ATP labeled DNA-
fragments for the use in DNA-binding and DNA-cleavage assays. The PCRs were performed as 
described in Table 39 and 40. The PCR products were purified with the DNA Clean & Concentrator Kit 
25 (Zymo) as described in the manual. The DNA fragments were eluted in 40 µl H2O and were 
analyzed by 7.5% TB-PAGEs. The DNA was stored at -20°C. 
 
 
Volume Component 
2 µl Oligonucleotide 
0.4 µl 10x PNK-buffer 
0.45 µl H2O 
0.4 µl T4-PNK 
0.75 µl γ-P32-ATP 
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Table 39: PCR reaction-mix to generate γ-P32-ATP labeled PCR products 
 
 
 
 
 
 
Table 40: PCR program used to generate γ-P32-ATP labeled PCR products 
 
 
 
 
 
 
 
 
3.8.3 DNA binding assay  
DNA binding assays were used to analize the DNA binding affinity of purified TraI and Yaf. Different 
γ-P32-ATP labeled DNA substrates were used in a concentration of 100 nm. The protein 
concentrations varied within the different assays and are given in the corresponding result part. The 
labeling of the DNA substrates was performed as described in Chapters 3.8.1 and 3.8.2. The 
reaction-mix is given in Table 41. The protein and the DNA were added as final components. The 
total reaction volume was 10 µl. The DNA binding was tested in the presence and the absence of 
different metal ions. The reaction was incubated at 25°C for 1 h. TB buffer was added to the reaction 
to a final concentration of 1x after incubation. The samples were shortly spun down and 1.5 µl 
5x native loading dye were added before running the samples on 7.5% TB-gels for 45 min with 100 V. 
The gels were incubated over night with reusable phosphoscreens (Molecular Dynamics). The 
autoradiographs were scanned with the Storm 840 Phosphoscanner (Molecular Dynamics) at the 
highest resolution.  
 
Table 41: Reaction-mix for DNA binding assays with γ-P32-ATP labeled DNA substrates  
Concentration Component  Concentration Component 
100 nM DNA substrate 6.9% (v/v) Glycerol 
variable Protein 0.03% (v/v) DDM 
34.5 mM Tris/HCl pH 7.6 5 mM Metal* 
103.5 mM NaCl   
* either Ca2+, Co2+, Cu2+, Ni2+, Mg2+, Mn2+, or Zn2+ 
Volume Component 
10 µl 5x Phusion HF-buffer 
2 µl γ-P32-ATP labeled Oligo 1 
2 µl γ-P32-ATP labeled Oligo 2 
1 µl dNTPs 
0.5 µl MS11 genomic DNA 
0.5 µl Phusion-Polymerase 
34 µl H2O 
Temperature Time Cycles 
98°C 30 sec 1x 
98°C 10 sec  
34x 53°C 30 sec 
72°C 15 sec  
72°C 10 min 1x 
4°C ∞ 1x 
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3.8.4 DNA binding and competition assay 
DNA binding and competition assays were performed with isolated native TraI and different ssDNA 
and dsDNA substrates. The reaction-mix was incubated with unlabeled Tn nucleotides (T6 till T28 with 
a difference of 3 nucleotides between each step) for 1 h on ice. The total reaction volume was 10 µl. 
After 1 h incubation the γ-P32 labeled competitor DNA was added and the samples were further 
incubated for 10 min on ice. The samples were shortly spun down and 2 µl of 6x DNA loading dye 
were added. The samples were analyzed on 7.5% native TB gels. TraI was used in a final 
concentration of 0.3 µM. The unlabeled Tn oligonucleotides were used in a final concentration of 
10 µM and were 100x higher concentrated than the γ-P32 labeled competitor DNA (final 
concentration 100 nM). The assays were performed with two dsDNA substrates (555 bps PCR 
product of GGI oriT; 425 bps PCR product of difA site) and three ssDNA substrates (T75; T25; 75 bps 
oligomer of GGI oriT fwrd). The gels were incubated over night with reusable phosphoscreens 
(Molecular Dynamics). The autoradiographs were scanned with the Storm 840 Phosphoscanner 
(Molecular Dynamics) with the highest resolution.  
 
3.8.5 DNA degradation assay 
DNA degradation assays were performed with purified dimeric and tetrameric Yaf with different 
γ-P32-ATP labeled DNA substrates. The total reaction volume was 10 µl and the reaction-mix is given 
in Table 42. The DNA and the protein were added as final components. The assays were performed 
with different pH conditions and metal ions. Negative controls were done with inactivated proteins 
which were incubated 10 min at 95°C prior the degradation assays. The mixed samples were shortly 
spun down and were incubated for 1.5 h at 37°C. After incubation the samples were again shortly 
spun down and 1 µl of 5x native loading dye were added. The samples were run on 7.5% TB gels for 
45 min with 100 V. The gels were incubated over night with reusable phosphoscreens (Molecular 
Dynamics). The autoradiographs were scanned with the Storm 840 Phosphoscanner (Molecular 
Dynamics) with the highest resolution.  
 
Table 42: Reaction-mix for DNA degradation assays with γ-P32-ATP labeled DNA substrates 
Concentration Component 
100 nM ssDNA/ds DNA PCR product 
2 µM Protein 
50 mM Buffer  
154.5 mM NaCl 
8% (v/v) Glycerol 
5 mM Metal  
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3.8.6 DNA relaxation assay 
DNA relaxation assays were performed with purified TraI or Yaf using circular supercoiled plasmid 
DNA substrates, containing either the GGI oriT region or the F-plasmid oriT region (pEP073 and 
pEP074). The total reaction volume was 15 µl. An overview on the reaction conditions is given in 
Table 43. The reaction conditions changed slightly in assays used for the comparison of the activity of 
TraI and Yaf to the activity of Topoisomerase I from E. coli. The reaction-mix used in these assays is 
given in Table 44. The protein concentrations used in different assays varied, but the total volume of 
protein containing samples was limited to 7.5 µl. The protein and the DNA were added as final 
components to the reaction and the samples were shortly vortexed and spun down. The relaxation 
reactions were performed for 1 h at 37°C and were stopped by the addition of 0.8 µl EDTA (0.5 M; 
pH 8.0) and 0.8 µl SDS (10% w/v). The reactions containing EDTA and SDS were incubated at 65°C for 
20 min and 3 µl of 5x colorless loading dye were added. The samples were shortly spun down before 
loading to 1% TB agarose gels. The gels were run for 45 min at 110 V in 1x TB buffer and the DNA was 
stained and visualized with ethidium bromide as described in Chapter 3.7.3.  
 
Table 43: Reaction-mix for DNA relaxation assays  
Concentration Component 
variable Protein 
2 nM (80 ng) DNA (pEP073 or pEP074) 
0.5 x Gelfiltration buffer (Yaf or TraI) 
1 x TB buffer 
5 mM Metal 
 
Table 44: Reaction-mix for DNA relaxation assays performed with Topoisomerase I 
Concentration Component 
variable Protein 
2 nM (80 ng) DNA (pEP073 or pEP074) 
0.5 x Gelfiltration buffer (Yaf or TraI) 
1 x TB buffer 
5 mM Metal 
3 mM KCl 
2 mM (NH4)2SO4 
0.01 mM EDTA 
0.06 mM DTT 
+ 3% (v/v) Glycerol 
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3.8.7 DNA cleavage assay 
To analize the DNA cleavage activity of TraI and Yaf the proteins were incubated with different 
γ-P32-ATP labeled DNA substrates under variable reaction conditions. The DNA labeling was 
performed as described in Chapters 3.8.1 and 3.8.2. An overview on the tested conditions is given in 
Table 45 and the used DNA substrates are given in Table 46. The protein and the DNA were added as 
final components and the samples were shortly vortexed and spun down. The total reaction volume 
was 10 µl. The reactions were incubated for 1 h at 25°C. After incubation the reactions were shortly 
spun down and stopped by the addition of one reaction volume of 2x stop solution. The samples 
were incubated for 4 min at 99°C and were shortly spun down before 4 µl 6x DNA loading dye were 
added. The samples were loaded on pre-run denaturing urea gels (see Chapter 3.7.6). The gels were 
run with 300 V for 1.75 h in 1x TB buffer and were incubated over night with reusable 
phosphoscreens (Molecular Dynamics). The autoradiographs were scanned with the Storm 840 
Phosphoscanner (Molecular Dynamics) with the highest resolution.  
 
Table 45: γ-P32-ATP labeled DNA substrates used in DNA cleavage assays 
Substrate Length 
GGI oriT F 75 bp 
GGI oriT R 75 bp 
F-plasmid oriT F 76 bp 
F-plasmid oriT R 76 bp 
T74 74 bp 
PCR product GGI oriT 550 bp 
 
Table 46: Reaction conditions used in DNA cleavage assays 
Reaction 
mix 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 
Tris/HCl 
pH 7.6 
105 
mM 
105 
mM 
105 
mM 
105 
mM 
105 
mM 
105 
mM 
105 
mM 
105 
mM 
105 
mM 
105 
mM 
105 
mM 
105 
mM 
105 
mM 
105 
mM 
105 
mM 
105 
mM 
HEPES 
pH 7 
5 
mM 
5 
mM 
5 
mM 
5 
mM 
5 
mM 
5 
mM 
5 
mM 
5 
mM 
5 
mM 
5 
mM 
5 
mM 
5 
mM 
5 
mM 
5 
mM 
5 
mM 
5 
mM 
NaCl 
 
100 
mM 
100 
mM 
100 
mM 
100 
mM 
100 
mM 
100 
mM 
100 
mM 
100 
mM 
100 
mM 
100 
mM 
100 
mM 
100 
mM 
100 
mM 
100 
mM 
100 
mM 
100 
mM 
Glycerol 
 
6 
% 
6 
% 
6 
% 
6 
% 
6 
% 
6 
% 
6 
% 
6 
% 
6 
% 
6 
% 
6 
% 
6 
% 
6 
% 
6 
% 
6 
% 
6 
% 
DDM 
 
0.025 
% 
0.025 
% 
0.025 
% 
0.025 
% 
0.025 
% 
0.025 
% 
0.025 
% 
0.025 
% 
0.025 
% 
0.025 
% 
0.025 
% 
0.025 
% 
0.025 
% 
0.025 
% 
0.025 
% 
0.025 
% 
DNA 100 
nM 
100 
nM 
100 
nM 
100 
nM 
100 
nM 
100 
nM 
100 
nM 
100 
nM 
100 
nM 
100 
nM 
100 
nM 
100 
nM 
100 
nM 
100 
nM 
100 
nM 
100 
nM 
TraI - 500 
nM 
500 
nM 
500 
nM 
- 500 
nM 
500 
nM 
500 
nM 
- 500 
nM 
500 
nM 
500 
nM 
- 500 
nM 
500 
nM 
500 
nM 
Yaf 
 
- - - 500 
nM 
- - - 500 
nM 
- - - 500 
nM 
- - - 500 
nM 
MgCl2 - - - - 5 
mM 
5 
mM 
5 
mM 
5 
mM 
- - - - - - - - 
MnCl2 - - - - - - - - 5 
mM 
5 
mM 
5 
mM 
5 
mM 
- - - - 
CoCl2 
 
- - - - - - - - - - - - 5 
mM 
5 
mM 
5 
mM 
5 
mM 
ATP 
 
- - 3 
mM 
3 
mM 
- - 3 
mM 
3 
mM 
- - 3 
mM 
3 
mM 
- - 3 
mM 
3 
mM 
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3.8.8 Quantitative image analysis 
Quantitative analyses of autoradiography images were performed with the Software ImageJ. To 
quantify and compare distinct areas of an autoradiography image a reference area was picked to 
subtract the background influence from all analyzed areas. All areas had the same size and 
quantitative values were calculated by defining the positive control as 100%. 
3.8.9 Dynamic light scattering 
Dynamic light scattering analyses coupled with size exclusion chromatography was performed in 
close collaboration with Dr. S. Smits from the group of Prof. Dr. L. Schmitt from the Heinrich-Heine-
University in Düsseldorf with different oligomeric forms of purified His-tagged Yaf.  
 
3.8.10 Limited proteolysis 
The limited proteolysis experiments were performed with support of J. Koch (technical staff). 
 
Limited trypsin digest of TraI 
Limited trypsin proteolysis was performed with purified TraI in reaction conditions given in Table 47. 
The protein was mixed with all reaction components except trypsin and the samples were incubated 
for 1 h at 37°C, at room temperature and on ice. Trypsin was added afterwards to final 
concentrations given in Table 49 and the samples were incubated again for 20 min on ice. The total 
reaction volume was 10 µl. The reactions were stopped by adding 5x SDS-loading dye and 10 min 
incubation at 99°C. The samples were analyzed with 13% and 15% SDS-PAGEs as described in 
Chapter 3.7.6. 
 
Table 47: Reaction conditions used within limited trypsin proteolysis expermiments with TraI 
Reaction 
mix 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 
Protein 
 
0.59 
µM 
0.59 
µM 
0.59 
µM 
0.59 
µM 
0.59 
µM 
0.59 
µM 
0.59 
µM 
0.59 
µM 
0.59 
µM 
0.59 
µM 
0.59 
µM 
0.59 
µM 
0.59 
µM 
0.59 
µM 
0.59 
µM 
0.59 
µM 
0.59 
µM 
MgCl2 
 
10 
mM 
10 
mM 
10 
mM 
10 
mM 
10 
mM 
10 
mM 
10 
mM 
10 
mM 
10 
mM 
10 
mM 
10 
mM 
10 
mM 
10 
mM 
10 
mM 
10 
mM 
10 
mM 
10 
mM 
Tn Primer 
 
- - - - - 2.5 
µM 
2.5 
µM 
2.5 
µM 
2.5 
µM 
- - - - - - - - 
oriT rev 
Primer 
- - - - - - - - - 2.5 
µM 
2.5 
µM 
2.5 
µM 
2.5 
µM 
- - - - 
ATP 
 
- - - - - - - - - - - - - 5 
mM 
5 
mM 
5 
mM 
5 
mM 
Trypsin 
 
0 
nM 
8 
nM 
16 
nM 
50 
nM 
4 
nM 
8 
nM 
16 
nM 
50 
nM 
4 
nM 
8 
nM 
16 
nM 
50 
nM 
4 
nM 
8 
nM 
16 
nM 
50 
nM 
4 
nM 
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Limited ProteinaseK digest of TraI  
The limited ProteinaseK digest of TraI was performed with 1.2 µM native TraI and increasing 
ProteinaseK concentrations. The total reaction volume was 10 µl. The samples were incubated for 
30 min at 37°C, followed by an inactivation of the enzymes at 99°C for 10 min. Afterwards the 
samples were mixed with 5x SDS loading dye and were analyzed on 13-15% gradient SDS gels as 
described in Chapter 3.7.6. 
Limited trypsin digest of Yaf 
Purified Yaf (3.4 µM dimer and 4 µM tetramer) was incubated with trypsin (0 µM; 12 µM; 16 µM; 
20 µM) (Sigma Aldrich) in total reaction volumes of 10 µl. The volume was filled up with the 
corresponding gelfiltration buffer. The mixed samples were incubated at 37°C for 30 min and the 
reactions were stopped by the addition of 5x SDS loading dye and incubation at 99°C for 10 min. The 
samples were analyzed on 13-18% gradient SDS gels as described in Chapter 3.7.6. 
 
Limited ProteinaseK digest of Yaf 
Limited proteolysis with ProteinaseK was performed in the corresponding gelfiltration buffer with 
purified Yaf (3.4 µM dimer and 4 µM tetramer) and increasing ProteinaseK (Merck) concentrations 
(0 µM; 0.86 µM; 1.73 µM; 2.6 µM; 3.46 µM; 6.9 µM) in total reaction volumes of 10 µl. The mixed 
samples were incubated at 37°C for 30 min and the reactions were stopped by adding 5x SDS loading 
dye and incubation at 99°C for 10 min. The samples were analyzed on 15-20% gradient SDS gels. 
 
3.8.11 Pull-down assay for protein-protein interaction 
Protein-protein interactions were tested with pull down assays using His-Mag-Sepharose beads 
(GE Healthcare). 100 µl bead-solution were 3x washed with 500 µl buffer (40 mM Imidazole; 
75 mM NaCl; 25 mM HEPES pH 7.5; 5% Glycerol). The tubes with the bead-solution were put into a 
magnetic tube-holder and the supernatants were carefully removed. The protein-protein interactions 
were tested with one protein containing a His-tag and a second protein having no His-tag. 90 µl of a 
protein mixture containing both putative interaction partners were incubated with the equilibrated 
magnetic beads. After a short incubation time the supernatants were carefully removed and the 
beads were 2x washed with 200 µl buffer (40 mM Imidazole; 75 mM NaCl; 25 mM HEPES pH 7.5; 
5% Glycerol). The bound proteins were eluted with 100 µl elution buffer (400 mM Imidazole; 
75 mM NaCl; 25 mM HEPES pH 7.5; 5% Glycerol). All samples were TCA precipitated and analyzed by 
SDS-PAGE. The pull down assays were performed in close collaboration with S. Rempel, a bachelor 
student in our group who was working on TraC.  
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3.9 Crystallization of Yaf and TraI 
The crystallization of His-tagged Yaf, native Yaf and native TraI is performed in close collaboration 
with Dr. S. Smits from the group of Prof. Dr. L. Schmitt from the Heinrich-Heine-University in 
Düsseldorf. The protein samples were analyzed with dynamic light scattering coupled size exclusion 
chromatography before initial crystallization screens were performed. The crystallization of Yaf is 
done with the dimeric and tetrameric form of the protein.  
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4. Results 
4.1 Computational analysis of the GGI encoded T4SS and related T4SSs  
In nature, many different conjugative T4SSs can be found. A phylogenetic analysis of these 
conjugative T4SSs revealed that they can be divided into different families based on I) targeting 
factors, exemplified by the different relaxases and coupling proteins, and II) based on their MPF 
complexes as exemplified by the VirB4 like ATPases. A differentiation of the T4SSs based on the 
relaxase and coupling protein families resulted in 8 different families (MOBB, MOBT, MOBV, MOBQ, 
MOBP, MOBH, MOBF and MOBC), while also the MPF complexes could be divided into 8 different 
families (MPFT, MPFF, MPFG, MPFI, MPFB, MPFC, MPFFA and MPFFATA). Remarkably, many different 
functional combinations of MOB and MPF families have been found (e.g. MPFT + MOBP, MPFG + MOBF 
or MPFG + MOBH) (111).  
Several T4SS related genes encoded with the GGI show homology to the E. coli F-plasmid. This 
homology is especially observed for genes in the ltgX-ych region. This region encodes proteins that 
are mostly involved in the formation and stabilization of the secretion complex. 13 of these genes 
(TraL, TraE, TraK, TraB, TraV, TraC, TraW, TraU, TrbC, TraN, TraF, TraH and TraG) are ordered in the 
same orientation as the E. coli F-plasmid. The gene of the peptidoglycan transglycosylase LtgX is 
oriented in a different direction, but represents a functional homologue of Orf169 of the F-plasmid. A 
phylogenetic analysis of TraCNG shows that these proteins form an MPF complex similar to those that 
belong to the MPFF family. Several proteins encoded within in the ltgX-ych region are not present in 
the F-plasmid, e.g. Yag, DsbC, Ybe, Ybi, Ycb, AtlA and Ych. Also the pilin subunit TraA, and TrbI, the 
protein that circularizes the TraA pilin subunits, are not found in the F-plasmid. These proteins are 
normally found in T4SSs that contain an MPF complex that belongs to the MPFT family. A functional 
analysis has shown that all proteins with homology to proteins encoded on the F-plasmid are 
essential for ssDNA secretion, but neither TraA and TrbI, nor the Yag, Ybe, Ybi, Ycb, and Ych proteins 
are essential for ssDNA secretion. Remarkably, although they are not found in the F-plasmid AtlA and 
DsbC are important for DNA secretion.  
The relaxase TraI and the coupling protein TraD are located together in an operon with the small 
hypothetical proteins Yaf and Yaa (110, 198, 202). The relaxase TraI belongs to the family of MOBH 
relaxases that are often associated with members of the MPFG family (eg. in the ICEHIN1056 
integrative conjugative element), but are also found to be associated with the MPFI, MPFF, MPFT, 
MPFFATA families. The coupling protein TraD clusters in phylogenetic analyses together with other 
coupling proteins that are always linked to a relaxase of the MOBH family. These TraD-like coupling 
proteins show a shared synteny with Yaa, a small hypothetical protein with 4 putative 
transmembrane domains. The fourth protein in this operon, Yaf shows only little homology to other 
proteins.  
Deletion studies of proteins encoded within the GGI, but outside of the yaa-ych region showed that 
these proteins, except for ParA and ParB did not affect DNA secretion (PhD thesis E. Pachulec, 2010). 
Both, ParA and ParB show homology to partitioning proteins that normally are involved in DNA 
partitioning during cell division. VirC1, a ParA homologue encoded on the Ti-plasmid was shown to 
be necessary for T-DNA transport in A. tumefaciens. 
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Different types of the GGI have been identified in N. gonorrhoeae and in N. meningitidis. To identify 
GGI-like T4SSs in other bacteria, all proteins essential for DNA secretion were screened for synteny 
using the absynte webtool (http://archaea.u-psud.fr/absynte/). Using this approach, several GGI-like 
T4SSs could be identified in other Proteobacteria. The genetic regions encoding proteins homologous 
to components of the T4SS of N. gonorrhoeae were visually analyzed with the Microbial Genome 
Viewer 2.0 (http://mgv2.cmbi.ru.nl/genome/index.html). 
PSI-Blast (http://www.ncbi.nlm.nih.gov/blast/Blast.cgi) was used to identify homologues of all genes 
surrounding the GGI-like regions, either for proteins encoded within the GGI or to other proteins. 
Remarkably, several GGI-like T4SSs were identified in other bacteria. Figure 4 shows the genetic 
organization of the identified T4SSs in comparison with the T4SSs of N. gonorrhoeae, N. meningitides 
and Neisseria bacilliformis. The GGI-like T4SS is not only restricted to Neisseriales. Moreover, similar 
T4SSs were identified in α-, β- and γ-Proteobacteria. Most of the organisms containing a GGI-like 
T4SS belong to the group of β-Proteobacteria. Furthermore, the two pathogenic γ-Proteobacteria 
species (S. enterica sp. enterica serovar Newport str. SL254 and P. mirabilis HI4320), as well as the 
α-Proteobacterium Novosphingobium aromaticivorans DSM12444 encode GGI-like T4SSs.  
The genetic organization of the dtr operon and the mpf operons of the identified GGI-like T4SSs is 
highly conserved. However, the orientation of the dtr operon to the mpf operons is changed 
compared to the orientation in Neisseriales in most of the identified T4SSs. In N. gonorrhoeae, as well 
as in N. meningitidis and N. bacilliformis, the dtr operon and the mpf operons have opposite 
directions, whereas in almost all of the other GGI-like T4SSs the dtr operon and the mpf operons are 
oriented in the same direction.  
A comparison of the different MPF regions shows that the TraL, TraE, TraK, TraB, TraV, TraC, TraW, 
TraU, TrbC, TraN, TraF, TraH and TraG proteins are conserved in most GGI-like T4SSs. Several of the 
identified GGI-like T4SSs show insertions in the mpf operon. For example, the T4SS of S. enterica sp. 
enterica serovar Newport str. SL254 has, next to an insertion of a transposase and several other 
smaller genes between the dtr genes and the mpf genes, a 6.5 kb insertion between two opposite 
oriented copies of dsbC and an additional insertion of 74 kb between traN and traF. The insertions 
within the mpf genes of the T4SS of P. mirabilis, the second γ-Proteobacterium with a GGI-like T4SS, 
are located at the same positions like in S. enetrica. An insertion of two genes, ynd/mosA and 
ync/mosB, is located between traA and dsbC and most likely does not influence the assembly of the 
secretion system. A second insertion of 21.5 kb is found between traN and traF. Since no biochemical 
data is available for these systems it is unknown whether these systems are functional.  
Remarkably, also the yag, dsbC, ybe, ybi, and ycb genes are present in almost all of the identified 
GGI-like T4SSs, however, these genes seem to be less conserved than the tra genes from the MPF 
region. Homologous genes of the outer membrane protein Yag are always associated with the gene 
encoding the lytic transglycosylase LtgX. Homologues of yag are not present in all of the identified 
GGI-like T4SSs. One of the two chromosomal T4SSs and the plasmid (pALIDE201) encoded T4SS of 
Alicycliphilus denitrificans K601, as well as the T4SS of N. aromaticivorans plasmid pNL1 do not 
contain yag homologues, but still encode homologues of ltgX. Whereas, the T4SSs of P. mirabilis and 
S. enterica, as well as the chromosomal T4SS of N. aromaticivorans lack in addition to yag 
homologues also ltgX homologues. Homologous genes of the disulfide-bond isomerase DsbC are 
present in all of the identified GGI-like T4SSs, with the exception of N. bacilliformis. In almost all of 
the T4SSs the dsbC homologues are associated with traV, however, the T4SSs of the γ-Proteobacteria 
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P. mirabilis and S. enterica represent exceptions. Actually, the T4SS of S. enterica includes two copies 
of dsbC homologues. The T4SS of A. denitrificans plasmid pALIDE201 and the chromosomal T4SS of 
Acidovorax Js42 contain homologous genes of dsbC also associated with the dtr genes, representing 
an exception to the other T4SSs. Homologues of ybe and ycb are conserved among almost all hereby 
identified T4SSs, only the T4SS of N. bacilliformis and both T4SSs of N. aromaticivorans lack ybe 
homologues, whereas ycb homologues are only missing in the T4SSs of N. aromaticivorans. 
Homologues of ybi are less conserved among the GGI-like T4SSs and are only present in 
N. gonorrhoeae, N. meningitidis and the plasmid encoded T4SSs of A. denitrificans (pALIDE201) and 
Acidovorax JS42 (pAOV001). Remarkably, genes encoding for the small putatively secreted protein 
Exp1 are present in most of the GGI-like T4SSs. The genes with homology to the exp1 gene are all 
transcribed in an opposite direction from the tra operons and seem to form a border between the 
T4SS and genes that encode proteins with other functions. An exp1 knock-out mutant is still able to 
secrete ssDNA, suggesting that the gene is not involved in the secretion of DNA. Only the T4SSs of 
N. aromaticvorans DSM12444 plasmid pNL1, P. mirabilis and Acidovorax Js42 lack homologues of this 
gene. However, since no biochemical data is available for these T4SSs it unknown whether or not 
these systems are functional. Exceedingly, many of these genes which are encoded together in the 
operon with the MPF components are conserved between the different species, but seem not to be 
involved in ssDNA transport in N. gonorrhoeae. 
The phylogenetic relationship between the different GGI-like T4SSs was further analyzed by 
comparing NJ trees of representative mpf and dtr proteins, generated with the neighbor joining 
algorithm with a bootstrap value of 1000.  
The dtr proteins of the GGI-like T4SSs were represented by the relaxases, the coupling proteins, 
homologues of the small predicted membrane protein Yaa, and homologues of the small predicted 
protein Yaf. Comparing the phylogenetic trees of all four represented dtr proteins shown in Figure 5, 
the overall clustering of the distinct branches of the trees is similar for TraI, TraD and Yaa. The NJ 
trees of the analyzed relaxases and coupling proteins essentially show two main branches. The first 
branch contains of the T4SSs encoded on the plasmids pALIDE201 and PAVO001 of A. denitrificans 
K601 and Acidovorax JS42 and the T4SSs encoded on the pNL1 plasmid and the chromosome of 
N. aromaticivorans. The second branch contains all the other organisms. The relaxases and the 
coupling proteins of the first branch are related to the MOBF family, while the relaxases and the 
coupling proteins of the second branch are related to the MOBH family. As expected, since the yaa 
gene is only found in syntheny with relaxases of the MOBH family, no homologues of Yaa could be 
identified for the organisms found in the first branch. This demonstrates that relaxases of two 
different MOB families can be found associated with a GGI-like MPF complex. Remarkably, all the 
GGI-like T4SSs encoded on plasmids contained relaxases and coupling proteins of the MOBF family. 
This suggests that relaxases of the MOBH family are preferentially found in T4SSs encoded on the 
chromosome.   
To compare the phylogenetic relationship of the targeting components with the components of the 
MPF complex, neighbor joining trees were generated for the pilin subunit TraA, the ATPase TraC, the 
pore forming protein TraB, and the MPF-stabilizing protein TraG. The NJ trees of the four proteins are 
shown in Figure 6. The four proteins show again essentially very similar trees, suggesting that the 
proteins in the mpf regions from the different organisms have followed the same evolution.   
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Also the T4SSs encoded on the plasmids pALIDE201 and PAVO001 of A. denitrificans K601 and 
Acidovorax JS42 are located close to each other, suggesting that these plasmids have recently been 
transferred. The T4SSs encoded on the chromosome and on the pNL1 plasmid of N. aromaticivorans 
are again located together, but now they are also located together with the two chromosomal T4SSs 
of A. denitrificans and the T4SSs encoded on the chromosomes of Delftia sp. and Acidovorax sp. JS42.  
It is difficult to draw a conclusion about the evolutionary relationship between the identified GGI-like 
T4SSs and every assumption has to be seen with caution. One possible scheme for the evolution of 
these T4SSs is that the ancestral T4SS contained an MPF complex and a targeting system of the MPFF 
and MOBF families respectively. Possibly the MPFF genes were integrated into the chromosome and 
acquired there a MOBH like relaxase and coupling protein, resulting in the genetic organization seen 
in most of the currently identified systems. In a final step, the MPFF genes might have been 
transferred to a plasmid which contained a MOBF like relaxase and coupling protein. These systems 
can be found in the pALIDE201, PAVO001, and pNL1 plasmids of A. denitrificans K601, 
Acidovorax JS42 and N. aromaticivorans. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: Comparison of the genetic organization of genome and plasmid encoded GGI-like T4SSs identified in α-, β-, and 
γ-proteobacteria. The official numbering and nomenclature of the genes is indicated within the gene-arrows. The 
corresponding homologues are indicated on top of the gene-arrows. T4SS genes are indicated by coloring, homologous 
genes are labeled in equal colors. The length of the gene-arrows corresponds to the length of the annotated genes. A 
scale bar of 3 kb is given on the right bottom of the scheme.  
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Figure 5: Analyses of the phylogenetic relation between GGI T4SS like homologues of TraI (A), TraD (B), Yaf (C), and Yaa 
(D). The neighbor-joining algorithm was performed based on amino acid sequence alignments of the homolgous proteins 
and was generated with a bootstrap value of 1000. The scale bars below the trees indicate the evolutionary distance 
between the homologues. The numbers at the branching cross-points indicate the percentage of identity of the 
homologues.  
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Figure 6: Analyses of the phylogenetic relation between GGI T4SS like homologues of TraA (A), TraC (B), TraB (C), and 
TraG (D). The neighbor-joining algorithm was performed based on amino acid sequence alignments of the homolgous 
proteins and was generated with a bootstrap value of 1000. The scale bars below the trees indicate the evolutionary 
distance between the homologues. The numbers at the branching cross-points indicate the percentage of identity of the 
homologues. 
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4.2 Biochemical characterization of the coupling protein TraD 
Coupling proteins (CPs) are essential for the function of T4SSs and are present in almost all known 
T4SSs. They mediate the contact between the secretion substrate and the MPF complex and also play 
an essential role in targeting the secretion substrates to the secretion complexes. As discussed in 
Chapter 1.6, the GGI encodes a CP and a relaxase that are related to the MOBH family of relaxases, 
but the MPF complex belongs to the MPFF family. CPs that are related to the MOBH family, often 
contain two N-terminal transmembrane domains and are often found associated with a small 
membrane protein. Like other CPs they contain a nucleotide binding domain (NBD) and an 
all-α domain (AAD). Computational predictions revealed that the GGI encoded CP also consists of an 
NBD and an AAD, and that it might also have two N-terminal transmembrane domains. However, 
both transmembrane domains seem to be less hydrophobic than the transmembrane domains of 
other members of the VirD4 like CP family. Currently, none of the coupling proteins related to MOBH 
like relaxases has been characterized biochemically. 
 
4.2.1 The recombinant overproduction of TraD leads to insoluble protein 
To functionally characterize TraD, the protein was overproduced recombinantly in E. coli to obtain 
soluble protein for further purification steps, since the overexpression of proteins in N. gonorrhoeae 
is not well established and further purifications steps are hampered by the fact that they have to be 
performed under biosafety level 2 conditions.  
Initial experiments showed that the overproduction of TraD is a difficult task, since almost all tested 
overproduction conditions resulted in the production of insoluble and misfolded protein. To optimize 
the expression level of traD, different traD expressing constructs either with or without the putative 
N-terminal transmembrane domains, as well as constructs with different TraD variants fused to the 
malE gene that encodes for the Maltose Binding Protein (MBP) were generated. In the different 
constructs, traD was always cloned behind a T7 promotor. Many attempts with different expression 
conditions were performed to optimize the overproduction of TraD. Conditions that have been 
varied included: I) different E. coli expression strains like BL21(DE3) and different strains derived from 
BL21(DE3), like e.g. BL21 Star (for an increased mRNA stability), C43 (for an optimized expression of 
membrane proteins), BL21(DE3) Tuner and LEMO21(DE3) (for a tunable expression level); II) different 
growth temperatures (18, 25, 30 and 37°C); III) different media (LB and autoinduction media); III) 
different IPTG concentrations (0.05 mM - 1 mM); IV) different induction times (1 - 18 h); and V) 
different temperature shifts (from 37°C to either 30°C, 25°C, or 17°C). Moreover, different conditions 
were tested in which the E. coli strains were co-transformed with a vector that expresses rare tRNAs 
(pRARE), and it was tried to slow down the production of TraD by adding the RNA-polymerase 
inhibitor Rifampicin shortly after the induction with IPTG, followed by a cold shock and further 
incubation of the culture as described in Chapter 3.4.1. In all conditions, the expression of TraD was 
tested for both, the soluble protein or protein associated with membranes. To distinguish between 
aggregated proteins in inclusion bodies and membrane proteins, the inner membranes were 
separated form inclusion bodies by sucrose density step gradient centrifugation as described in 
Chapter 3.4.4. Table 48 summarizes the results of the optimized expression conditions used with the 
most promising traD constructs. Most conditions resulted in the overproduction of large amounts of 
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TraD, but unfortunately, non of these conditions resulted in a successful overproduction of large 
quantities of soluble TraD.  
 
Table 48: Summary of constructs used for the recombinant overproduction of TraD 
Protein Protein 
amount 
Protein 
soluble 
Membrane 
bound 
Inclusion 
bodies 
Purfication 
successful 
TraDΔtm  
C-terminal His-tag 
high  - partly high  partly 
TraDΔtm  
N-terminal His-tag 
high  - partly high  partly 
TraDΔtm  
N-terminal MBPc-fusion 
low  yes - low  partly 
TraD 
N-terminal His-tag 
high  - in partly high  partly 
TraD 
N-terminal His-MBP-TEV fusion 
high  yes - high  - 
 
The expression of traD with constructs that either produce the full-length TraD or a truncated TraD 
without the transmembrane domain (TraDΔtm) fused to a truncated malE gene without signal 
sequence, resulted in the production of small but detectable amounts of soluble MBP-TraD. Both 
constructs were generated and overexpressed in close collaboration with T. Deinzer, who performed 
his bachelor thesis within our group. Even though both constructs resulted in the expression of small 
amounts of soluble protein, extensive attempts to optimize the purification of these proteins have 
failed. TraD aggregated on different column materials and could not be eluted from the column after 
binding. Furthermore, these proteins were inactive in ATP binding and hydrolysis assays. This 
strongly indicates that these proteins most likely are not folded correctly.  
Promising results were obtained with full-length TraD and TraDΔtm grown in autoinduction medium 
at 30°C. Under this condition still large amounts of inclusion bodies were produced, but TraD could 
be detected in isolated inner membranes. To optimize the expression conditions for the membrane 
insertion of TraD, growth experiments with autoinduction medium were performed and inner 
membranes were isolated at different time points. The large amounts of TraD forming inclusion 
bodies at the later stages of autoinduction affected the separation of the inner and outer 
membranes by the sucrose density step gradient centrifugation. Most of the TraD that remains from 
inclusion bodies formed small pellets at the bottom of the sucrose gradients, but the inner and the 
outer membranes could not be separated completely from each other. Reloading of the isolated 
membranes on a second sucrose gradient did not result in either a better separation of inner and 
outer membranes or a detachment of TraD from the membrane. This suggested that TraD is tightly 
bound to these membranes and might indicate that full-length TraD is indeed a membrane anchored 
protein, as it has been observed for other CPs. However, TraDΔtm was detected in similar amounts 
as full-length TraD in isolated inner membranes derived from TraDΔtm producing strains. Since 
TraDΔtm lacks the putative transmembrane domains, this result might indicate that TraDΔtm also 
localizes to the inner membrane in the absence of transmembrane domains. However, it cannot be 
excluded that the observed proteins in the isolated inner membranes are contaminations derived 
from inclusion bodies. A comparative SDS-PAGE analysis of isolated inner membranes derived from a 
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TraDΔtm producing strain collected at different growth times is shown in Figure 7. The overproduced 
TraDΔtm migrates on SDS-PAGE gels at a position corresponding to a molecular mass of 70 kDa and is 
dominantly represented in the membrane samples obtained from 12 and 16 h growth time. After 
further evaluation of the overexpression data (data not shown) the best ratio between the yields of 
membrane inserted TraD and the begining of the formation of large amounts of inclusion bodies 
have been determined at a growth time of approximately 10 hours. These conditions were used for 
further attempts to solubilize and isolate TraD and TraDΔtm from inner membranes of E. coli. 
 
Figure 7: SDS-PAGE with isolated inner membranes of 
TraDΔtm overproduced in autoinduction medium at 30°C. 
The corresponding growth time is indicated on top of the 
lanes. TraDΔtm migrates at a position corresponding to a 
molecular mass of 70 kDa. A molecular size standard is given 
on the left site of the gel (PageRuler Plus Protein Ladder; 
Fermentas). 
 
 
 
 
4.2.2 Membrane-bound TraD cannot be solubilized from isolated inner membranes 
The overproduction of full-length TraD and TraDΔtm in autoinduction medium led to an 
incorporation of the overproduced protein into the inner membranes of E. coli. To purify TraD, the 
overproduced protein should be extracted from the isolated membranes. Therefore, isolated inner 
membranes were either incubated under conditions with high ionic strength (1 M NaCl or 
0.1 M NaCO3; pH 8.0) or in the presence of 10 different detergents. The conditions with high ionic 
strength have previously been used to extract membrane associated proteins, whereas in the 
conditions with different detergents the membranes are completely solubilized and also integral 
membrane proteins are extracted. The 10 different detergents that have been tested to solubilize 
TraD from the inner membranes included non-ionic, zwitter-ionic and anionic detergents with a 
range of different critical micellar concentrations. After incubation of the isolated inner membranes, 
the mixture was centrifuged and the supernatant and pellet fractions from all conditions were 
analyzed by 11% SDS-PAGEs (see Table 49 and Figure 8). Neither the extraction with 1 M NaCl nor 
with 0.1 M NaCO3 led to a removal of TraD or TraDΔtm from the membrane. Interestingly, small 
amounts of solubilized TraD could be observed within 6 different conditions including all tested 
detergent types (Zwittergent 3-14; DM; LDAO; Laurylsarcosine; ASB-14; Triton X-100). Slight 
differences were observed comparing the different detergent types with each other. The largest 
amount of soluble TraD was observed for the two zwitter-ionic detergents Zwittergent 3-14 and 
ASB-14, as well as the anionic detergent Laurylsarcosine. All three of them are considered as ‘harsh’ 
detergents. The other three conditions showed less soluble TraD and contained the ‘mild’ non-ionic 
detergents LDAO, DM and Triton X-100. Even though TraD was solubilzed in part from the inner 
membranes by using different detergents, further extensive attempts to optimize the purification of 
TraD have failed. The protein aggregated on different column materials and could not be eluted after 
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binding. This indicates that the solubilized protein most likely is not folded correctly and suggests 
that it might represent a contamination of aggregated protein remaining from the inclusion bodies.  
 
 
Figure 8: Solubilization and membrane-detachment screen of 
isolated inner membranes with overproduced TraDΔtm. 
Quantitative SDS-PAGE analyses with supernatants (S) and 
resuspended pellet fractions (P) from solubilization and 
detachment experiments. The corresponding detergents are 
indicated on top of the gels. The migration position of TraD∆ tm is 
indicated with the black arrows on the left site. 
 
 
 
 
 
 
Table 49: Summary of solubilization and membrane-detachment screen with membrane-bound TraDΔtm.  
Symbol explanation: + almost all protein; +/- approximately half of the protein amount; - no protein 
Detergent  Concentration Protein insoluble Protein soluble 
Zwittergent 3-14  1 % +/- +/- 
n-Decyl-β-maltosid (DM) 1 % +/- +/- 
n-Undecyl-β-D-maltopyranosid (UDM) 1 % + - 
n-Dodecyl-β-maltosid (DDM) 1 % + - 
Lauryldimethylamin-N-oxid (LDAO)  1 % +/- +/- 
Na-laurylsarcosine  2 % +/- +/- 
Na-deoxycholate  1 % + - 
Chaps  1 % + - 
ASB-14  1 % + +/- 
Triton X-100  1 % + +/- 
NaCl  1 M + - 
Na-carbonate  100 mM + - 
 
 
4.2.3 TraD can be isolated and purified as denatured protein 
Neither purified TraD nor TraDΔtm could be obtained in an active form after overproduction in E.coli. 
Large amounts of both proteins were, however, available as inclusion bodies. Therefore, it was tried 
to purify the protein from inclusion bodies. An initial purification of the inclusion bodies was 
achieved after several wash and centrifugation steps leading to large quantities of insoluble TraD and 
TraDΔtm. The insoluble protein was denatured in 6 M guanidine and was further purified with 
Results 
 
 
 
Page | 81  
 
Ni-affinity chromatography as described in Chapter 3.4.2. A representative SDS-PAGE analysis 
showing the diffent steps of a purification of TraDΔtm is shown in Figure 9. The purified protein 
migrates at a position corresponding to a molecular mass of 70 kDa and represents the most 
dominant protein within the samples. The smeary migration pattern of the samples results from 
remaining guanidine rests which were not removed by TCA precipitation. High losses of protein were 
observed during the purification due to a weak binding interaction with the column material. This 
could either result from the choosen buffer conditions or, rather unlikely in denaturing conditions, a 
suboptimal accessibility of the His-tag. The fact that large amounts of unbound TraD could be 
detected in the flowthrough also strengthens the assumption of a weak binding affinity. The elution 
of TraDΔtm started already in the presence of low Imidazole concentrations of 20 mM within the 
performed wash steps. Several optimization trials to reduce the loss of protein failed. Other elution 
protocols, like e.g. elution at lower pH also failed and resulted in aggregation of the protein on the 
column. Despite this, the purification of denatured TraDΔtm in the presence of Triton X-100 resulted 
in the elution of TraDΔtm of high purity, as shown in Figure 9. Since this condition resulted in 
reasonable amounts of purified protein, this protocol was used for further isolation of TraD. The 
purification of denatured protein was succesfull for full-length TraD and TraDΔtm, but the highest 
amounts and the best purity were obtained with TraDΔtm. Therefore, this protein was used 
preferably in further refolding assays. 
 
 
 
 
 
 
 
 
 
 
Figure 9: Ni-affinity purification of TraDΔtm under denaturing conditions. 11% SDS-PAGEs with TCA precipitated samples 
of different purification steps. Molecular masses are indicated on the left site. TraDΔtm migrates at the position of 
70 kDa. The labeling of the lanes corresponds the following: M - Prestained Plus Protein Ladder (Fermentas); 
IB - inclusion bodies; FT - flowthrough; W1 till W11 - different wash steps with increasing Imidazole concentration as 
described in Chapter 3.4.2.  
 
4.2.4 Soluble TraD can be obtained by refolding the denatured protein 
To test whether the purified denatured TraD could be refolded to an active state the purified 
denatured protein was rapidly diluted into different buffers (buffer conditions are summarized in 
Chapter 3.4.3 Table 19). After refolding the mixture was centrifuged. The supernatants containing 
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the soluble and possibly actively refolded protein and pellet fractions of the different refolding 
conditions were quantitatively analyzed by 11% SDS-PAGEs and are summarized in Figure 10. The 
results were compared with regards to the solubility of the protein, an immediate pellet formation 
after mixing the protein with the buffer, and aggregation of the protein in refolding buffer over night. 
The observed results are summarized in Table 50.  
Almost all tested conditions resulted in soluble protein, but differed among each other in terms of 
the amount of soluble protein. Five conditions showed a slight precipitation of the protein after 
mixing with the corresponding buffer (‘5’; ‘6’; ‘10’; ‘12’; ‘14’). One refolding condition including 
Na-deoxycholate (‘17’) immediately ended up in a complete precipitation of the protein after mixing 
with the refolding buffer. Apperently, the Na-deoxycholate containing buffer and the protein reacted 
with each other to a white gel-like mixture resulting in an almost complete loss of the protein.  
Interestingly, the solubility of TraDΔtm is influenced by the different pH values and detergents. In 
several conditions TraDΔtm was successfully refolded to soluble protein. The most promising 
refolding conditions were found with 0.1% (‘7’) and 0.5% (‘8’) Triton X-100, with almost no 
aggregation of the protein after incubating the samples over night on ice. Condition ‘7’ was used to 
refold larger volumes of the denatured protein which were further used for purification trials. 
Unfortunately, the refolded protein could not be purified further since it was not possible to elute 
the bound protein from the column material. Even testing several different column materials could 
not solve this problem. Since the refolded protein was already reasonable pure initial ATP binding 
experiments were performed, but no ATP binding was observed with the soluble protein.   
Unfortunately, even after screening many different overexpression conditions, solubilization 
conditions and refolding conditions, no active protein was obtained. Therefore, a biochemical 
characterization of the coupling protein TraD was not possible.  
 
 
Figure 10: Refolding screen performed with purified TraD∆tm. 
Quantitative SDS-PAGE analyses of supernatants (S) and 
resuspended pellet fractions (P) from over night refolding 
experiments. The buffer conditions are given on top of the 
lanes corresponding the numbering in Table 50. The migration 
position of TraD∆tm is indicated with the black arrows on the 
left site. 
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Table 50: Summary of refolding screens performed with purified denatured TraDΔtm. The numbering of the buffers 
correspond the numbering in Table 19, Chapter 3.4.3. Symbol explanation: + almost all protein; +- approximately half of 
the protein amount; - no protein 
Buffer Protein 
soluble  
Protein 
precipitated 
Protein 
aggregates  
 Buffer Protein 
soluble  
Protein 
precipitated 
Protein 
aggragates 
1 + - +-  10 + + (yellow) +- 
2 + - +-  11 + - +- 
3 + - +-  12 + + (white) + 
4 + - +-  13 + - +- 
5 +- + (white) +  14 +- + (white) + 
6 +- + (white) +  15 + - +- 
7 + - -  16 + - +- 
8 + - +-  17 - + (white) - 
9 + - +-      
 
4.3 Biochemical characterization of Yaf 
The DNA processing mechanism of T4SSs is often mediated by several different proteins which form 
together with the DNA a nucleo-protein-complex, the so called relaxosome. The most important 
component of the relaxosome is the relaxase that introduces a strand specific nick in one strand of 
the dsDNA. The relaxase is often covalently linked to the nicked DNA strand and is transferred to the 
recipient cell. In addition to the relaxase, several other proteins are involved in facilitaing DNA 
processing and targeting, for example by providing access of the relaxase to the DNA, by stabilizing 
the nucleo-protein complex, by positioning the relaxase in close proximity to the nick site or by 
facilitating the targeting of the complex to the coupling protein. These proteins are either called 
nicking accessory proteins or spatial positioning factors.  
Many nicking accessory proteins are relatively small proteins (approximately 12-17 kDa) and have a 
conserved ribbon-helix-helix domain that is often found in transcriptional regulators. To facilitate 
accessibility of the relaxase to the nick site within the oriT region, two homodimers bind to specific 
DNA sequences near the oriT and tetramerize via protein-protein interactions. The formation of a 
tetramer introduces a bend into the dsDNA that enables the positioning of the relaxase. The overall 
homology of these proteins is very low and, therefore, these proteins are difficult to identify in 
genomes or on plasmids using bioinformatical approaches. Possibly, the DNA processing mechanism 
of the T4SSs of N. gonorrhoeae also involves, next to the relaxase TraI, other relaxosome 
components. However, until now, no such relaxosome components have been identified. Since the 
hypothetical protein Yaf is encoded within the same operon like traI and traD, it represents a 
promising candidate for a putative nicking accessory protein in N. gonorrhoeae. Similar to other 
accessory proteins, Yaf is a small protein and has no homology to other proteins. Furthermore, a 
possible ribbon-helix-helix domain organization of Yaf was suggested by computational secondary 
structure predictions. Therefore, the hypothetical protein Yaf was isolated and biochemically 
characterized to study its possible role in the DNA processing mechanism of the T4SS of N. 
gonorrhoeae.  
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4.3.1 Recombinant overproduction of Yaf leads to high yields of soluble protein 
His-tagged Yaf and native Yaf were overproduced in E. coli BL21(DE3) Star cells. After induction with 
IPTG the cells were further incubated at 37°C and reached optical densities of 2.5 – 3.5. None of the 
cultures showed retarded growth rates. The expression levels of His-tagged and native Yaf were high 
and large amounts of soluble protein were produced. The yields of soluble protein were 
approximately equal for both constructs. The purification from 1 L liquid culture yielded in 
approximately 25 mg Yaf of high purity. 
 
4.3.2 His-tagged Yaf can be isolated using a two step protocol 
The isolation of His-tagged Yaf was performed using a two step protocol including a Ni-affinity 
chromatography step and a size exclusion chromatography step as described in Chapter 3.6.4. Yaf 
elutes from the Ni-affinity column at an imidazole concentration of 100 mM. The elution profile is 
shown in Figure 11 A. All elution fractions were analyzed by 15% SDS-PAGEs. Yaf migrates on 
SDS-PAGE gels at a position corresponding to a molecular mass of 14 kDa. The calculated molecular 
mass of monomeric His-tagged Yaf is 17.6 kDa. The difference between these two masses can be 
explained by the influence of several different factors during electrophoresis that interfere with the 
migration of proteins. These are for example: different salt concentrations in the samples, the pI of 
the protein with regard to the pH of the electrophoresis buffer, the denaturing state of the protein 
with regard to the SDS concentration, or different substances present in the sample which could 
influence the migration of the proteins. Taking the performed SDS-PAGE analysis into account, 
elution fractions corresponding to fractions B7 to C7 (see Figure 11 A) were pooled together and the 
pooled samples were directly loaded on a gelfiltration column. The elution profile from the size 
exclusion chromatography showed several peaks that are in part difficult to separate from each 
other (see Figure 11 B). The gelfiltration column was calibrated with commercially available 
molecular weight standards and the molecular masses of the different elution peaks from isolated 
Yaf were calculated using the calibration data as reference. A peak with low intensity (25 mAU) was 
observed at an elution volume of 45 ml which corresponds to the exclusion volume of the column 
containing aggregated proteins. The maximum of the most dominant protein peak (480 mAU) was 
observed at 54 ml corresponding to an approximate molecular mass of 69 kDa, which is in agreement 
with the calculated molecular mass of a Yaf tetramer (70.3 kDa). Another peak eluted with its 
maximum at 67.5 ml, together with a left and a right shoulder that eluted at 63 ml and 71 ml. The 
peak at 67.5 ml corresponds to a molecular mass of 29 kDa and most likely represents the Yaf dimer. 
The shoulders at 63 ml and 71 ml correspond to masses of 38.5 and 23.5 kDa. These peaks most 
likely correspond with the calculated molecular masses of monomeric Yaf (17.6 kDa) and trimeric Yaf 
(52.8 kDa). Deviations between the observed molecular masses and the calculated molecular masses 
can result from a changed migration behavior of the different oligomeric forms on the gelfiltration 
column, but might also be a result of a slow dynamic equilibrium between the different oligomeric 
states. The different elution fractions were analyzed by SDS-PAGE and Yaf was detected in each of 
the fractions confirming the presence of different oligomeric forms of Yaf. The purified protein was 
free of any detectable contamination on Coomassie stained SDS-PAGE gels and after silver staining 
only at high protein concentration a second very weak band with a molecular mass of 30 kDa 
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(possibly the dimeric form of Yaf) appeared, but mass spectrometry analysis did not detect any 
contamination of the samples. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11: Purification of His-tagged Yaf. (A) Left: Elution profile of Ni-affinity chromatography. The protein was detected 
at 280 nm and is indicated with the blue line. The intensity is given in mAU. The collected fractions are labeled in red. 
Right: 15% SDS-PAGEs with elution fractions from the Ni-affinity chromatography. The labeling of the lanes corresponds 
to the labeling of the elution fractions shown left. Molecular masses are indicated on the left site (PageRuler prestained 
protein ladder; Fermentas). Yaf migrates at a position corresponding to a molecular mass of 14 kDa. (B) Left: Elution 
profile from size exclusion chromatography. The labeling and color-code correspond to the description in ‘A’. Right: 15% 
SDS-PAGE with elution fractions from size exclusion chromatography. The lanes represent the corresponding elution 
fractions. Molecular masses are indicated on the left site (PageRuler prestained protein ladder; Fermentas). Yaf migrates 
at a molecular mass of 14 kDa. 
Results 
 
 
 
Page | 86 
 
4.3.3 Native Yaf can be isolated using a four step protocol 
The isolation of native Yaf requires a four step protocol including an anion exchange step followed by 
two cation exchange steps and a size exclusion chromatography step. The protocol is described in 
detail in Chapter 3.6.5.  
Native Yaf eluted from the anion exchange column at NaCl concentrations of 250 – 500 mM 
(fractions A6 till A11 in Figure 12 A). The elution fractions were analyzed by 15% SDS-PAGEs shown 
next to the elution profile in Figure 12 A. Yaf eluted in fractions A6 till A11 and migrated at a 
molecular mass of 13 kDa, which is in reasonable agreement with the molecular mass of a monomer 
(16.2 kDa) (see Figure 12 A). Several contaminating proteins still remain in the Yaf containing 
fractions after this first purification step. 
Therefore, the Yaf containing elution fractions were pooled and diluted in the buffer from the anion 
exchange chromatography without NaCl, to enable the binding of the proteins to a cation exchange 
column in the second purification step. The Yaf containing elution fractions were pooled and again 
diluted with buffer without NaCl. Yaf was concentrated with a second cation exchange 
chromatography with a slightly changed protocol. The elution profile from this second cation 
exchange chromatography, as well as the SDS-PAGEs with different elution fractions are shown in 
Figure 12 B. Yaf was observed in the peak corresponding to the fractions A5 and A6 (300 – 500 mM 
NaCl) (see Figure 12 B). The migration patterns of the eluted proteins from the second cation 
exchange chromatography on SDS-PAGE gels look similar to the results obtained from the anion 
exchange chromatography and still most of the previously observed contaminations are present.  
The Yaf containing fractions were pooled together and were further concentrated before size 
exclusion chromatography was performed as a final purification step. Similar to His-tagged Yaf, 
native Yaf showed almost no aggregation during the purification, but differs in the elution profile of 
the size exclusion chromatography from the His-tagged protein. Native Yaf eluted from the 
gelfiltration column with two distinct peaks (see Figure 12 C). The first peak had a low intensity (600 
mAU) and eluted at a volume corresponding to a molecular mass of 72 kDa. The calculated mass of 
native Yaf tetramer (64.8 kDa) differs only slightly from the calculated mass of His-tagged Yaf 
tetramer (70.4 kDa). The second peak had a much higher intensity (> 5000 mAU) and eluted at a 
volume corresponding to a molecular mass of 33.3 kDa. This peak most likely represents dimeric Yaf 
(calculated mass of the native dimer is 32.4 kDa). The elution profiles of the size exclusion 
chromatography of His-tagged and native Yaf clearly show that the presence of a His-tag influences 
the oligomeric state of Yaf, by stabilizing the tetrameric form. Native Yaf could thus be purified at 
high concentrations. The fractions from the gel filtration column containing tetrameric Yaf are still 
contaminated by small amounts of a protein with a molecular mass of 45 kDa.   
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Figure 12: Purification of native Yaf. (A) Left: Elution profile of anion exchange chromatography. The protein was 
detected with UV light at 280 nm and is indicated as blue line. The intensity of the UV light is given in mAU. The 
concentration of ‘Ion exchange buffer B’ is indicated as green line (gradient from 0 – 1 M NaCl). The collected fractions 
are labeled in red. Middle: 15% SDS-PAGE with elution fractions from anion exchange chromatography. The labeling of 
the lanes corresponds to the elution fractions. Molecular masses are indicated on the left site (PageRuler unstained 
protein ladder; Fermentas). Yaf migrates with a molecular mass of 13 kDa within fractions A5 - A10. (B) Left: Elution 
profile from the second cation exchange chromatography. Right: 15% SDS-PAGE with elution fractions from the second 
cation exchange chromatography. Yaf migrates with a molecular size of 13 kDa in fractions A5 and A6. The labeling 
corresponds to the description in ‘A’. (C) Left: Elution profile from size exclusion chromatography. Right: 15% SDS-PAGE 
with elution fractions from size exclusion chromatography. Yaf migrates with a mass of 13 kDa and within fractions A12 - 
B9. The labeling corresponds to the description in ‘A’.  
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4.3.5 Yaf oligomerizes in four different states with a strong dependency on pH and the 
presence of a N-terminal His-tag 
Several different oligomeric states were observed for isolated His-tagged and native Yaf. The 
estimated molecular masses of the observed oligomeric forms deviate slightly from the calculated 
molecular masses and are summarized in Table 51. The most abundant oligomeric forms are dimers 
and tetramers. The equilibrium between different oligomeric states of Yaf is influenced by the 
presence of an N-terminal His-tag and by different buffer conditions. The influence of the N-terminal 
His-tag on the oligomerization of Yaf is depicted in an overlay of the elution profiles from 
gelfiltrations of His-tagged Yaf and native Yaf (see Figure 13). Both proteins tend to form dimers and 
tetramers; the His-tagged Yaf mainly forms tetramers, whereas the native Yaf mainly forms dimers, 
even at high protein concentrations. From these results it can be concluded that the N-terminal 
His-tag has a stabilizing effect on the formation of tetremeric Yaf, whereas the dimeric form seems to 
be the naturally oligomeric state of Yaf. 
 
 
Figure 13: Overlay of elution profiles from 
gelfiltrations performed with His-tagged Yaf and 
native Yaf. The elution of the protein was monitored 
with UV light at 280 nm. The intensities are given in 
mAU. The collected elution fractions are indicated in 
red, the elution volume is given in ml below the 
fractions. The elution profile of His-tagged Yaf is 
labeled in dark blue, the elution profile of native Yaf 
is labeled in cyan. The tetramer of Yaf elutes within 
fractions A11 - B10. The dimer of Yaf elutes within 
fractions B8 - B4. 
 
 
 
 
 
Table 51: Overview of the calculated and observed molecular masses of the different oligomeric states of Yaf 
Oligomer MWCalulated MWGelfiltration MWSDS-PAGE 
MonomerHis-tagged 17.6 kDa 20 kDa 14 kDa 
DimerHis-tagged 35.2 kDa 34.7 kDa 28 kDa 
TrimerHis-tagged 52.8 kDa 48 kDa - 
TetramerHis-tagged 70.4 kDa 74 kDa - 
MonomerNative 16.2 kDa - 13 kDa 
DimerNative 32.4 kDa 33.3 kDa - 
TrimerNative 48.6 kDa - - 
TetramerNative 64.8 kDa 72 kDa - 
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To test whether the oligomeric state of Yaf is further influenced by different buffer conditions, 
His-tagged Yaf was transferred to different buffers and gelfiltration experiment were performed in 
the same buffer conditions. The buffer exchanges were performed with a desalting column 
(GE Healthcare) as described by the manufacturer and the samples were concentrated before 
injection to the gelfiltration column. To exclude an influence of different buffer components only one 
component was changed in each experiment. Figure 14 shows an overlay of the elution profiles from 
different gelfiltration experiments performed under different pH conditions.  
Incubation of His-tagged Yaf at pH 6.0 led to significant aggregation of the protein. The 
non-aggregated protein showed a significant change in the observed elution volumes compared to 
the protein at pH 7.0. At pH 6.0 His-tagged Yaf eluted at volumes corresponding to molecular masses 
of 81 kDa and 43 kDa. Most likely these two peaks still correspond to the tetrameric and dimeric 
forms of Yaf. Possibly the lower pH influences the interaction of the protein with the column material 
which might lead to a faster elution of the protein from the column then expected.  
At pH 7.0, only very little aggregation was observed during the concentration steps and the size 
exclusion chromatography. Three oligomeric states were identified (see Figure 14; dark grey line). 
One peak (2100 mAU) eluted at 53.5 ml (corresponding to a mass of 71 kDa) and fits almost perfect 
with the calculated mass of a tetramer. A second peak (750 mAU) eluted at 65 ml and corresponds 
with a mass of 34.7 kDa to the size of a dimer (35.2 kDa). A small shoulder (250 mAU) was observed 
at 71 ml, corresponding to a molecular mass of 23 kDa. The observed mass deviates from the 
calculated mass but most likely represents the monomer. At pH 7.0 the tetramer is clearly the most 
abundant oligomeric form.  
At pH 8.0 the elution profile shows two distinct peaks with almost no aggregation (see Figure 14; 
light blue line). Similar to pH 7.0 a peak (2600 mAU) with tetrameric His-tagged Yaf eluted at 53.5 ml. 
The second observed peak (1450 mAU) eluted at a volume of 73 ml, corresponding a molecular mass 
of 20 kDa representing the approximate size of a Yaf monomer (17.6 kDa). The oligomerization 
pattern of Yaf observed at pH 8.0 differed significantly from that observed for pH 6.0 and 7.0, with 
the loss of the dimeric form and the appearance of the monomeric form.  
At pH 9.0 three different oligomeric states can be observed (see Figure 14; violet line). The first 
elution peak with a volume of 53.5 ml represents tetrameric Yaf, as already observed for the other 
tested conditions. At a volume of 60 ml a second peak eluted at a volume corresponding to a 
molecular mass of 48 kDa. The third peak contained monomeric Yaf with a molecular mass of 20 kDa 
and eluted at a volume of 73 ml. The oligomeric form of a dimer was not observed at pH 9.0. The 
identity of the peak that eluted at a volume corresponding to a molecular mass of 48 kDa is unclear, 
but the size suggests that this peak might be related to the trimer. Taken together, these results 
clearly show that the oligomeric state of Yaf is strongly influenced by the pH. 
Additionally, it was analyzed whether the equilibrium between the different oligomers was static or 
dynamic. To test this, purified Yaf was concentrated using an Amicon concentrator and the 
oligomerization state was analyzed by size exclusion chromatography. A representative comparison 
of the elution profiles from gelfiltrations with two different Yaf concentrations is depicted in 
Figure 15 A. It can be clearly observed that an increasing protein concentration results in a shift from 
the lower oligomeric states to the higher oligomeric states. This indicates that Yaf is indeed in a 
dynamic equilibrium between the different oligomeric states. During these experiments it was also 
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observed that the elution profiles of Yaf differed when they were injected at different times after the 
concentration. This indicates that the dynamic conversion between the different oligomeric states is 
a slow process. Fractions corresponding to dimeric and tetrameric Yaf were immediately frozen at 
-80°C after elution from the gelfiltration column. After thawing the samples were used as quickly as 
possible to prevent conversion between the different oligomeric states as much as possible. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14: Overlay of elution profiles of gelfiltrations performed in buffers of different pHs. The elution of the His-tagged 
Yaf was monitored at 280 nm. The elution fractions are indicated in red, the elution volume is given in ml below the 
fractions. The molecular masses of the eluted proteins are indicated on top of the peaks. Color code of elution profiles 
from the different tested buffering conditions: green - pH 6; dark grey - pH 7; light blue - pH 8; violet - pH 9 
 
Finally, it was tested whether the presence of the divalent cation Mg2+ has an influence on the 
oligomerization state of Yaf. Therefore, Yaf was transferred to a buffer containing 10 mM MgCl2 and 
the protein was loaded on a gelfiltration column equilibrated with the same buffer. The overlay of 
both profils is shown in Figure 15 B. Since no significant effect of MgCl2 was observed, it can be 
concluded that Mg2+ does not influence the oligomerization state of Yaf.  
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Figure 15: Oligomerization of His-tagged Yaf at different protein concentrations and in the presence of MgCl2. The elution 
of the proteins was monitored at 280 nm. The collected elution fractions are indicated in red, the elution volume is given 
in ml below the fractions. (A) Overlay of elution profils with His-tagged Yaf injected at 2 mg/ml (blue) and 4 mg/ml 
(green). (B) Overlay of elution profiles from His-tagged Yaf without MgCl2 (blue) and in the presence of 10 mM MgCl2 
(green).  
 
Interestingly, long term storage of dimeric Yaf at 4°C led to the formation of SDS stable dimers. After 
storage of dimeric Yaf for > 2 months at 4°C a novel band was reproducibly observed at 28 kDa 
corresponding to the molecular mass of Yaf dimers. A comparison of the same elution fraction with 
freshly purified protein and long term stored protein is shown in Figure 16. The samples were mixed 
with sample buffer containing DTT before loading on the gel. The precise reason why the dimeric 
state of Yaf is stabilized over time is not known. Most likely, it is caused by the formation of a 
stabilized form of the dimer over time. This stable dimer was not observed with samples stored 
frozen at -80°C.   
 
Figure 16: Comparison of freshly purified Yaf dimer and a sample after 2.5 
month storage at 4°C. The samples were analyzed with 15% SDS gels. 
Molecular masses are indicated on the right site (PageRuler unstained 
protein ladder; Fermentas). Fresh purified Yaf migrates at a position 
corresponding to a mass of 14 kDa. The 2.5 month old Yaf migrates at 
positions corresponding to masses of 14 kDa and 29 kDa.  
 
 
 
 
 
4.3.6 Limited proteolysis revealed a high resistance of Yaf against trypsin and elucidates a 
possible domain organization of Yaf 
To obtain insights into the structural organization of Yaf, limited proteolysis experiments with trypsin 
and ProteinaseK were performed. The experiments were performed as described in Chapter 3.8.10. 
The samples were analyzed by SDS-PAGE and the obtained results from both proteolysis experiments 
are shown in Figure 17. For these experiments elution fractions corresponding to the dimeric and 
tetrameric forms of Yaf were used. 
Remarkably, tetrameric His-tagged Yaf was not digested in the presence of 20 µM trypsin, even after 
30 min incubation at 37°C. This demonstrates that the His-tagged tetrameric Yaf is highly resistant to 
trypsin. The two proteins migrating at molecular masses of 14 and 12 kDa (indicated with ‘3’ on the 
left site in Figure 17 A) are also present in the trypsin control, indicating that they are most likely 
either contaminations of the trypsin or autocatalytic cleavage products.  
A proteolytic digest of dimeric His-tagged Yaf seems to start at trypsin concentration of 12 µM 
(see Figure 17 A) suggesting that dimeric His-tagged Yaf is more sensitive to trypsin then tetrameric 
His-tagged Yaf. Indeed, also dimeric native Yaf was more sensitive to the proteolytic activity of 
trypsin than tetrameric His-tagged Yaf and was digested at lower trypsin concentrations (data not 
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shown). This suggests that either the N-terminal His-tag itself prevents the proteolytic digest of Yaf, 
or that tetrameric Yaf is more resistant to the proteolytic activity of trypsin, possibly due to a 
restricted accessibility of the protease.  
Similar results were obtained for limited proteolysis with ProteinaseK. Like observed with trypsin, 
dimeric Yaf was also in the presence of ProteinaseK more sensitive to the proteolytic activity, 
whereas tetrameric Yaf was only digested at higher protease concentrations (see Figure 17 B). Yaf 
was more sensitive to the proteilytic activity of ProteinaseK than to trypsin, and even the tetrameric 
Yaf was digested. A digested fragment migrating with a molecular mass of 10 kDa was observed at 
ProteinaseK concentrations of 0.9-1.7 µM. Such a fragment was not detected in the ProteinaseK 
control. Thus, the obtained 10 kDa fragment most likely represents a structurally stabilized domain of 
Yaf.  
Based on these results, it can be concluded that Yaf has a structural organization that is higly 
resistant to digestion with the endopeptidase trypsin, and is more sensitive to the exopeptidase 
ProteinaseK. Yaf is a very stable protein, and the tetrameric form of Yaf seems to be more stable to 
proteolytic digestion than the dimeric Yaf. These results also confirm that the dimeric and tetrameric 
states of Yaf are maintained after rapid freezing of the protein in liquid nitrogen and storage at -80°C, 
and that these oligomeric states only interconvert slowly.  
 
 
Figure 17: Limited proteolysis of isolated dimeric and tetrameric Yaf. (A) Limited trypsin digest with increasing trypsin 
concentrations incubated with 3.4 µM dimeric Yaf and 4 µM tetrameric Yaf. The lanes are labeled with the corresponding 
trypsin concentrations and the digested Yaf oligomer. A typsin control is indicated with the black triangle. Molecular 
masses are indicated on the right site (PageRuler unstained protein ladder; Fermentas). (B) Limited ProteinaseK digest 
with increasing ProteinaseK concentrations incubated with 3.4 µM dimeric Yaf and 4 µM tetrameric Yaf. The labeling of 
the lanes and the molecular size standard correspond to the description in ‘A’. Proteins and peptide fragments indicated 
on the left site: 1-trypsin; 2-Yaf; 3-contamination/self digest products of trypsin; 4-ProteinaseK; 5-contamination/self 
digest products of ProteinaseK; 6-putative fragments of digested Yaf 
 
4.3.7 Yaf binds to dsDNA with low affinity 
The DNA binding activity of Yaf was tested with electrophoretic mobility shift assays with different 
dsDNA and ssDNA substrates as described in Chapter 3.8.3. Increasing concentrations of Yaf 
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(0.1-5 µM) were incubated with different γ-P32-ATP labeled PCR products containing either the GGI 
oriT sequence or the GGI flanking difA site and were analyzed for DNA binding with native TB PAGEs.  
The binding of dsDNA substrates was tested with two different dsDNA substrates. At protein 
concentrations above 0.5 µM a higher migrating DNA fragment was observed, suggesting that Yaf 
binds dsDNA with low affinity (> 5 µM). The higher migrating DNA fragment was observed for both 
dsDNA substrates suggesting that the binding is sequence unspecific (see Figure 18 A). The dsDNA 
binding was observed in elution fractions corresponding to dimeric and tetrameric forms of Yaf.   
Similar DNA binding assays were performed with ssDNA substrates. Even though several ssDNA 
substrates were tested with different Yaf concentrations, no ssDNA binding was observed. The 
results from DNA binding experiments with elution fractions containing dimeric and tetrameric Yaf 
and two different ssDNA substrates are depicted in Figure 18 B, reflecting the results of other ssDNA 
binding assays. These results clearly demonstrate that Yaf does not bind to ssDNA under the tested 
conditions. 
 
Figure 18: Autoradiographs of DNA binding assays of dimeric and tetrameric Yaf performed with γ-P32-ATP labeled DNA 
substrates. (A) DNA binding experiment with two dsDNA substrates tested in buffer conditions at pH 7.0 analyzed on 
7.5% native TB gels. The lanes are labeled with the corresponding concentrations of dimeric and tetrameric Yaf. The DNA 
controls are indicated with black triangles. The corresponding dsDNA fragments are indicated on the right site. (B) DNA 
binding assays performed with two different ssDNA substrates analyzed on 7.5% native TB gels. The corresponding 
ssDNA substrate is indicated on top. The labeling of the lanes corresponds the labeling described in ‘A’. 
 
4.3.8 A Co2+ and Mn2+ dependent sequence unspecific nuclease activity is associated with 
dimeric and tetrameric Yaf 
To test whether the DNA binding activity of Yaf is influenced by the presence of divalent cations, DNA 
binding assays were performed in the presence of Mg2+, Mn2+ and Co2+ and several other possible 
metal cofactors (Ca2+, Ni2+, Cu2+, Zn2+). The obtained results revealed a nuclease activity that is 
associated with elution fractions containing dimeric and tetrameric Yaf in the presence of Co2+ and 
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Mn2+ (see Figure 19). This activity was not observed with the other tested divalent cations (data not 
shown). The degradation of the DNA was observed for different PCR products and was sequence 
unspecific. Control experiments with heat inactivated Yaf did not show DNA degradation. The 
degradation of dsDNA leads to the appearance of small nucleotide fragments in the lower part of the 
gels (labeled with ’b’). Remarkably, the level of nuclease activity observed in fractions containing 
dimeric and tetrameric Yaf differed between both oligomeric states and was stronger in fractions 
containing dimeric Yaf. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 19: Autoradiographs of DNA degradation assays with His-tagged Yaf and two γ-P32-ATP labeled dsDNA substrates. 
Left: Native TB PAGE (7.5%) of DNA degradation assay using a 349 bps PCR product with the sequence of GGI oriT as 
dsDNA substrate. The assay was performed with 2 µM of dimeric (1) and tetrameric (2) Yaf in the presence of CoCl2 and 
MnCl2. Negative controls with inactivated proteins were performed for dimeric (3) and tetrameric (4) Yaf. DNA controls 
are indicated with black triangles. PCR fragments are indicated with the black arrow (a) and degradation products are 
indicated with the black arrow (b) on the left site. Right: Native TB PAGE (7.5%) of DNA degradation assay with a 425 bps 
PCR product containing the difA site. The labeling corresponds to the previous description. 
 
To test if Yaf also degrades ssDNA substrates in the presence of different divalent cations, similar 
experiments were performed with different oligonucleotides. Figure 20 shows an overview of the 
nuclease activity of Yaf on five different oligonucleotides. Two complimentary oligonucleotides 
containing the sequence of the GGI oriT (see Figure 20 A), as well as two complementary 
oligonucleotides containing the sequence of the F-plasmid oriT (see Figure 20 B) and a T74 
oligonucleotide (see Figure 20 C) were used as ssDNA substrates. Interestingly, the nuclease activity 
of Yaf on ssDNA substrates was again only observed in the presence of Mn2+ and Co2+, but not in the 
presence of Mg2+. Both GGI oriT containing oligonucleotides and the ‘rev’ F-plasmid oriT containing 
substrate were completely degraded (see Figure 20 A and B (right gel)). The degradation of the F-
plasmid oriT ‘fwrd’ substrate occured via an intermediate fragment (‘b’) that migrates only slightly 
faster than the unprocessed substrate (see Figure 20 B (left gel)). Remarkably, the T74 substrate was 
not degraded, regardless of the presence of metal cofactors. Remarkably, the degradation of ssDNA 
was only observed for elution fractions containing dimeric Yaf and not for tetrameric Yaf.  
Taking these results into account, it can be concluded that the Mn2+ and Co2+ dependent nuclease 
activity associated with fractions containing dimeric and tetrameric Yaf is sequence unspecific and 
that dsDNA and ssDNA substrates can be degraded, although the degradation of ssDNA substrates 
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seems to require the formation of secondary structures. Comparing the degradation efficiency of 
dimeric and tetrameric Yaf on dsDNA and ssDNA substrates, it is obvious that the dsDNA substrates 
were degraded faster than the ssDNA substrates and that tetrameric Yaf did not degrade ssDNA 
substrates, demonstrating that the nuclease activity associated with fractions containing dimeric and 
tetrameric Yaf preferentially degrades dsDNA. 
The DNA degrading activity was only observed in elution fractions containing dimeric and tetrameric 
Yaf. A background activity caused by a contamination of these fractions can be most likely excluded 
since no contaminating proteins were detected on Coomassie stained SDS gels and by mass 
spectrometry analysis, however, a possible contamination with DNAse cannot be completely 
excluded. 
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Figure 20: Autoradiographs of DNA degradation assays with His-tagged Yaf dimer and different ssDNA substrates. 
Samples were analyzed on 7.5% native TB gels. DNA controls are indicated with black triangles. Lanes with active Yaf 
dimer are labeled ‘1’, lanes with inactivated protein are labeled ‘2’. All ssDNA substrates were tested with Mg2+, Mn2+ 
and Co2+ as metal cofactor. Unprocessed oligonucleotides are indicated with the black arrow (a) on the left site, 
degraded fragments are indicated with the black arrows (b) and (c). Lanes with obvious degradation activity are 
indicated with black triangles below the gels. (A) TB PAGEs of degradation assays performed with two complementary 
75 bps oligonucleotides with GGI oriT sequence. (B) TB PAGEs of degradation assays performed with two complementary 
75 bps oligonucleotides with F-plasmid oriT sequence. (C) TB PAGE using a T74 oligonucleotide as ssDNA substrate.  
 
4.3.9 Yaf does not degrade supercoiled plasmid DNA but shows a sequence unspecific 
metal dependent relaxation activity enhanced in the presence of Mn2+ and Co2+ 
To characterize the DNA processing activity of Yaf further, DNA relaxation assays were performed 
with supercoiled plasmid DNA substrates in the presence of different metal cofactors.  
All Yaf containing elution fractions from the size exclusion chromatography were tested for 
relaxation activity. Reactions were performed in the presence of 10 mM Mg2+. Plasmid pEP074 which 
contains the GGI oriT sequence was converted to the relaxed form when incubated with elution 
fractions containing dimeric and tetrameric forms of Yaf (see Figure 21 A). The same assay was 
performed using supercoiled pEP073 plasmid DNA containing the F-plasmid oriT sequence as 
substrate. The obtained results were similar to the results observed for plasmid pEP074 (data not 
shown). Since the relaxation activity only occurs in elution fractions containing dimeric and 
tetrameric Yaf, it can be concluded that the relaxation activity is associated with elution fractions 
containing these two oligomeric states of Yaf.  
To obtain information on the efficiency of the relaxation reaction of Yaf, a relaxation assay was 
performed over a time period of 1 h. The results are depicted in Figure 21 B. Samples were taken 
each 5 min and the reactions were stopped immediately. An initial relaxation of the supercoiled DNA 
(‘II’) was already observed after an incubation time of 5 min. Interestingly, a faster migrating reaction 
intermediate (‘III’) started to occur after an incubation time of 35 min. At this time point almost all 
supercoiled DNA was processed to the relaxed form (‘I’). The observed fragment (‘III’) most likely 
represents a linearized DNA fragment.  
Yaf containing fractions were further incubated with relaxed DNA generated by relegation of 
linearized plasmid (‘I’), supercoiled DNA (‘II’), and a linearized plasmid (‘III’) (see Figure 21 C). The 
results show that Yaf containing fractions only relaxed supercoiled plasmid DNA (‘II’), whereas no 
effect was observed for relaxed (‘I’) or linearized plasmids (‘III’). Since Mg2+ was provided as metal 
cofactor and the previously described degradation activity is dependent on Mn2+ and Co2+, no 
degradation activity on the linearized DNA fragment was observed under the conditions used. The 
results obtained for the religated plasmid DNA show an additional slower migrating fragment (‘IV’). 
This fragment might represent two concatenated plasmids that migrate with a higher molecular 
mass. But, since this fragment was also observed in lower intensities in the DNA control and in the 
negative control with heat inactivated protein, it is most like an artifact of the religation reaction and 
not a Yaf catalysed reaction. This experiment clearly demonstrates that the relaxation activity 
associated with dimeric and tetrameric Yaf containing fractions is a metal dependent reaction leading 
to a convertion of supercoiled plasmids to their relaxed state (see Figure 21 C, lanes 1-4).  
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Taking the previously observed metal dependency of the DNA degradation activity into account, it 
was tested if Mn2+ and Co2+ also influence the relaxation activity of Yaf. A comparison of the results 
obtained with Mg2+, Mn2+ and Co2+ is depicted in Figure 22. Both, Mn2+ and Co2+, increased the 
relaxation activity of Yaf. In the presence of Mg2+ even the highest Yaf concentrations did not lead to 
a complete relaxation of the substrate. Thus, the relaxation reaction of Yaf is enhanced by Mn2+ and 
Co2+ in comparison with Mg2+ and is most efficient in presence of Mn2+. 
 
Figure 21: DNA relaxation assays with His-tagged Yaf. Mg2+ was provided as metal cofactor in all reactions. (A) DNA 
relaxation assay performed with Yaf containing elution fractions from gelfiltration. pEP074 was used as supercoiled DNA 
substrate. The DNA control is indicated with the black triangle. The lanes are labeled corresponding to the elution 
fractions. (B) Time range experiment of DNA relaxation activity of Yaf performed with supercoiled pEP074 substrate. The 
samples were taken each 5 min. The lanes are labeled with the corresponding time points. The 0 min sample represents 
the negative control. (C) Analyses of DNA relaxation and processing activity of Yaf involving three different DNA 
topologies. The different topologies are indicated on top of the gels. The corresponding DNA controls are indicated with 
black triangles. The labeling of the lanes corresponds to following reactions: 1 - Yaf incubated 5 min at 95°C after the 
performed reaction; 2 - reaction with standard conditions; 3 - reaction without Mg2+; 4 - reaction with additional EDTA; 
5 - reaction with standard conditions; 6 - reaction with additional EDTA; 7 - reaction with standard conditions; 
8 - reaction with additional EDTA. The black arrows at both sites of the gels indicate the topology states as following: 
I - relaxed state; II - supercoiled state; III - linearized form; IV - putative plasmid dimer 
 
The observed relaxation activity of Yaf on supercoiled DNA substrates has a high similarity to the 
relaxation activity of E. coli Topoisomerase I. Therefore, further experiments were performed to 
distinguish between both enzymatic activities. It has been reported that Topoisomerase I is strongly 
dependant on the metal cofactor Mg2+ and shows a reduced activity in the presence of Mn2+ and Co2+ 
(293). By contrast, the relaxation activity of Yaf was increased in the presence of Mn2+ and Co2+, and 
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showed reduced levels in the presence of Mg2+. Moreover, the incubation of Yaf containing fractions 
with supercoiled plasmid DNA also resulted in the formation of a linear fragment. These observations 
were used to distinguish between the enzymatic activities of Yaf and a possible contamination with 
E. coli Topoisomerase I. A comparison of the relaxation activity of both enzymes in the presence of 
either Mg2+, Mn2+ or Co2+ is shown in Figure 22.  
Topoisomerase I processed the supercoiled plasmid DNA to the relaxed form via the characteristic  
reaction intermediates forming a “ladder” on the agarose gel (294). Relaxation assays indicated a 
possibly slightly higher activity of Topoisomerase I in the presence of Mg2+, but did not differ much 
between the three metal cofactors. Comparing the results obtained from the performed relaxation 
assays, five differences between both enzymes are observed: I) the activity of Yaf containing 
fractions was contrary to Topoisomerase I enhanced in the presence of Mn2+ and Co2+, II) the 
relaxation reaction of Yaf containing fractions showed no Topoisomerase I typical reaction 
intermediates, III) incubation with Yaf containing fractions resulted in a band migrating at the 
position of the linearized plasmid which is not observed after incubation with Topoisomerase I, 
IV) the relaxation activity of Yaf co-eluted with dimeric and tetrameric Yaf (35 kDa and 70 kDa), 
whereas Topoisomerase I elutes with a molecular mass of 97.5 kDa, and V) Topoisomerase I was not 
detected in fractions containing Yaf at levels necessary for the observed activity. Considering these 
differences, a background activity of E. coli Topoisomerase I resulting from a possible contamination 
of the recombinant overproduced Yaf can be excluded. 
 
Figure 22: Comparison of DNA relaxation activity of Yaf and E. coli Topoisomerase I. The provided metal cofactors are 
indicated on the right site. The DNA control is indicated with the black triangle. The lanes in ‘A’ and ‘B’ are labeled with 
the corresponding protein concentration. The relaxed form of the DNA is indicated with the black arrow (I) and the 
supercoiled form is indicated with the black arrow (II) at the left site. Supercoiled pEP074 plasmid DNA was used as 
substrate. (A) DNA relaxation activity of Yaf. (B) DNA relaxation activity of E. coli Topoisomerase I.  
 
4.3.10 Point mutations lead to significant changes in the solubility of Yaf  
The identification of the catalytical sites of Yaf is very important to further characterize the enzymatic 
activity of the protein. Therefore, attempts have been made to identify homologous proteins with 
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bioinformatical approaches. Such proteins can be used to find conserved residues in the sequence of 
Yaf, which might form the catalytical site of the protein. Initially, Yaf was only identified in Blast 
searches in a few N. gonorrhoeae strains and no other homologous proteins were found. Only 
recently, two other homologous proteins could be identified in N. meningitides and N. bacilliformis. 
The homology between the N. bacilliformis protein and Yaf is very low, but a few conserved residues 
have been identified, highlighted in light blue in the Alignment in Figure 23. Based on these 
conserved residues several point mutations were introduced into the sequence of Yaf by site 
directed mutagenesis as described in Chapter 3.3.6. Besides the conserved residues also mutants 
from a few other residues of possible importance for the DNA processing reaction were generated. 
The mutants were overexpressed, purified and tested for there DNA relaxation activity as performed 
for the wild type protein. A summary of the obtained results is given in Table 52. Remarkably, all 
single point mutations resulted in the formation of high amounts of inclusion bodies, even at a lower 
growth temperature of 18°C after induction. Besides the formation of inclusion bodies also the 
amounts of soluble protein differed strongly from that observed for the wild type constructs. Only 
small amounts of soluble proteins were obtained and could be used for purifications, resulting in very 
low yields of the isolated mutants. Before testing the purified mutants for DNA relaxation activity, 
most of them were concentrated with Amicons. So far, all analyzed mutants showed a metal 
dependent DNA relaxation activity like the wild type protein. Up to now, the mutants were not 
tested for the DNA degradation activity.  
Taken all these observations together, it is obvious that most of the single point mutations 
introduced into the sequence of Yaf result in destabilization or misfolding of the protein. The elution 
profiles of size exclusion chromatographies performed with different mutants also indicated a 
significant influence of the mutations on the oligomerization of Yaf, which corroborates this 
assumption. A catalytical site could not be identified up to now, but at least two different sites can be 
asummed to be involved into the DNA processing reaction of Yaf, which must be a metal ion 
coordination site and DNA binding or processing site, most likely in close proximity to each other.  
 
Table 52: Overview on expression levels, solubility, purification properties, and enzymatic activity of Yaf mutants 
Mutant Expression  IB fomration Soluble protein Purification Activity 
Wild type high no yes high binding relaxation 
Y47F medium yes low amounts low binding relaxation 
E57A medium yes low amounts medium binding relaxation 
D89A medium yes low amounts low binding relaxation 
D90A medium yes low amounts low binding relaxation 
D89A/D90A medium yes low amounts low binding relaxation 
F91A low  yes low amounts low binding relaxation 
Y100F/Y104F medium yes low amounts low binding relaxation 
S107A low yes low amounts low binding relaxation 
F115A low yes low amounts low binding relaxation 
W33A low yes low amounts low binding n.a. 
E49A low yes low amounts low binding n.a. 
W105A low yes low amounts low binding n.a. 
F112A low yes low amounts low binding n.a. 
DDD-GEA high  no yes high binding n.a. 
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Figure 23: Aligment of Yaf from different N. gonorrhoeae strains as well as homologues proteins from N. meningitides 
and N. bacilliformis. The overall conserved residues are labeled in light blue.  
 
4.3.11 Crystallization of Yaf 
The crystallization of Yaf is performed in close collaboration with the group of Prof. L. Schmitt from 
the Heinrich Heine University in Düsseldorf.  
Before initial crystallization screenings were performed, the oligomeric state of isolated N-terminal 
His-tagged Yaf was analyzed with dynamic light scattering. These data demonstrated that His-tagged 
Yaf indeed forms a stable tetramer. The fractions with tetrameric protein were used to screen the 
initial crystallization conditions. The optimal growth conditions for crystals of Yaf with N-terminal 
His-tag have been identified with 100 mM Mops/NaOH pH 8.0 (or 100 mM Tris/HCl pH 9.0), 
100-250 mM Mg-Acetate and 16% (w/v) PEG 8000. An overview with several examples on the growth 
of Yaf crystals is given in Figure 24. Interestingly, native Yaf did not crystallize under the conditions 
optimized for Yaf with N-terminal His-tag and up to now, no growth of crystals with the native 
protein could be observed. This suggests that the Yaf crystallizes better in its tetrameric form.   
 
 
 
Figure 24: Examples of protein crystals obtained with crystallization conditions using tetrameric N-terminal His-tagged 
Yaf and buffering conditions of 100 mM Mops/NaOH pH 8.0 (or Tris/HCL pH 9.0), 100-250 mM Mg-Acetate and 
16% (w/v) PEG 8000. The size and shape of the obtained Yaf crystals differ significantly within the same and different 
samples.  
 
The X-ray diffraction pattern of the obtained crystals was measured in a Synchrotron beam-line and 
revealed a crystal packing according to a monoclinic C2 space group. The crystals showed diffraction 
to a resolution of 3 Å. Figure 25 shows the X-ray diffraction pattern of a Yaf crystal diffracting within 
a range of 50 to 3.7 Å. 
To solve the crystal structure without any structural homologue, phasing information is essential. 
Therefore, N-terminal His-tagged Yaf was overproduced in minimal medium in the presence of 
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selenomethionine. This N-terminal His-tagged Yaf was isolated in similar yields and purity as the wild 
type protein with N-terminal His-tag. Crystals were obtained under the same conditions used for the 
protein grown in the absence of SeMe. Initial diffraction experiments showed that Selenomethionine 
is incorporated into the protein, and as soon as a novel dataset of SeMet-Yaf is obtained, it will be 
tried to solve the structure of Yaf. This will provide structural insight into the remarkable properties 
of this protein.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 25: X-ray diffraction measurement of a crystal with N-terminal His-tagged Yaf. The resolution range of the 
diffraction patter is within 50 to 3.7 Å. The space group of the crystal packing is C2. The cell dimensions 
(a b c [Å] α β γ [°]) are measured with 40.194.1177.9 90.089.690.0. The R factor of the highest resolution shell is 36.2%. 
  
4.4 Biochemical characterization of the relaxase TraI 
The relaxase TraI of the novel T4SS of N. gonorrhoeae represents the prototype of the 
uncharacterized relaxase family MOBH (110). Relaxases are essential proteins within conjugative DNA 
transfer since they are processing dsDNA into single stranded T-DNA at the oriT region. Up to now, 
only little is known about the biochemical properties of TraI and its role in the DNA processing 
mechanism. TraI consists of at least two different domains, a relaxase domain and a C-terminal 
DUF1528 domain. At its N-terminus TraI contains a hydrophobic amphipathic α-helix that most likely 
facilitates an interaction with the inner membrane. The relaxase domain of TraI strongly differs from 
previously characterized relaxase domains of relaxases from other MOB families and contains several 
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unique sequence motifs that are described in detail in Chapter 1.8. The function of the DUF1528 
domain is still unknown, but this domain is always found fused to a relaxase domain.  
The results described below represent the first biochemical characterization of the MOBH prototype 
relaxase TraI and shed light on DNA processing mechanism of this novel relaxase family. 
 
4.4.1 Soluble TraI can be obtained with recombinant overproduction in E. coli 
To study the DNA processing reaction of the neisserial relaxase TraI, it was tried to overproduce the 
protein recombinantly with a T7 based expression system in E. coli. This turned out to be a 
challenging task, since the expression levels of traI were often very low and the overproduction 
almost always resulted in the formation of inclusion bodies with insoluble protein. For this reason 
several attempts using different constructs, changing the growth conditions or the expression strains 
were made to improve the expression level and the solubility of TraI. Many of the different tested 
conditions were similar to the conditions that have been tested for TraD. A summary of the most 
promising constructs is given in Table 53.  
Interestingly, the location of a tag on either the C-terminal or the N-terminal site of the protein 
strongly influenced the solubility and the stability of TraI. This observation was made while 
comparing the expression levels, the solubility and the purification results obtained from 
overexpressed traI constructs with C-terminal His-tag or Strep-tag and constructs expressing traI with 
an N-terminal His-tag. The expression levels of both N-terminal tagged constructs, as well as for the 
C-terminal Strep-tagged construct were significantly less compared to the expression level of the 
construct producing C-terminal His-tagged TraI. Both constructs expressing C-terminal tagged traI led 
to a high production of inclusion bodies and only very low amounts of soluble protein could be 
obtained after cell breakage. However, the expression of the two constructs producing N-terminal 
tagged TraI did not result in the formation of inclusion bodies and soluble TraI was observed after cell 
breakage. Considering these results, all further generated constructs were designed to contain either 
N-terminal tags or fusion-genes to enhance and optimize the yield of soluble TraI. With most of these 
constructs higher yields of expression and significantly reduced amounts of inclusion bodies were 
observed. Two truncated constructs, the relaxase domain of TraI with an N-terminal eXact-tag and 
the middle domain of TraI with an N-terminal His-MBP-TEV fusion, resulted in the production of 
insoluble proteins after overexpression, which could not be used for further isolation approaches. 
The fusion of TraI with a cytosolic MBP was initially thought to improve the solubility and stability of 
the protein during the folding process and in the following purification. Both MBP fusion constructs 
indeed resulted in very high amounts of soluble protein, but, like almost all of the other constructs 
the protein tended to aggregate during further isolation steps, which will be discussed in more detail 
in the following Chapter. Only one construct which is based on a vector that is normally used to fuse 
an N-terminal eXact-tag to the target protein finally resulted in the production of soluble TraI in such 
quatities that TraI could be purified. Initial overexpression experiments with this constructs resulted 
in high amounts of soluble TraI. Remarkably, the overproduced protein did not contain the eXact-tag, 
but mass spectrometric peptide finger print analysis confirmed the presence of the start methionine 
within the isolated protein. Sequencing of the construct revealed a frame shift mutation between the 
multiple cloning site and the inserted traI gene. The precise reason for the observed successful 
overproduction of TraI based on the expression of this ‘frame shift’ construct is up to now not 
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known, but, most likely the traI gene is translated from an internal start-site, resulting in the 
overproduction of full-length TraI without the N-terminal eXact-tag. 
In addition to the numerous tested expression constructs, it was tried to improve the isolation of 
soluble TraI by using different expression strains. Therefore, the E. coli strains BL21(DE3), 
BL21(DE3) Star and LEMO21(DE3) were tested in various growth and expression conditions. The most 
successful overproduction of native TraI could be observed using BL21(DE3) Star cells grown in 
LB medium incubated at 37°C in the presence of 0.5% glucose. Remarkably, a lowering of the 
expression temperature also resulted in lower expression levels of traI.  
 
Table 53: Summary of overproduction and purification results obtained from different traI constructs 
Protein Protein 
amount 
Protein 
soluble 
Inclusion 
bodies 
Purification 
successful 
TraI C-terminal His-tag medium in part yes no 
TraI C-terminal Strep-tag low in part Yes no 
TraI N-terminal His-tag low yes No in part (aggregation) 
TraI N-terminal Strep-tag low yes No in part (aggregation) 
TraI N-terminal eXact-tag high Yes No no 
TraI N-terminal MBP fusion high Yes no in part (aggregation) 
TraI N-His-MBP-TEV fusion very high Yes no in part (aggregation) 
TraI native high Yes no yes (soluble protein) 
TraI (relaxase dom.) N-terminal eXact-tag high No yes no 
TraI (middle dom.) N-His-MBP-TEV fusion medium No no no 
TraI (DUF1528 dom.) N-terminal His-tag high Yes no in part (aggregation) 
 
4.4.2 Soluble native TraI can be isolated in the presence of the detergent DDM 
The isolation of purified TraI was a challenging and difficult task since TraI strongly tends to 
aggregate, either already during overproduction or during the purification. Many different 
approaches with different constructs, overexpression conditions and purification protocols were 
performed to obtain soluble TraI. Initial attempts to purify TraI containing a His- or Strep-tag resulted 
in very low amounts of TraI that still contained a high number of contaminats. Mass spectrometry 
analysis indicated that many of these contaminations were chaperones, which suggests a misfolding 
of TraI. Indeed, size exclusion chromatography showed that these proteins eluted in the exclusion 
volume of the column.  
Two constructs expressing malE-traI fusions have been generated to prevent protein aggregation and 
to obtain higher protein yields. The fusionprotein without a His-tag and a TEV cleavage site was 
overproduced in high yields and was purified in one step using an MBPTrap (GE Healthcare) column. 
Unfortunately, the MBP-TraI fusionprotein only had a weak binding affinity to the column material 
and only very low amounts of the protein were eluted. Most of the protein remained unbound in the 
flowthrough. The other MBP-TraI fusionprotein with an N-terminal His-tag and a TEV cleavage site 
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between both proteins yielded in high amounts of soluble protein and was purified using two affinity 
chromatography steps followed by a size exclusion chromatography. The final amounts of purified 
protein were much higher than the obtained yields from the other MBP-TraI fusionprotein. 
Nevertheless, like in previous purification attempts also this purification ended up with the elution of 
TraI in the exclusion volume of the gelfiltration column, indicating aggregation of the protein. These 
results represented for a long time the best purification of TraI. Unfortunately, attempts to cleave off 
the MBP protein by TEV protease and to further purify the native TraI were not successful.  
Besides different approaches to purify tagged proteins, attempts have been made to isolate native 
TraI by a combination of different purification methods like ion exchange chromatography, 
hydrophobic interaction chromatography, and size exclusion chromatography. Unfortunately, this 
purification protocol including a Q-Sepharose column, a Phenyl-Sepahrose column, a Hydroxyapatite 
column, and a Superdex 200 gelfiltration column, resulted in >95% loss of the protein during the 
different purification steps and the purified TraI eluted again as an aggretated protein in the final gel 
filtration step. The obtained protein yields from the purification of native TraI were slightly lower 
than the obtained yields in the purification of the His-MBP-TEV-TraI.  
An important breakthrough in the purification of soluble native TraI was made by performing an 
extensive screen of different detergents. The addition of the detergent DDM to the different 
purification steps prevented aggragation of TraI during the different purification steps, and resulted 
in the purification of soluble and active TraI. The results of the purification are shown in Figure 26. In 
the performed SDS-PAGE analysis using 11% gels, TraI migrates at a position corresponding to a 
molecular mass of 120 kDa.  
The successful purification protocol includes an additional solubilization step with DDM after cell 
disruption. The further purification of the protein includes an anion exchange chromatography step 
followed by a cation exchange chromatography step (see Figure 26 A) and a second cation exchange 
chromatography step to concentrate the protein. The final purification step is performed with size 
exclusion chromatography using a Superdex 200 column (see Figure 26 B). In the first anion exchange 
chromatography, TraI did not bind to the column material under the conditions used and remained 
in the flowthrough. Most of the contaminating proteins were bound to the anion exchange column 
and, therefore, this step resulted in a significant purification of TraI. The flowthrough was loaded on 
a cation exchange column and bound TraI eluted at an approximate NaCl concentration of 125 mM 
(see Figure 26 A (left); Fractions A2 to A4). Since TraI tends to aggregate during concentration with 
centrifugal filter units, the TraI containing fractions were first diluted and then concentrated in a 
second cation exchange chromatography step by using a steep elution gradient (see Figure 26 A 
(middle)). The concentrated elution samples were analyzed on 11% SDS gels (see Figure 26 A (right)). 
In the final purification step performed by gel filtration most of the contaminating proteins that were 
still present after the second cation exchange chromatography were removed (see Figure 26 B). 
Using this purification protocol TraI did no longer elute in the exclusion volume of the gelfiltration 
column, but eluted at a volume corresponding to a molecular mass of approximately 280 kDa, 
suggesting the existence of a higher oligomeric state of TraI, which will be discussed in detail in the 
following Chapter. The TraI containing fractions still contain some contaminating proteins which 
could not be removed. These proteins were analyzed by mass spectrometry and most of them were 
identified as degradation products of TraI. With this purification protocol approximately 0.5 mg of 
TraI can be isolated per 1 L E.coli overexpression culture.  
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Relaxases are difficult proteins to purify and a successfull isolation of the full-length protein has been 
reported for only a few of them. The hereby described purification method is the first successful 
protocol to isolate a native soluble full-length relaxase of the novel and uncharacterized MOBH 
family.  
 
Figure 26: Isolation of native TraI in the presence of DDM. (A) Elution profiles of the first cation exchange 
chromatography step (left) and the second cation exchange chromatography step (right). Protein was detected with a 
wavelength of 280 nm (blue line). The intensity of the UV light is given as mAU. The collected fractions are labeled in red. 
The concentration of the ‘Ion exchange TraI detergent B’ buffer is indicated as green line (gradient from 0-100%). The 
elution fractions of the cation exchange chromatography were analyzed with 11% SDS gels (right). Molecular masses are 
indicated on the left site (PageRuler unstained protein ladder; Fermentas). The labeling of the lanes corresponds the 
labeling of the elution fractions. (B) Elution profile of size exclusion chromatography (left) and 11% SDS-PAGE analysis of 
the protein containing elution fraction. The labeling corresponds to the description given in (A).  
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4.4.3 The oligomeric state of TraI  
Purified TraI elutes from the gelfiltration column at a volume which corresponds a molecular mass of 
approximately 280 kDa. Interestingly, TraI has a calculated molecular mass of 94.7 kDa, but migrates 
on SDS-PAGE gels at a position corresponding to a molecular mass of 120 kDa. Western blot analyses 
using a TraI antibody on N. gonorohoeae cells have shown that also the native protein in 
N. gonorrhoeae migrates on SDS-PAGE gels at a molecular mass of 120 kDa (202). The reason for the 
observed difference of 25 kDa is up to now not known. This difference was also observed in 
preparations without DDM, excluding an influence of the detergent DDM in this abreviant migration 
behavior on SDS-PAGE gels. Also other purified TraI proteins expressed from different constructs 
migrate on SDS-PAGE gels with a higher molecular mass. The abreviant migration behavior of TraI is 
possibly caused by its hydrophobic N-terminus. Alternatively, TraI does not unfold completely in the 
presence of SDS or the protein is post-translationally modified.  
The observed molecular mass of TraI (280 kDa) on the gelfiltration column seems to fit with the 
calculated mass of a trimer of TraI (285 kDa). However, the abreviant migration behavior on 
SDS-PAGE gels might also occur on the gelfiltration column, and the protein might be a dimer (190 
kDa) surrounded by a DDM micelle (70 kDa) (295). To further study the oligomeric state of TraI, the 
isolated protein was analyzed on a Blue Native gel (5-13% acrylamide gradient). The results from this 
experiment are shown in Figure 27. Six different marker proteins with known masses were used as 
references to enable an approximate mass estimation of TraI. The molecular masses and the relative 
mobility of the proteins were plotted as a function of each other (see Figure 27 B). Using this graph 
to calculate the molecular mass of TraI, the Protein migrated at a mass corresponding to 260 kDa, 
which is smaller than the calculated mass for a trimer. Taking the abreviant behavior of TraI on 
SDS-PAGE gels into account, it can be concluded that TraI is purified as an oligomer that is most likely 
a dimer.  
 
Figure 27 : BN-PAGE analysis of the oligimomeric state of TraI. (A) BN-PAGE with 5-13% acrylamide gradient gel. 
Molecular masses are indicated on the left site. The labeling of the lanes correspond the following: 1 - Ferritin + 
Ovalbumine standard; 2 - Thyroglobuline + Conalbumin standard; 3 - Aldolase + Ribonuclease standard; 4 - 458 ng TraI; 5 
- 915 ng TraI; 6 - 1.4 mg TraI; 7 – 1.8 mg TraI (B) Plot of the molecular masses of the marker proteins in relation to their 
relative mobility within BN-PAGE analysis. Each marker protein was loaded and measured in dublicate (black and 
colorless dots). The trendline correspond a sigmoidal regression.  
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4.4.4 Limited proteolysis elucidates the domain organization of TraI 
Analysis of the primary amino acid sequence of TraI suggested that TraI consists of different domains 
including an N-terminal hydrophobic amphipathic α-helix (4-5 kDa), followed by a relaxase domain 
(42.5 kDa), a non conserved domain of unknown function (34 kDa) and a DUF1528 domain 
(11.8 kDa). To obtain more information about the domain structure of TraI, limited proteolysis with 
trypsin and ProteinaseK was performed. Therefore, TraI was incubated with increasing 
concentrations of trypsin and ProteinaseK and the samples were analyzed on 13-15% gradient SDS 
gels.  
Interestingly, TraI showed significant diffences in the sensitivity for both proteases. Comparing the 
concentrations of trypsin and ProteinaseK which are necessary to initiate the proteolysis of TraI        
(1 nM for trypsin vs. 0.04 nM for ProteinaseK) and to reach a complete digest of the protein (12 nM 
for trypsin vs. 1.28 nM for ProteinaseK), it is obvious that TraI is very sensitive to ProteinaseK and is 
less sensitive to trypsin. Both proteolysis experiments do not only differ with regard to their protease 
sensitivity, but also with respect to the migration pattern of the obtained fragments. Allmost all 
observed fragments from the trypsin proteolysis (see Figure 28 A) are also present in the ProteinaseK 
digest, but some fragments are only observed in the ProteinaseK digestion (see Figure 28 B). 
Whereas the proteolytic digest with trypsin resulted in the formation of specific fragments, the 
digest with ProteinaseK seems to result in an initial digestion of TraI into specific fragments followed 
by further digestion of these fragments.  
At least a trypsin concenteration of 1 nM was necessary to detect a proteolytic activity on TraI. 
Increasing trypsin concentrations finally ended up with seven disting fragments which could be 
observed within trypsin concentration >1 nM, representing different domains and peptide fragments 
of TraI. Initial fragments migrating at positions corresponding to molecular masses of 100 (‘2’), 
85 (‘3’) and 35 kDa (‘6’) were observed within trypsin concentrations of 1-8 nM. At trypsin 
concentrations of > 4 nM an additional fragment (‘4’) appeared at the position corresponding to 
80 kDa and fragment ‘2’ (100 kDa) was almost complete digested. Next to the occurence of fragment 
‘7’ (26 kDa), fragment ‘6’ (35 kDa) started to disappear at trypsin concentrations >8 nM. Finally, the 
last two fragments ‘5’ (55 kDa) and ‘8’ (17.5 kDa) appeared at trypsin concentrations above 16 nM. 
Considering the observed masses of the fragments ‘4’, ‘7’ and ‘8’ a total mass of 123.5 kDa will be 
obtained, corresponding to the mass of undigested TraI. Based on Figure 28, the following model 
might be conclusive: 
Fragment ‘1’: resents the full-length protein in an undigested state. 
Fragment ‘2’:  first formed fragment that is also produced in absence of protease. Most likely it results 
m degradation of TraI. 
Fragments ‘3’ and ‘6’: h derive from fragment ‘2’ and start to appear when fragment ‘2’ disappears. Most likely 
gment ‘3’ represents the relaxase and the middle domain of TraI and fragment ‘6’ represents 
 DUF1528 domain and a linker region between middle domain and DUF1528 domain. 
Fragments ‘4’ and ‘8’: gment ‘4’ derives from fragment ‘3’ and represents the relaxase domain and/or the middle 
main. Fragment ‘8’ derives from fragment ‘7’ and represents the DUF1528 domain.  
Fragment ‘7’: st likely this fragment represents either the DUF1528 domain that is cleaved with an 
itional sequence part and further digest produce fragment ‘8’, or it represents a part of the 
dle domain of TraI. 
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The fragmentation pattern of the proteolytic digest with ProteinaseK revealed a similar domain 
organization as observed with trypsin and confirmed the assumption that TraI consists of at least 
three domains. Almost all of the previous described fragments ‘1’ till ‘8’ are also present in the 
ProteinaseK digested samples. Only fragment ‘5’ was not observed on its expected position, but 
seems to be represented by the fragments ‘10’ to ‘12’, which migrate in a range of 45-50 kDa. 
However, in comparison with the obtained results from the trypsin digest the ProteinaseK digest 
leads to a much stronger fragmentation and degradation of TraI. One of the most obvious differences 
between both proteolysis experiments is the high sensitivity of TraI against ProteinaseK. This could 
be especially observed for fragments ‘3’ and ‘4’ that are already almost complete digested at a 
ProteinaseK concentration of 0.64 nM, whereas within the proteolysis with trypsin both fragments 
are still present at the highest protease concentration. 
These results lead to the conclusion that the N-terminal relaxase domain has a certain resistance 
against endopeptidases like trypsin, but is very sensitive to exopeptidases like ProteinaseK, which has 
an endo- and an exopeptidase activity. This difference between both proteases could be a reason for 
the observed numberous degradation fragments in the ProteinaseK experiment. Most likely, the 
different sensitivities of TraI to both proteases result from the structural integrity of the observed 
domains, which possibly influences and restricts the accessibility to endopeptidases. Taking all 
observed fragments from the proteolytic digest with trypsin into account, it is most likely that TraI 
constists of at least three different domains. 
 
Figure 28: SDS-PAGE analysis of limited proteolysis of TraI. (A) Limited trypsin digest of TraI with increasing trypsin 
concentrations indicated on top of the lanes. (B) Limited ProteinaseK digest of TraI with increasing ProteinaseK 
concenterations indicated on top of the lanes. The molecular masses for both gels are given on the left sites (PageRuler 
unstained protein ladder; Fermentas). The black arrows on the right gel sites indicate the migration positions of TraI (1) 
and of several fragments obtained from the proteolytic digest (2-15). 
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4.4.5 TraI binds ssDNA and dsDNA in a sequence unspecific competative reaction 
Different DNA binding and competition experiments were performed with native TraI to study the 
DNA binding mechanism of this novel relaxase family. To characterize the DNA binding reaction of 
TraI, γ-P32 labeled ssDNA substrates were incubated with increasing concentrations of TraI and were 
analyzed for mobility shifts on 7.5% native TB gels. Besides different substrates it was tested whether 
different metal cofactors can influence the binding reaction of TraI. It was observed that TraI binds to 
all tested ssDNA substrates in a sequence unspecific reaction (see Figure 29; comparison of a T74 
primer with a primer containing the putative oriT region of the GGI). The DNA binding reaction was 
not dependent on a metal cofactor (see Figure 29). The observed DNA binding affinity of TraI was at 
least 200 nM, however, further experimental approaches like anisotropy measurements with ssDNA 
substrates are necessary to determine the Kd of the DNA binding reaction of TraI. 
 
 
Figure 29: Autoradiographs of DNA binding assays of TraI providing Mg2+, Mn2+ or Co2+ as metal cofactors and either γ-P32 
labeled ‘T74’ oligonucleotide or ‘75 bps GGI oriT’ oligonucleotide as DNA substrates. The samples were analyzed on 7.5% 
native TB gels. Negative controls without TraI are indicated with black triangles. The labeling of the lanes corresponds to 
the used TraI concentrations (10 - 800 nM). The DNA substrate concentration used in each reaction was 100 nM. The 
different metals are indicated on top of the gels, the DNA substrates are indicated on the right sites. The migration 
position of unbound DNA is indicated with black triangles on the left sites, the position of protein-bound DNA is 
indicated with colorless triangles. 
 
To further characterize the DNA binding reaction of TraI, competition assays with γ-P32 labeled 
dsDNA and ssDNA substrates, which were competed with unlabeled Tn oligonucleotides were 
performed. At first, two labeled dsDNA substrates either containing the GGI oriT sequence or the difA 
site sequence were competed with Tn oligonucleotides in a length range of 6-28 nucleotides 
(see Figure 30 A and B). Subsequently, a polyT primer with a length of 25 nucleotides and a primer 
corresponding to the putative oriT sequence with a length of 75 nucleotides were competed with Tn 
oligonucleotides in a length range of 6-28 nucleotides (see Figure 30 C and D). 
Interestingly, it could be observed that TraI binds sequence unspecific to all tested DNA substrates, 
but the DNA binding affinity differs between dsDNA substrates and ssDNA substrates and seems to 
be higher then 200 nM. Both dsDNA and ssDNA substrate show similar results for the competition of 
Tn oligonucleotides. However, oligonucleotides shorter than T9 cannot compete with the binding of 
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the other DNA substrate, whereas Tn oligonucleotides with a length between 12 and 21 nucleotides 
competed with increasing efficiency. Tn oligonucleotides that are longer than 21 nucleotides were 
able to compete completely with the binding of both ssDNA and the dsDNA substrates.  
Taking into account that oligonucleotides shorter than 9 nucleotides were not able to compete 
longer DNA substrates, but Tn oligonucleotides longer than 9 nucleotides were able to compete with 
the bound DNA substrates, it can be concluded that TraI has a minimal binding frame of 9 
nucleotides. The observation that Tn oligonucleotides with increasing lengths are more efficient 
competitors than shorter onligonucleotides indicates that the binding affinity of TraI for ssDNA rises 
with increasing length of the oligonucleotide.   
Thus, from the obtained results it can be concluded that TraI binds sequence unspecific to ssDNA and 
dsDNA substrates in a metal independent reaction. The minimal binding frame of TraI for ssDNA 
substrates was determined to be 9 nucleotides. Increasing the length of the oligonucleotide further 
increases its binding affinity to TraI. The sequence specificity of the DNA binding reaction of TraI is 
not influenced by Yaf (data not shown). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 30: Autoradiography of DNA binding and competition assay with different γ-P32-labeled DNA substrates competed 
with different unlabeled Tn oligonucleotides. The assay was performed with isolated native TraI. Negative controls 
without protein are indicated with black triangles and reactions without competitor DNA are indicated with a dash on 
top of the lanes. The labeling of the lanes indicates the corresponding competitative Tn oligo-nucleotide. The migration 
position of unbound DNA is indicated with black triangles on the left sites, the position of protein-bound DNA is 
indicated with colorless triangles. (A) reaction with γ-P32-labeled 555 bps PCR product with GGI oriT sequence; (B) 
reaction with γ-P32-labeled 425 bps PCR product containing the difA site sequence; (C) reaction with γ-P32-labeled T25 
oligonucleotide; (D) reaction with with γ-P32-labeled 75 bps GGI oriT oligonucleotide. 
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4.4.6 TraI relaxes supercoiled plasmid DNA in a metal dependent sequence unspecific 
reaction similar to the activity of E. coli Topoisomerase I  
To further characterize the mechanism of the relaxase TraI, DNA relaxation assays were performed 
as described in Chapter 3.8.6. Several different conditions including various DNA substrates, different 
divalent cations and changes in the reaction conditions were tested to study the DNA relaxation 
activity of TraI.  
The relaxation activity of TraI was tested on supercoiled DNA substrates containing either the oriT 
sequence from the GGI or from the F-plasmid. Remarkably, both supercoiled DNA substrates were 
converted from the supercoiled to the relaxed form. Figure 31 A shows the time dependent 
relaxation activity on a plasmid that contains the oriT sequence of the GGI, but a similar result was 
obtained for the plasmid that contains the oriT of the F-plasmid (data not shown). Relaxation assays 
on plasmids that contain neither the oriT sequence from the GGI nor the oriT sequence of the 
F-plasmid, showed that also these plasmids were converted to the relaxed form (data not shown). 
This suggested that a sequence unspecific relaxation activity was present in the fractions that 
contained purified TraI. This was an unexpected result since almost all characterized relaxases show a 
sequence specific relaxation reaction and might indicate that TraI requires an accessory protein to 
promote efficient cleavage of the oriT sequence.  
To demonstrate that the slower migration of the different plasmids is caused by relaxation of the 
supercoiled DNA and not by binding of TraI to the DNA, several experiments were performed. At 
first, TraI was incubated with supercoiled, linearized and religated plasmid DNA (see Figure 31 B). In 
this experiment a mobility shift was only observed for the supercoiled plasmid. Secondly, after 
incubation with TraI, the plasmid was treated with ProteinaseK to degrade the protein. After 
incubation with ProteinaseK, the slower migrating band was still observed (data not shown). The shift 
to a band with a slower mobility is dependent on the presence of divalent cations, whereas binding 
of TraI to the DNA is independent of divalent cations. 
In view of the high similarity of the relaxation reaction observed for purified TraI to the enzymatic 
activity of Topoisomerase I from E. coli, further experiments were performed to exclude that the 
observed reaction is a result of a Topoisomerase I contamination. The final gelfiltration 
chromatography step of the purification of TraI should separate TraI (elutes at a volume 
corresponding to 280 kDa) and Topoisomerase I (should elute at 97 kDa). Titration experiments with 
commericially obtained Topoisomerase I (New England Biolabs) showed that the amounts required 
for the observed relaxation activity should be visible on SDS-PAGE gels and thus should also be easily 
detectable with mass spectrometry. Topoisomerase I could however never be detected in fractions 
containing TraI using mass spectrometry (data not shown). In a second experiment, similar to that 
performed for Yaf (see Figures 22 B and 31 C), the metal dependency and the formation of different 
intermediates by TraI and Topoisomerase I were compared to distinguish between both activities. 
Like for Yaf, also the relaxation activity of TraI was observed in the presence of Mg2+ but is strongly 
enhanced in presence of Mn2+ and Co2+ (see Figure 31 C). Also no typical Topoisomerase I reaction 
intermediates were observed (see Figure 22 B), but one fragment migrating at the position of the 
linearized plasmid was observed in the presence of TraI. Considering these differences, it can be 
concluded that the relaxation activity associated with the fractions containing TraI is not a 
background activity of E. coli Topoisomerase I.  
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Remarkably, also TraI of the E. coli F-plasmid cleaves DNA more efficient in the presence of Mn2+ 
then in the presence of Mg2+ (246, 296). 
Thus, the fractions containing purified TraI kept a relaxase activity which resembled the activity 
observed for purified Yaf. Unfortunately, both relaxation activities were sequence independent. TraI 
showed no strong preference for any of the tested plasmids and those plasmids that contained the 
putative oriT encoded within the GGI were not processed faster. The addition of Yaf to the relaxation 
assays did also not result in a more specific relaxation activity (data not shown). Purified TraI binds in 
electrophoretic mobility assays to DNA with a high affinity, demonstrating that the purified TraI is 
active in DNA binding under the tested conditions, making it unlikely that the inability to detect 
sequence specific relaxation is caused by inactive TraI. Possibly the relaxation assays were not 
sensitive enough to detect the specificity of TraI. Therefore, also DNA cleavage assays were 
performed which will be described in detail in the following Chapter.  
 
Figure 31: Comparative analyses of the DNA relaxation activities of TraI. (A) Relaxation time range experiment with TraI. 
The control (T0) is indicated as black triangle. Samples were taken in 5 min steps and were immediately inactivated with 
SDS and EDTA. The labeling of the lanes indicates the corresponding reaction time. (B) Influence of the DNA topology on 
the relaxation activity of TraI. Supercoiled, linearized, and religated DNA derived from plasmid pEP074 was used as 
substrate. The labeling of the controls and the DNA topolgies ‘I’ and ‘II’ correspond to ‘A’. The migration position of 
linearized DNA is indicated with (III). The labeling of the lanes correspond the following: 1 - TraI incubated 5 min at 95°C 
after reaction; 2 - standard conditions; 3 - no Mg2+; 4 - additional EDTA; 5 - standard conditions; 6 - additional EDTA; 7 - 
standard conditions (C) Influence of different metal cofactors on the relaxation activity of TraI. The relaxation assay was 
performed with increasing protein concentrations in presence of Mg2+, Mn2+ and Co2+ (indicated on the right site). 
Negative controls without protein are indicated with black triangles on top of the lanes. The migration positions of 
supercoiled (II) and relaxed (I) DNA fragments are indicated with the black arrows on the left site. 
 
4.4.7 TraI cleaves ssDNA sequence unspecific in presence of Mn2+ and Co2+ 
To test whether TraI cleaves ssDNA, cleavage assays were performed with isolated TraI under many 
different conditions using several different oligonuceolotide substrates. The experiments were 
performed as described in Chapter 3.8.7. Five different oligonucleotides have been tested: two 
complementary oligonucleotides containing the putative oriT of the GGI (see Figure 32 A), two 
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complementary oligonucleotides containing the F-plasmid oriT (see Figure 32 B) and a 
T74 oligonucleotide (see Figure 32 C).  
The cleavage assays were performed in the presence of Mg2+ or Mn2+, and in the presence and 
absence of ATP and Yaf. Remarkably, cleavage was reproducibly observed for the “GGI oriT ‘fwrd’” 
and the “F oriT ‘fwrd’” oligonucleotides in the presence of Mn2+, whereas the other three 
oligonucleotides did not show any cleavage (see Figure 32). A similar preference of Mn2+ instead of 
Mg2+ has been observed previously for TraIF from E. coli in cleavage experiments with ssDNA 
substrates (296). The size of the cleavage products was compared with a standard made of different 
polyT oligonucleotides of different lengths (data not shown). The cleavage products of the “GGI oriT 
‘fwrd’” oligonucleotide and the “F oriT ‘fwrd’” oligonucleotide had lengths of 6-15 and 65-70 
nucleotides respectively. A comparison of the putative cleavage sites did not show any sequence 
similarity between both oligonucleotides. Remarkably, cleavage of the “GGI oriT ‘fwrd’” 
oligonucleotide was inhibited in the presence of ATP.  
Further cleavage assays with several shorter oligonucleotides along the sequence of the “GGI oriT 
‘fwrd’” oligonucleotide and oligonucleotides with mutations in single nucleotides are required to 
determine the exact cleavage site and the specificity of TraI. 
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Figure 32: Autoradiographs of DNA cleavage assay with TraI and Yaf. The samples were analyzed with Urea PAGEs with 
7.2% gels. The labeling of the different lanes represents the corresponding reaction conditions. The assays were 
performed with six different γ-P32-labeled DNA substrates. (A) Cleavage reaction performed with complementary ‘75 bps 
GGI oriT’ oligonucleotides; (B) Cleavage reaction performed with complementary ‘75 bps F-plasmid oriT’ 
oligonucleotides; (C) Cleavage reaction performed with ‘T74’ oligonucleotide (left) and a 555 bps PCR product containing 
the GGI oriT sequence (right) 
 
4.5 Protein-protein interaction studies on the relaxase TraI, Yaf and the 
ATPase TraC 
The studies on possible protein-protein interaction of TraI, Yaf, and TraC were performed in close 
collaboration with S. Rempel (a bachelor student of our group), whose bachelor project focused on 
the isolation and biochemical studies of the ATPase TraC of the T4SS from N. gonorrhoeae.  
Different combinations of isolated proteins were co-incubated with magnetic His-beads and were 
eluted from the beads as described in Chapter 3.8.11. The different fractions from the elution of the 
magnetic beads were analyzed by SDS-PAGE. Putative protein-protein interaction will be indicated by 
co-elution of the different proteins, since only one of the two co-incubated proteins contains a His-
tag. Possible protein-interactions of native TraI were tested with dimeric and tetrameric Yaf with an 
N-terminal His-tag as well as with N-terminal His-tagged TraC. A possible interaction of Yaf with the 
ATPase TraC was tested using native Yaf and N-terminal His-tagged TraC.  
However, putative protein-protein interactions between TraI, Yaf, and/or TraC were not observed 
within the tested conditions. A similar experimental approach to study the interaction of TraI and Yaf 
was performed using Ni-NTA (Sigma-Aldrich) instead of magnetic beads for the binding of His-tagged 
proteins. Like observed for the magnetic bead material, also the obtained results from the Ni-NTA 
material do not indicate an interaction between TraI and Yaf.  
Nevertheless, it has to be taken into account that a weak interaction between the different proteins 
could possibly be disturbed by various factors like e.g. buffering conditions or the treatment of the 
samples. For instance, TraI needs the presence of the detergent DDM to keep a soluble dimeric state 
in solution. The micelle formed by DDM could hinder possible protein interactions of TraI. Besides 
the possibly disturbing influence of DDM also the concentration of salts and ionic components could 
have a strong influence on protein-protein interactions and should be considered in the 
interpretation of the obtained results.  
In addition to the performed pull down assays, a possible influence of TraI and Yaf on each other was 
tested in DNA cleavage assays and DNA binding experiments. The obtained results from the cleavage 
assays are in agreement with the results of the pull down assays. No indication of a putative 
influence of TraI and Yaf on each other could be observed. However, within the experimental set-up 
of the DNA cleavage assays it is not possible to detect a direct protein-protein interaction between 
TraI and Yaf.  
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5. Discussion 
5.1 GGI-like T4SSs in Proteobacteria 
GGI-like T4SSs show variations within different Proteobacteria 
Generally, the GGI-like T4SSs that have been identified in several Proteobacteria within the current 
study show a highly conserved genetic organization of the different T4SSs components. However, a 
few exceptions show little variation in their genetic organization, which result from additional 
insertions. The largest insertions are present within the GGI-like T4SSs identified in γ-Proteobacteria, 
but also α-Proteobacteria show significant additional insertions. The most conserved GGI-like T4SSs 
can be found in β-Proteobacteria. The additional insertions in the identified T4SSs of α- and γ-
Proteobacteria presumably derive from evolutionary adaptation processes within highly variable 
genomes. 
The GGI of N. gonorrhoeae has been proposed to derive from an ICE, since it is surrounded by two dif 
sites that are recognized by the XerCD recombinase (198, 200). One of the two dif sites has been 
mutated to an imperfect dif site (189). The mutation within this dif site influences the recognition of 
the XerCD recombinase and leads to a strongly decreased excision and integration frequency of the 
GGI. The GGI-like T4SSs identified in other Proteobacteria are often surrounded by transposases or 
integrases, indicating a possible origin from a mobile genetic element similar to the GGI of 
N. gonorrhoeae. It is most likely that the GGI-like T4SSs derive from one ancestral T4SS which has 
been distributed via a mobile element or due to bacterial phages, since very often also many phage 
related proteins are in close proximity to the genes of the GGI-like T4SSs. Interestingly, only the 
conserved core genes necessary for DNA processing and the formation of the secretion channel are 
found in most of the identified GGI-like T4SSs. This indicates a clear tendency of these T4SSs to 
spread only essential core genes among different organisms. The bioinformatical analysis of the 
different GGI-like T4SSs does not give information about possible useful cargos within the spread of 
these systems, like e.g. antibiotic resistances or metabolic advantages.  
 
Functional role of GGI-like T4SSs 
Almost all identified species harboring a GGI-like T4SSs are pathogenic organisms, suggesting a 
possible function of the T4SSs in pathogenesis or in immune defense. A direct influence of the GGI 
encoded T4SS on the pathogenicity of N. gonorrhoeae has not been reported up to now, however, 
GGI versions encoding a specific sac-4 allele have been associated with an increased risk of PID 
infection (113). Furthermore, it has been reported that the GGI encoded T4SS promotes a ton-
independent intracellular survival of N. gonorrhoeae being an advantage for invasion and 
colonization of distinct tissues (196). However, it is unclear whether the GGI-like T4SSs secret 
additional virulence factors like it has been reported for many other T4SSs (102, 104, 121). No 
secreted proteins that possibly act as virulence factors have been identified in N. gonorrhoeae and it 
is currently assumed that the GGI encoded T4SS is a pure DNA secretion system. GGI-like T4SSs might 
be involved in surface modulation to evade the host immune system. For instance, N. gonorrhoeae 
strain MS11 has a mutated pilus subunit TraA and does not assemble T4SS pili. Other N. gonorrhoeae 
strains do not have this mutation and have the ability to form intact T4SS pili. However, the presence 
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of a pilus in the neisserial T4SS significantly influences the level of DNA secretion (PhD thesis 
E. Pachulec 2010). Besides a putative role within pathogenicity, it is very likely that GGI-like T4SSs are 
important for the spread of information via DNA secretion. The different species might benefit from 
the exchange of genetic information in acquiring antibiotic resistances or metabolic advantages that 
could easily be distributed via DNA secretion.  
The obtained bioinformatical data does not give information about the functionality of the identified 
GGI-like T4SSs. Moreover, the large insertion in the GGI-like T4SSs found in α- and γ-Proteobacteria 
most likely lead to a loss of functionality, since operons with essential core genes are disrupted and 
could not be further coexpressed. The strict regulation of certain secretion system components 
within T4SSs is a crucial mechanism to enable a sufficient assembly of the secretion complex. The 
GGI-like T4SSs identified in β-Proteobacteria presumably are functional T4SSs since the essential core 
genes are not disrupted by additional insertions. The insertions between the dtr genes and the mpf 
genes most likely do not affect the functionality of the T4SSs, instead of that it is more likely that 
these insertions belong to a more ancestral T4SS and have been lost within N. gonorrhoeae and 
N. meningitidis. If this assumption will be true, it is most likely that the GGI-like T4SS ancestrally 
derives from one of the other β-Proteobacteria species and not from Neisseria, like it has been 
previously assumed. This implies that the T4SS of N. bacilliformis resembles a more ancestral T4SS. 
However, conclusions considering the functionality and the ancestral relationship of the GGI-like 
T4SSs have to be seen with caution as long as no further experimental and bioinformatical analyses 
have been performed. 
 
Some GGI-like T4SS encode different classes of dtr genes and mpf genes 
Some of the GGI-like T4SSs have a different composition of dtr genes and mpf genes. The T4SSs of 
N. aromaticivorans, the secretion system of A. denitrificans plasmid pALIDE201, and the T4SS of 
plasmid pAOV001 of Acidovorx encode dtr and mpf genes belonging to the MOBF and the MPFF 
family, whereas all other identified GGI-like T4SSs encode dtr genes belonging to the MOBH family 
and mpf genes belonging to the MPFF family. Such an exchange between different MOB and MPF 
families has also been reported for other T4SSs (111). Most of the identified mixed T4SSs are 
encoded on the chromosome and derive most likely from mobile genetic elements. These “original” 
secretion systems might have changed due to different evolutionary processes that finally resulted in 
a mix of different MOB and MPF families. Many of the mixed GGI-like T4SSs are surrounded by or 
even encode different phage related proteins. This gives rise to the assumption that the change of 
the dtr genes might result from phage integration events. Nevertheless, conclusions about the origin 
of the mixed GGI-like T4SSs have to be drawn with caution since several other factors might lead to 
an exchange of different MOB and MPF families.  
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5.2 Isolation of the coupling protein TraD 
Soluble TraD could not be isolated using a recombinant overexpression approach in E. coli 
The recombinant overproduction of the neisserial CP TraD led to the formation of large amounts of 
insoluble inclusion bodies, even though various overexpression conditions, different constructs and 
different E. coli host strains have been tested.  
In general, T4SS CPs are integral inner membrane proteins with at least two TM domains. A few CPs 
have been reported to lack TM domains, but these proteins always occur together with small integral 
membrane proteins that mediate the attachment of the CPs to the cytoplasmic membrane (105). The 
CP of N. gonorrhoeae is, based on its conserved nucleotide binding motifs, classified into the group of 
VirD4AT like CPs (105). Taking the results from computational TM domain predictions of TraD into 
account, it is more likely that TraD clusters together with the class of TM domain-less CPs since no 
TM domain has been predicted for TraD. Instead, a hydrophobic patch could be identified within the 
N-terminal region of TraD, which most likely is responsible for the attachment of TraD to the 
cytoplasmic membrane. Considering these results, it might be possible that TraD needs an additional 
protein to enable an attachment or integration into the membrane. This assumption is strengthened 
by the close proximity of the yaa gene to the traD gene, which encodes a small predicted membrane 
protein with at least 4 TM domains. The possibility of a missing component that might be necessary 
for the successful attachment or integration of TraD into the cytoplasmic membrane could be one 
reason for the production of large amounts of insoluble TraD during overproduction. The membrane 
attachment or insertion of TraD could be triggered by an up to now unknown additional spatial 
positioning factor in N. gonorrhoeae, which is not present in recombinant overexpression host E. coli. 
This assumption is of special interest with regard to the low abundance of T4SS components, often 
with only one copy per cell. Furthermore, CPs oligomerize to homohexameric holoenzymes and 
resemble a similar shape like F1F0-ATPases (274). This implies the formation of several protein-
protein interactions between CP subunits, indicating a possibility for an aggregation tendency of CPs 
while overproduction in high amounts. It is assumed that CPs assemble into their active 
homohexameric state after receiving a certain signal, which initiates the activation of substrate 
translocation (229). Like previously discussed in context with a putative missing spatial positioning 
component, also a missing oligomerization triggering signal might lead to the observed aggregation 
of TraD during the recombinant overproduction. In addition to oligomerization related challenges 
that need to be considered within the recombinant overproduction of TraD, also host specific 
peculiarities could result in the formation of inclusion bodies. For instance, the lipid composition of 
the cytoplasmic membrane could strongly influence the integration of a recombinant membrane 
protein into the host membrane, if reasonable differences in the lipid composition of both species 
exist. This might be possible for the recombinant overexpression of TraD from N. gonorrhoeae 
(β-Proteobacteria) in E. coli (γ-Proteobacteria), even though both belong to the group of 
Proteobacteria. Furthermore, the overexpression of traD results in the production of high amounts 
of protein, which could cause membrane insertion problems due to limited membrane space in the 
host organism leading to the formation of inclusion bodies. Besides this, the fast production of large 
protein amounts during the induction with IPTG can lead to a misfolding of the protein that ends up 
in the formation of inclusion bodies. The recombinant overproduction of membrane proteins is in 
general a challenging task and faces often problems of insolubility or misfolding of the produced 
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proteins. Also other T4SS CPs could not be isolated and purified as full-length proteins; only the 
soluble cytoplasmic part could be successfully overproduced and purified (e.g. TrwBR388) (270, 274).  
 
Denatured TraD could be purified from inclusion bodies but aggregates within refolding 
experiments 
Denatured TraD was isolated and in part purified from inclusion bodies, but any further purification 
steps resulted in aggregation or loss of the protein. A few of the tested refolding conditions ended up 
with soluble protein, indicating a structural rearrangement of the denatured protein during refolding. 
However, it is not possible to draw conclusions about the correct folding state of TraD from the 
obtained data. A misfolding of the denatured protein during the refolding reaction most likely results 
in the aggregation of the protein, like it has been observed for TraD. Therefore, it is obvious to 
assume that TraD does not refold into its correct structural arrangement. The unpsecific binding of 
refolded and purified TraD to any kind of surface (e.g. different column material or reaction tubes) 
gives additional evidence for a misfolding of the protein. The strong surface attachment of TraD is 
very likely caused by surface-protein interactions of hydrophobic residues within TraD and charged 
surface material; possibly these interactions occur within the computationally predicted hydrophobic 
patch in the N-terminal domain of TraD. It is an overall observation that certain proteins, especially 
membrane proteins, tend to attach due to hydrophobic interactions to various surfaces (e.g. reaction 
tubes). Interestingly, even the presence of detergents did not prevent the surface attachment of 
TraD. Currently, there is no explanation for this contradictory behavior of TraD. 
 
Membrane-bound TraD could not be solubilized from isolated E. coli membranes 
Small amounts of membrane-bound TraD have been observed during numerous isolation attempts, 
but it was not possible to solubilize the membrane-bound TraD, even though several different 
detergents and solubilization conditions have been tested. Considering the observed data from 
different solubilization screens, it can be concluded that the membrane-bound TraD represents 
strongly aggregated protein. It is not clear from the obtained results, whether the membrane-bound 
TraD was integrated in small amounts into the cytoplasmic membrane during the overproduction, or 
if it results from persisting contaminations with inclusion bodies. Separation of the inner and outer 
membranes with sucrose density step centrifugation was used to remove possible inclusion body 
contaminations from the isolated membranes. Nevertheless, it cannot be absolutely excluded that 
small amounts of inclusion bodies were merged with the cytoplasmic membranes due to strong 
mechanical forces occurring during the cell breakage. The possibility of a mixed membrane 
contaminated with inclusion bodies explains the observed insolubility of the membrane-bound TraD. 
 
5.3 Isolation and functional characterization of the hypothetical protein Yaf 
Yaf forms different oligomeric states in solution 
Yaf forms different oligomeric states in solution: the most dominant forms are dimers and tetramers, 
but also monomers and trimers have been detected. Interestingly, the presence of an N-terminal 
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His-tag strongly influences the equilibrium between dimeric and tetrameric Yaf and results in a 
switch of the oligomer ratio. The changes within the oligomerization pattern of Yaf in the presence of 
an N-terminal His-tag indicate that the N-terminal region of Yaf might be involved in protein-protein 
interactions. Considering a putative nicking accessory function of Yaf, the observed influence of the 
N-terminal region on protein-protein interactions is in contrast to reported data from other nicking 
accessory protein, which have C-terminal regions involved in protein-protein interactions and 
N-terminal regions facilitating the DNA binding (250, 259). However, from the obtained data it is not 
clear whether Yaf consists of two domains like other nicking accessory proteins, or if it resembles a 
one domain protein.  
The functional role of the different oligomeric states of Yaf still needs to be elucidated further, to 
identify the final stoichiometry of the Yaf-holoenzyme. The current study revealed the dimeric and 
tetrameric forms of Yaf representing the active states of the protein, with a slightly stronger activity 
of the dimeric form. Many regulatory proteins with conserved RHH motifs, as well as nicking 
accessory proteins bind DNA in a dimeric form and tetramerize afterwards to bend the DNA either 
for the regulation of gene-expression or to enable access of the relaxase (215, 250, 260). The 
observed distribution of the DNA degradation activity within the different oligomeric states of Yaf is 
in agreement with reported data from RHH regulatory proteins and nicking accessory proteins (215, 
259), even though no direct DNA binding of Yaf has been observed and the functional mechanism of 
Yaf still needs to be further studied.   
 
Limited proteolysis revealed a high level of trypsin resistance of Yaf 
Limited proteolysis experiments revealed a high grade of resistance (>20 µM) of Yaf against the 
proteolytic activity of trypsin. No significant differences have been observed between dimeric and 
tetrameric Yaf, even though a tendency of an increased resistance has been observed for tetrameric 
Yaf. The stability of Yaf against the proteolytic activity of trypsin is correlated with the structural 
exposure of accessible trypsin cleavage sites, since trypsin is an endoprotease that cleaves specific 
after the alkaline amino acids lysine and arginine. It is most likely that the oligomerization of Yaf 
protects the protein on a certain level against the proteolytic attack of trypsin. Besides the protection 
of Yaf due to its oligomeric assembly, also the structural arrangement of the monomers itself 
influences the accessibility of trypsin cleavage sites. The obtained data does not give reliable 
information about the domain organization of Yaf monomers, however, it is conclusive to assume 
that Yaf consist of only one domain facilitating the DNA degradation reaction and the oligimerization.  
Limited proteolysis of different nicking accessory proteins revealed a common two domain 
organization of these proteins into an N-terminal DNA binding domain and a C-terminal protein-
protein interaction domain (250, 259). Both domains have been reported to be highly resistance 
against the proteolytic activity of trypsin. It is obvious that trypsin starts to attack a protein initially 
on easy accessible sites that are often inter-domain regions forming exposed loop structures. 
Therefore, limited proteolysis is a commonly used method to characterize the domain organization 
of proteins. The reported data from the proteolytic digest of different nicking accessory proteins 
strengthens the assumption that Yaf resembles a one domain protein, since no second Yaf related 
fragment has been observed. This implies that Yaf combines both, the catalytic site for DNA 
degradation and the protein-protein interaction site within one domain, contrary to nicking 
accessory proteins. 
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Point mutations strongly influence the solubility and the overproduction yields of Yaf 
The introduction of single point mutations into the sequence of Yaf strongly influences the solubility 
of recombinant overproduced Yaf and results in significantly reduced protein yields. The obtained 
data indicates a strong influence of the mutations on the folding and structural arrangement of Yaf. 
Considering the drastic changes on the solubility and the protein yields related to the introduction of 
point mutations, it is conclusive to assume a densely packed structure of Yaf that is very sensitive to 
changes in the amino acid assembly. It has to be considered that most of the introduced mutations 
were non conserved mutations to alanine and only a few of them were conserved mutations with 
similar structural amino acid properties (e.g. Y to F mutations). A possible influence due to changed 
biochemical and structural properties of the amino acids on the structural assembly of Yaf cannot be 
excluded, however, reduced protein yields and the formation of inclusion bodies have also been 
observed for conserved mutations (Y to F mutants).  
 
Yaf binds to dsDNA substrates with low affinity 
Evidences for a weak binding of dsDNA substrates have been observed within several DNA binding 
assays, but the obtained results have to be interpreted with caution. It has to be considered that 
maybe the tested in vitro conditions do not reflect the optimal DNA binding conditions of Yaf and 
further optimization of the assay might be necessary.  
 
Yaf has a sequence unspecific metal dependent relaxation activity on supercoiled plasmid 
DNA 
Isolated dimeric and tetrameric Yaf has a sequence unspecific relaxation activity on supercoiled 
plasmid DNA similar to TraI and E. coli Topoisomerase I. The relaxation activity of Yaf is dependent on 
divalent metal ions as cofactors and is strongly enhanced in the presence of Mn2+ and Co2+ in 
comparison to Mg2+. 
A possible contamination of the isolated protein can be excluded for the same reasons as described 
for TraI, namely the enhanced activity of Yaf and the reported reduced activity of Topoisomerase I in 
presence of Mn2+. Additionally, the relaxation activity of Yaf has been observed for dimeric and 
tetrameric protein which has been purified via size exclusion chromatography, and a putative 
contamination with Topoisomerase I most likely would not be present in both fractions, since the 
size of Topoisomerase I is supposed to elute in a complete different volume (Topoisomerase I – 97.4 
kDa; Yaf dimer – 34.2 kDa; Yaf tetramer – 70.4 kDa). 
Currently, it is not known why the hypothetical protein Yaf has a DNA relaxation activity similar to 
that of the relaxase TraI. However, it might be possible that Yaf is involved in the DNA processing 
mechanism not as an NAP like previously assumed, but as a protein that supports the activity of TraI, 
which seems to lack a distinct helicase domain. Considering the relaxation activity and the DNA 
degradation activity of Yaf, it is obvious that Yaf has the ability to cleave DNA; therefore, Yaf might 
also be involved in the termination reaction during DNA processing. Nevertheless, it is more likely 
that the termination reaction during the DNA processing reaction in N. gonorrhoeae is mediated by 
the relaxase TraI, like it has been reported for other T4SSs (30, 239, 240).  
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Several lines of evidence give rise to the speculation that Yaf possibly has a regulatory function in 
N. gonorrhoeae, even though the detailed mechanism is up to now not known. For instance, Yaf 
might act in a control mechanism for the correct excision and circularization of the GGI from the 
chromosome, similar to RDFs (Recombination Directionality Factors) within ICEs (179, 180). The 
neisserial GGI has been reported to excise in a low frequency (due to an imperfect dif site) from the 
chromosome and forms a circular intermediate (189). The imperfect dif site possibly leads to a 
certain amount of incorrect excised GGIs and the cells would need a mechanism to reintegrate or 
even degrade the incorrect excised DNA, which might be enabled by the observed nuclease activity 
of Yaf. Evidence for this assumption is given with the specific nuclease activity of Yaf that is restricted 
to linearized DNA fragments. Furthermore, it has been reported that some RDFs show an E. coli 
Topoisomerase I like DNA relaxation activity in vitro, like it has been observed for Yaf (180).  
 
Yaf degrades linear ssDNA and dsDNA fragments in a sequence unspecific metal 
dependent reaction 
Dimeric and tetrameric Yaf degrade ssDNA and dsDNA fragments in a sequence unspecific and metal 
dependent reaction. The DNA degradation activity of Yaf is dependent on the metal cofactors Mn2+ 
and Co2+, and is not observed in the presence of Mg2+. Interestingly, the DNA degradation activity of 
Yaf is restricted to linearized DNA fragments and circular plasmid DNA is not degraded. This might 
indicate a putative exonuclease activity of Yaf, since there is evidence that Yaf initiates the 
degradation from the edges of the DNA fragments, which would also explain why Yaf does not 
degrade plasmid DNA. However, further experimental studies are necessary to prove this 
assumption.  
A possible background activity resulting from a contamination with an exonuclease of E. coli can be 
most likely excluded as, on the one hand, the DNA degradation activity of Yaf can be observed for 
ssDNA and dsDNA and is dependent on Mn2+, whereas the exonucleases of E. coli are mostly either 
specific to ssDNA, to dsDNA or to RNA, or they require Mg2+ or Ca2+ as metal cofactors. Furthermore, 
the DNA degradation activity of Yaf can be observed for two different oligomeric forms of Yaf that 
elute within size exclusion chromatography in volumes representing complete different molecular 
masses and it is very unlikely that a possible contamination of an exonuclease will elute in exact the 
same volumes as dimeric and tetrameric Yaf.  
The functional role of the nuclease activity of Yaf still needs to be elucidated in further studies. 
However, considering the assumption that Yaf might have a regulatory function in N. gonorrhoeae, 
two different mechanisms might be possible. One might function as a control mechanism for the 
correct excision of the GGI, like it has already been discussed in detail in the previous passage. 
Another possible role of Yaf might be the regulation of the DNA secretion level under oxidative stress 
conditions. Evidence for this assumption is given in the observed decreased DNA cleavage activity of 
TraI in presence of Yaf and the Mn2+ dependent DNA degradation activity of Yaf. Such a regulative 
mechanism would facilitate access to an important phosphate source, which is given in the ssT-DNA 
that could be used for the production of either pyrophosphate (PPi) or poly-phosphate (polyP). Both, 
PPi and polyP are known to act together with Mn
2+ as antioxidants (297, 298). If N. gonorrhoeae 
secretes DNA in a constitutive process like it is currently assumed, such a mechanism might be of 
special interest for the detoxification of reactive oxygen species (ROS) during oxidative stress.  
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5.4 Isolation and functional characterization of the relaxase TraI 
The MOBH relaxase TraI resembles certain features of membrane proteins  
The isolation and purification of recombinant overproduced TraI showed a strong tendency of TraI to 
aggregate during the purification process. Various overproduction conditions, different expression 
constructs and purification procedures have been tested to optimize the isolation of TraI, but finally 
ended up with insoluble aggregated protein. Recently, it was for the first time possible to isolate and 
purify soluble TraI in presence of the detergent DDM.  
Most likely, the aggregation tendency of TraI rises from several factors that together have an additive 
effect resulting in the aggregation of the protein. For instance, the enzymatic activity of TraI comes 
along with a high DNA binding affinity that could cause an aggregation of TraI already in the initial 
isolation step during cell breakage, since the protein strongly tends to bind sheered DNA fragments 
resulting from the high forces occurring during cell breakage. To avoid an aggregation due to multiple 
protein binding on sheered DNA fragments, DNAseI is added before the cells were broken to degrade 
the DNA immediately after release. However, DNAseI treatment alone was not sufficient to avoid the 
aggregation of TraI, indicating either a protection of the DNA against the degrading activity of DNAseI 
by bound TraI, or other factors are responsible for the observed aggregation. Taking into account 
that TraI is a relatively large protein consisting of 850 amino acids (94.7 kDa) that is most likely 
secreted via the T4SS, like it has been reported for several other relaxases, it is obvious that TraI 
needs a certain structural flexibility to enable a partial unfolding which is necessary for the secretion 
through the secretion complex (103). This property of TraI might result in an aggregation of the 
protein during the recombinant overproduction in E. coli, since the protein could easily be misfolded 
within the fast folding procedure. However, the most probable reason for the observed aggregation 
of TraI is the hydrophobic N-terminus. The accumulation of hydrophobic residues in the N-terminal 
region of TraI tends to aggregate with other N-termini in a non-polar solution. This aggregation can 
be circumvented by the use of detergents that keep the hydrophobic N-termini separate from each 
other by forming micelles around TraI, like it is a standard procedure for membrane proteins. The 
fact that TraI stays soluble during the purification in presence of the detergent DDM strengthens the 
assumption that the hydrophobic N-terminus of TraI is causing the observed aggregation. 
Considering the purification properties of TraI and the fact, that reasonable amounts of TraI can be 
detected in isolated membranes, TraI shows in vitro some features that are typically found in 
membrane proteins.  
 
TraI forms stable dimers in solution 
Experimental data reveals the formation of stable TraI dimers in solution. In size exclusion 
chromatography TraI eluted in a volume corresponding a molecular mass of 278 kDa, which 
represents the approximate mass of a TraI dimer surrounded by a DDM micelle (189.4 kDa + 70 kDa). 
Data obtained from Blue Native PAGE indicate a molecular mass of TraI of 260 kDa, which 
corresponds to the mass of a TraI dimer and is in accordance with the data obtained with size 
exclusion chromatography.  
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The observed results are in agreement with reported data from several other relaxases forming 
dimers in solution (239, 240, 299). Most relaxases stay covalently bound to the single stranded 
transfer DNA after the cleavage reaction and a second relaxase protein is needed to terminate the 
DNA processing reaction (212, 214). However, it is still under discussion if this hypothesis can be 
generalized for all relaxase families since many relaxases differ in their catalytic site (one or two 
catalytic tyrosines) and examples have been reported that do not bind covalently to the ssT-DNA 
(236). Experimental data obtained from DNA binding and competition assays indicate that isolated 
TraI from N. gonorrhoeae does not bind DNA in a covalent reaction in vitro, however, it cannot be 
excluded that TraI possibly attaches covalently to the DNA after the initial cleavage reaction. Since no 
biochemical data is available for the MOBH prototype relaxases TraI from N. gonorrhoeae, it is not 
known, whether the DNA processing reaction is terminated with a second relaxase protein, or if one 
relaxase protein is sufficient to enable initial cleavage and termination. The experimental data 
obtained within the current study indicate the formation of stable TraI dimers, which most likely 
represent the active form of TraI. These data suggest the involvement of a second TraI protein in the 
termination of the DNA processing reaction. Sequence analysis and mutagenesis studies coupled 
with DNA secretion assays revealed at least three conserved tyrosines in TraI that might form the 
catalytic site, but up to now the active tyrosine of TraI has not been identified (202). Therefore, it is 
not known whether one or two catalytic tyrosines are involved in initializing and terminating the DNA 
processing reaction in TraI. Considering the observed dimer formation of TraI in solution, it is most 
likely that one TraI protein initiates the cleavage reaction and a second one terminates the reaction, 
however, this assumption need to be proven experimentally. 
 
TraI can be separated into three different domains 
Limited proteolysis with trypsin and ProteinaseK revealed at least three distinct domains in TraI. In 
lower trypsin concentrations the formation of two initial domains has been observed, representing 
molecular masses of 80-85 kDa and 35 kDa on SDS-PAGE gels. In high Trypsin concentrations, a third 
domain with a molecular mass of 55 kDa occurred on the gel and the 80-85 kDa starts to disappear.  
Generally, relaxases consist of at least two different domains, a relaxase domain for the DNA 
cleavage reaction and a helicase domain for the unwinding of the ssT-DNA (212). TraI from 
N. gonorrhoeae contains besides the N- terminal relaxase domain an additional C-terminal DUF1528 
domain that often can be found in proteins with an N-terminal metal-dependent phosphohydrolase 
(HD) region (e.g. helicases or relaxases). In average, DUF1528 domains consist of 100 amino acids 
with an approximate molecular mass of 10-12 kDa. The distinct function of this domain is still 
unknown, but it is assumed that the DUF1528 domain of the neisserial relaxase TraI is involved in 
protein-protein interactions (202). The DUF1528 domain of TraI has a predicted molecular mass of 
11.8 kDa.  
The observed formation of at least three different domains in TraI is consistent with reported data 
from other relaxases, even though no data is available on MOBH relaxases (211, 300). The large 
domain with a molecular mass of 80-85 kDa represents most likely the N-terminal relaxase domain of 
TraI. This assumption is based on bioinformatical data that indicate a large N-terminal TraI_2 relaxase 
domain with a length of 328 amino acids (42.5 kDa). The relaxase domain itself does not completely 
represent the observed 80-85 kDa domain, indicating the presence of an additional middle part 
within TraI. Bioinfomatical alignment data (not shown) revealed the presence of an in part conserved 
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middle domain within many TraI_2 relaxases. This conserved middle domain most likely represents 
the remaining molecular mass of the obtained fragment. The occurrence of an additional 55 kDa 
fragment at higher trypsin concentrations accompanied with the disappearance of the large 80-85 
kDa fragment, indicating a separation of the relaxase domain and the remaining conserved middle 
part. However, the obtained experimental results are inconclusive about whether the 55 kDa 
fragment is the N-terminal relaxase domain or if this fragment represents the conserved middle part 
of TraI. Further experiments (e.g. peptide finger print analysis or N-terminal sequencing of the 
obtained domains) need to be done to gain information about the sequence composition of the 
different domains, to identify their specific location within the sequence of TraI. The domain with a 
molecular mass of 35-17.5 kDa most likely represents the C-terminal DUF1528 domain, which has a 
predicted length of 105 amino acids (11.8 kDa). Considering the reported domain organization of TraI 
with an N-terminal relaxase domain and a C-terminal DUF1528 domain and taking into account that 
the proteases attacks at first easy accessible sites, e.g. loop regions between two domains, it is most 
likely that the observed 35-17.5 kDa fragment represents the C-terminal DUF1528 domain since this 
fragment occurs already in low trypsin concentrations. The difference within the predicted mass of 
the DUF1528 domain (11.8 kDa) and the obtained mass of 35-17.5 kDa most likely results from the 
cleavage position of the protease, which could be in a significant distance to the actual domain since 
the attack occurs at an easily accessible structural region between two domains.  
 
Identification of catalytic residues involved in the DNA cleavage reaction of TraI 
The relaxase domain of the MOBH relaxase TraI contains several conserved sequence motifs typically 
found in other relaxase families, but also includes an altered histidine motif and conserved HD 
domains that have not yet been identified in other relaxase families (110, 202). 
The structural modeling program Phyre2 was used to obtain a model of the possible structure of TraI 
by comparing the amino acid sequence of TraI with available structures with similar sequences. A 
ribbon model of the modeled TraI structure is given in Figure 33. The overall modeled structure of 
the neisserial TraI has a similar shape like the crystal structures of TraIF, TrwCR388, and MobARSF1010 
(227, 245, 246). The modeled structure of TraI has a handcuff like shape and resembles the typical 
structural arrangement of at least five α-helices and an anti-parallel two stranded β-sheet forming 
the binding cleft with the catalytic site.  
 
Figure 33: Side view on the structural ribbon 
model of TraI from N. gonorrhoaea. The structure 
has been modeled using the Phyre2 software. 
α-helices are colored in blue, β-sheets are colored 
in red and coiled structures are represented as 
grey line. The highest conservation has been 
identified within the N-terminal relaxase domain 
that resembles the typical handcuff like structure 
at the right part of the model.  
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Most likely, the active site of TraI is located within the binding cleft and the DNA binding is mediated 
via a similar “knob-into-hole” mechanism like it has been described for TraIF, TrwCR388 and 
MobARSF1010 (227, 245, 246). The altered histidine motif (H
106-108), as well as the conserved D120, 
presumably represent the metal binding site and coordinate the metal ion in close proximity to the 
catalytic tyrosine. A spherical space filling model of TraI with color-labeled conserved residues is 
shown in a top view in Figure 34. The H-triad is indicated as yellows spheres and locates almost 
centrally within the cleft-vale. The conserved D120 is labeled in blue color and locates within an 
α-helix close to the histidine triad. The conserved Y93, which has been reported to be essential for 
DNA secretion, is labeled in green and seems to be in close proximity to the histidine triad and D120. 
However, Y93 seems to be buried within the structure and represents probably not the catalytic 
residue, since it seems not to be surface exposed. The second tyrosine (Y201) that has been reported 
to have significant influence on DNA secretion is labeled in orange and is located on the edge of the 
opposite site of the binding cleft, in far distance to the metal ion coordination site. Therefore, Y201 
probably does not represent the catalytic tyrosine as well. The third conserved tyrosine (Y212; labeled 
in red color) does not have any significant influence on DNA secretion, but represents most likely the 
catalytic site, since it localizes surface exposed in close proximity to the metal ion coordination site.  
 
 
Figure 34: Top view on the spherical space filling model of 
the modeled structure of TraI from N. gonorrhoeae. 
Important catalytic residues putatively forming the active 
site are color labeled. The conserved histidine motife 
(H106-108) are indicated as yellow spheres, the conserved 
D120 is colored in blue. The three conserved tyrosines are 
colored in green (Y93), orange (Y201) and red (Y212). 
 
 
 
 
 
A surface model of the modeled TraI structure gives additional information about the surface 
accessibility of the conserved residues and is depicted in Figure 35. The color labeling of the 
conserved residues corresponds to the previous description. The left model represents a site view 
with the metal ion coordination site and the conserved Y212 and illustrates the structural 
arrangement of the conserved putative catalytic residues within the binding cleft. On the opposite 
site of the binding cleft locates a small surface exposed part of Y201 (orange color) in far distances to 
the metal ion coordination site. The model on the right site represents a top view onto the binding 
cleft and indicates that only Y212 seem to be surface exposed, and the green labeled Y93 buried in the 
structure. However, Y212 probably needs to perform conformational changes to enable a closer 
localization next to the metal ion coordination sites, which might represent the active state of TraI.  
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Figure 35: Spherical surface model of the modeled structure of TraI from N. gonorrhoeae. Important active site residues 
are color labeled. The conserved histidine motife (H106-108) are indicated as yellow spheres, the conserved D120 is colored 
in blue. The three conserved tyrosines are colored in green (Y93), orange (Y201) and red (Y212). Left: side view; Right: top 
view 
 
Three conserved tyrosines have been identified in the relaxase domain of TraI (Y93, Y201, and Y212), 
with one of them resembling the active residue for catalyzing the cleavage reaction of TraI (202). 
Mutagenesis screens and DNA secretion assays revealed that Y93 is important for DNA secretion and 
mutation to phenylalanine result in an abolished DNA secretion (202). A phenylalanine mutant of Y201 
also shows significant effects on the DNA secretion activity of the T4SS of N. gonorrhoeae and results 
in a reduced secretion level (half of the standard level) (202). The mutation of the third conserved 
Y212 did not influence the levels of DNA secretion and seems to have no significant effect on the 
function of TraI (202). Besides the conserved tyrosines, also the altered histidine motif (H-triade) was 
mutagenized and has been tested for DNA secretion, but both, H106 and H108 mutants do not 
influence the DNA secretion levels significantly (202). The conserved HD domains have been assumed 
to be involved in the coordination of the metal ion, but until now no experimental evidence on this 
has been reported for TraI (202). However, mutations within H161 and D162 do not affect DNA 
secretion levels, whereas, a mutation of D120 leads to significant reduced secretion levels that are 
comparable to the results described for the Y201 mutant (202).  
The experimental approach of measuring the DNA secretion activity the T4SS of N. gonorrhoeae does 
not give reliable information about the catalytic site within TraI and has to be interpreted with 
caution since N. gonorrhoeae tend to autolyze and high background signals have to be considered 
during the experiment. Furthermore, the mutations can cause structural rearrangements or 
misfolding of TraI resulting in an inactive protein, even though the substituted amino acids have 
biochemical and structural similarity. Therefore, the results of the described DNA secretion assays 
can be seen as an indication for a possible active site within TraI, and further experiments like e.g. 
DNA cleavage assays need to be done to gain detailed information about the active residues involved 
in the DNA processing reaction. 
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DNA binding properties of TraI 
The current study has shown that TraI binds in a non-covalent sequence unspecific reaction to dsDNA 
and ssDNA fragments, with a preference to ssDNA. A minimal binding frame of 9 nucleotides has 
been identified for ssDNA fragments.  
The minimal binding frame of at least 9 nucleotides most likely represents the length of the DNA 
strand that is needed to enable sufficient binding within the DNA binding site in the cleft. Other 
relaxases have been reported to bind DNA with a “knob-into-hole” mechanism using binding pockets 
distributed across the distance of the binding cleft, indicating the necessity of a certain minimal 
fragment length for DNA binding (232). Without having a structural prove it is very difficult to 
speculate about the DNA binding site of TraI, however, it is most likely that TraI binds DNA in a 
similar mechanism like other relaxases. Interestingly, TraI binds DNA in a compatible reaction 
demonstrating the non-covalent DNA binding activity. The obtained data does not give information 
about whether TraI binds generally in a non-covalent mechanism to DNA, or if the cleaved transfer 
DNA is bound in a covalent reaction and only the initial binding to the DNA fragments is a non-
covalent reaction. It has to be taken into account that other relaxases have been reported to bind 
cleaved DNA in a non-covalent reaction, similar to the obtained data of TraI (236). If the neisserial 
TraI indeed binds also the processed transfer DNA in a non-covalent reaction, it is most likely that the 
termination reaction of TraI is mediated probably by the same tyrosine that is already involved in the 
initial DNA cleavage reaction. Nevertheless, further experiments to characterize the DNA binding of 
TraI within the cleavage reaction need to be done to elucidate the catalytic residues and the 
mechanism of DNA processing of the MOBH relaxase TraI. The sequence unspecific DNA binding of 
TraI in the initial DNA binding reaction has also been reported for other relaxases and is in 
compliance with common literature (301). Very often other proteins, which probably have not yet 
been identified within N. gonorrhoeae, are necessary to enable a sequence specific DNA cleavage 
reaction of relaxases (210, 218). The preference of TraI to bind ssDNA fragments is in agreement with 
the commonly believed model that relaxases stay bound to the cleaved ssT-DNA and triggers the 
nucleo-protein complex to the secretion complex. Very often relaxases are also secreted together 
with the ssT-DNA into the recipient organism (103). The presence of 5’ protected ssDNA in the 
culture medium has been reported for N. gonorrhoeae, indicating the possibility for a secretion of 
TraI possibly bound to ssDNA (202). Considering the enzymatic function of relaxases with special 
regard to their DNA binding properties and the fact that they stay bound to the ssDNA while 
secretion to the recipient cell, it is obvious that ssDNA substrates are preferably bound by these 
enzymes. 
 
TraI relaxases supercoiled plasmid DNA and cleaves ssDNA fragments in a metal 
dependent and sequence unspecific reaction 
A sequence unspecific relaxation activity on supercoiled plasmid DNA containing either the predicted 
oriT region of the GGI or the oriT region of the F-plasmid from E. coli has been observed for TraI. The 
relaxation activity of TraI is a metal dependent reaction using Mn2+ and Co2+ as preferred metal 
cofactors, and is very similar to the enzymatic activity of E. coli Topoisomerase I.  
Considering the recombinant overproduction of the neisserial TraI in E. coli, a possible contamination 
of the isolated TraI with E. coli Topoisomerase I cannot be excluded. However, the observed 
Discussion 
 
 
 
Page | 128 
 
relaxation activity of TraI differs in several parts significantly from the activity of E. coli 
Topoisomerase I. The main differences between both enzymes are the preferred metal cofactors and 
the formation of characteristic reaction intermediates. Topoisomerase I has been reported to have a 
significant reduced activity in the presence of Mn2+ and Co2+ compared to the activity in the presence 
of Mg2+, whereas the activity of TraI is strongly increased in the presence of Mn2+ and Co2+ and is 
decreased in the presence of Mg2+ (293). In addition to the preferred metal cofactor, the reaction of 
E. coli Topoisomerase I and TraI differs significantly in the formation of reaction intermediates. TraI 
does not form characteristic intermediates, whereas E. coli Topoisomerase I form a typical and 
commonly reported ladder-like intermediate pattern within agarose gel electrophoresis (302). Taking 
the observed differences of E. coli Topoisomerase I and TraI into account, it is clearly demonstrated 
that the observed relaxation activity of isolated TraI in vitro descended not from a contamination 
with Topoisomerase I, but represents a characteristic enzymatic function of TraI. Actually, the 
observed relaxation of supercoiled plasmid DNA is a typical property of relaxases and has been 
reported for many of them (299, 303). Relaxases generally cleave DNA (and relax supercoiled DNA) in 
a sequence specific reaction often supported by other relaxosome components that mediate the 
sequence specificity, however, TraI relaxases supercoiled plasmid DNA sequence unspecific. Most 
likely, the specificity of the relaxation reaction of TraI is triggered by an up to now unknown 
component, like e.g. an uncharacterized nicking accessory protein. Even though no relaxosome 
formation has been reported for TraI up to now, the formation of a putative relaxosome cannot be 
excluded. Possible evidences for the formation of a putative relaxosome are several small 
uncharacterized proteins that encode within the same operon like traI and traD. A very promising 
candidate for a putative nicking accessory protein is the small hypothetical protein Yaf, whose 
function is initially characterized within the current study. Another possible reason for the sequence 
unspecific relaxation activity of TraI might be a missing important part within the predicted oriT 
region of the GGI in the used constructs, since often oriT regions are very large sequence parts 
including several recognition sites for nicking accessory proteins, spatial positioning proteins, and the 
relaxase that together enable a sufficient sequence specificity within T4SSs. Finally, it has to be 
considered that the DNA processing mechanism of TraI has not been characterized up to now and no 
biochemical data of TraI is available. It is most likely that the sequence specific relaxation activity of 
TraI in vitro is caused by a missing additional component, which is presumably present in the host 
in vivo (e.g. TraD), or the predicted oriT region is too short and is possibly wrong annotated. 
TraI has, in addition to the previously described relaxation activity, a metal dependent and sequence 
unspecific cleavage activity on ssDNA substrates. However, the observed cleavage activity is 
restricted to ssDNA fragments with secondary structures and has not been observed with poly-T 
ssDNA substrates. The cleavage activity of TraI is, similar to its relaxation activity, dependent on the 
two metal cofactors Mn2+ or Co2+. The cleavage activity seems to be slightly reduced in presence of 
ATP and Yaf, indicating a possible regulatory function of Yaf, which will be discussed later in detail. It 
has been observed that TraI cleaves ssDNA substrates containing either the oriT region of the 
F-plasmid from E. coli or the oriT region of the GGI in a strand specific reaction, which is in agreement 
with common observations from other characterized relaxases, even though TraI differs from other 
relaxases in its sequence unspecific cleavage reaction (227, 304). The most probable reason for the 
sequence unspecific cleavage reaction is either a missing nicking accessory protein or the lack of 
certain recognition sites in the GGI oriT region containing oligonucleotide. However, this is the first 
report of a DNA cleavage activity of the uncharacterized MOBH prototype relaxase TraI and it has to 
be taken into account that no comparable data of this novel relaxase family is available. To gain 
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further information about the DNA cleavage reaction of TraI it is necessary to optimize the cleavage 
assay and additional ssDNA substrates, as well as dsDNA substrates with different oriT regions need 
to be tested. Interestingly, TraI has been observed to bind to poly-T ssDNA substrates, but within the 
currently used cleavage assay no cleavage of these ssDNA substrates has been observed. This 
indicates a dependency of the cleavage activity of TraI on either secondary structures in the DNA 
substrates or a certain base composition. Many relaxases often nick the DNA at a distinct scissile 
phosphate that is mostly located between a “GC” within the nic site (212). It is very likely that the 
lack of a scissile phosphate exposed via the “GC” within the nic site is the reason for the not cleaved 
poly-T substrate. Further experiments are necessary to identify the minimal nic site components for 
the cleavage reaction of TraI and to identify whether secondary structures or the sequence itself are 
necessary to enable cleavage. However, the obtained data from the DNA cleavage assay excludes a 
possible role of Yaf as nicking accessory protein and give rise to the assumption of a putative 
regulatory function.  
 
5.5 TraI and Yaf favor the extraordinary metal cofactor Mn2+ 
Both, TraI and Yaf have been observed to favor Mn2+ as metal cofactor within DNA cleavage, DNA 
relaxation, and DNA degradation assays. The enzymatic activity of TraI is strongly enhanced with 
Mn2+ as metal cofactor compared to the activity level observed with Mg2+. Furthermore, the DNA 
cleavage activity of TraI only occurs in presence of Mn2+ and could not be observed with Mg2+. The 
relaxation activity of Yaf is, like observed for TraI, enhanced in presence of Mn2+, but could be also 
observed with Mg2+. The nuclease activity of Yaf is, however, strongly dependent on Mn2+ and has 
not been observed with Mg2+. Both proteins show a similar enhanced enzymatic activity with Co2+, 
which most likely is not the preferred natural metal cofactor, since the intracellular concentration of 
Co2+ in bacteria (5-10 µM) is much lower than the Co2+ concentration used in the in vitro assays 
(5 mM) (305). 
The concentration of Mn2+ in different human tissues differs significantly within a range of nM up to 
µM and it has been commonly accepted that Mn2+ is an important triggering signal and virulence 
factor for many pathogenic organisms (306-308). Mn2+ significantly influences the regulation of 
several metabolic enzymes, as well as certain virulence factors (e.g. surface structures involved in 
adhesion) and plays an important role in the detoxification of ROS and RNS (reactive nitrogen 
species). During infection and colonization N. gonorrhoeae prefers to accumulate in human tissues 
with high Mn2+ concentrations, and proteomic studies of N. gonorrhoeae strain 1291 under different 
Mn2+ stress conditions revealed the important functional role of Mn2+ in the detoxification 
mechanism of ROS in N. gonorrhoeae. It has been reported that an accumulation of Mn2+ in 
N. gonorrhoeae results in an increased resistance to oxidative stress and reduces cell killing via post-
translational modifications (306). The Mn2+ dependent detoxification of ROS is mediated either by 
Mn2+-PPi or Mn
2+-polyP complexes that act as non-enzymatic antioxidants (297).  
The intracellular Mn2+ concentration within different bacterial species has been reported with µM up 
to mM levels (32 mM in Lactobacillus plantarum) (307, 309). The Mn2+ concentration used within in 
vitro activity assays of TraI and Yaf are in the possible physiological range and represent almost 
natural conditions. The reason why TraI and Yaf prefer Mn2+ as metal cofactor is up to now not 
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known and need to be further studied. Most likely, the concentration of Mn2+ in N. gonorrhoeae is 
within such a range that it is more efficient to use Mn2+ instead of Mg2+, which is mostly used as 
metal cofactor in other T4SS relaxases (306, 310). Both metals have very similar biochemical 
properties and their most significant difference is the ion size (Mg2+ has an atomic radius of 1.72 Å, 
Mn2+ has an atomic radius of 1.79 Å) (www.environmentalchemistry.com). Therefore, it is easy to 
exchange both metals as enzymatic cofactors and the MOBH relaxase TraI uses in the following Mn
2+ 
instead of Mg2+ as metal cofactor.  
Considering the fact that Mn2+ strongly influences the expression and regulation of several cellular 
components in N. gonorrhoeae and the obtained Mn2+ dependency of Yaf and TraI, it could be 
suspected that the T4SS of N. gonorrhoeae is possibly regulative influenced by Mn2+, possibly in 
context with a detoxification mechanism during oxidative stress. To prove this assumption, further 
studies under oxidative and manganese stress conditions have to be done and a release of single 
phosphate resulting from the nuclease activity of Yaf should be tested. 
 
5.6 TraI, Yaf, and TraC do not interaction in pull down assays in vitro  
Possible protein-protein interactions between the relaxase TraI, the hypothetical protein Yaf and the 
ATPase TraC were tested with pull-down assays under different conditions. However, no interactions 
between Yaf and TraI, Yaf and TraC, as well as TraI and TraC have been observed. Possible 
interactions between TraI and Yaf were tested additionally within DNA cleavage assays, but no direct 
interaction between both proteins has been observed, even though the cleavage activity of TraI 
seems to be reduced in the presence of Yaf. Assuming a putative functional role of Yaf (e.g. as nicking 
accessory protein or as spatial positioning factor) within the DNA processing reaction of the neisserial 
T4SS, it is most likely that Yaf interacts with the relaxase TraI and possibly also with the core complex 
ATPase TraC. Several examples for protein-protein interactions within relaxosome components and 
the secretion complex have been reported (222, 255). For instance, it has been reported that the 
spatial positioning protein TraMF strongly interact with the coupling protein TraDF, and the nicking 
accessory protein complex VirC1AT/VirC2AT interacts with the relaxase complex VirD1AT/VirD2AT (220, 
255). It is therefore to be expected that Yaf interact most likely at least with TraI, if it has a functional 
role as putative nicking accessory protein. If Yaf would fulfill a regulatory function in N. gonorrhoeae 
it might be possible that is does not directly interact with TraI and TraC. Considering the obtained 
data, it is more conclusive to assume a putative regulatory role of Yaf, since there is evidence for a 
decrease of the cleavage activity of TraI in presence of Yaf and no direct protein-protein interaction 
between both proteins has been observed.  
The possibility of having suboptimal in vitro reaction conditions has to be taken into account and 
maybe the experimental set up has to be changed to obtain possible protein-protein interactions. 
Other promising approaches to analyze putative interactions would be size exclusion 
chromatography or Surface Plasmon Resonance measurements. These assays would also allow the 
use of native proteins, whereas the pull down assay needs at least one protein with a tag. 
Considering the strong influence of the N-terminal His-tag on the oligomerization of Yaf, it is most 
likely that the N-terminal domain is involved in protein-protein interactions and possibly the His-tag 
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abolishes an interaction with TraI or TraC. Using another experimental approach with native proteins 
would exclude the possibility of a disturbing effect of a tag.  
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6. Future perspectives 
The coupling protein TraD 
Unfortunately, it was not possible within the current study to isolate soluble TraD for a biochemical 
characterization of this protein. Therefore, the main focus of future studies on TraD should be the 
production of soluble protein. One approach could be the overproduction in a different host 
organism, e.g. the Bacillus species, Lactococcus lactis or Pichia pastoris. Another approach for the 
isolation of soluble protein could be the fusion of TraD with small stabilizing proteins at its N- and C-
terminus. This could be e.g. fusions with different combinations of the two small proteins YaiN and 
YbeL, which have been reported to optimize the integration and overproduction of membrane 
protein in recombinant E. coli expression systems (311). Also the fusion with TrxA (thioredoxin) could 
possibly increase the solubility of TraD and has been reported to circumvent the formation of 
inclusion bodies while overproduction in E. coli (312). Finally, a third possibility could be a fusion with 
GFP, which has been reported to optimize the membrane integration of proteins in E. coli. An 
advantage of the GFP-fusion approach would be the possibility of monitoring the correct insertion 
into the membrane by detecting the GFP signal (313).  
To obtain soluble TraD it could be also necessary to coexpress traD together with other genes from 
the dtr opreon, most likely yaa, which encodes a small polytopic membrane protein and is located 
directly next to traD. This approach is based on the fact that several coupling proteins need 
additional small polytopic membrane proteins to integrate and attach to the membrane, especially 
coupling proteins without transmembrane domains. A construct for the coexpression of traD and yaa 
has already been generated with a pCOLA-Duet vector. To simplify the purification another vector 
with a higher copy number and a tag on traD should be used.  
To study the mechanism of DNA translocation in the neisserial T4SS it is crucial to understand the 
enzymatic activity and function of the key player TraD. To be able to draw conclusions about the 
mechanism of TraD in context with other characterized coupling proteins it is important to gain 
information about the oligomeric state of TraD, as well as its ATP binding and hydrolysis activity. The 
oligomeric state of TraD could be either studied with size exclusion chromatography or with dynamic 
light scattering in consideration of a possible influence on the oligomerization of ATP. The ATP 
binding activity and a possible binding affinity could be measured with fluorescence spectroscopy 
and anisotropy measurements with the ATP analogues Mant-ATP or TNP-ATP. The ATP hydrolysis 
activity of TraD could be studies with commonly established ATP hydrolysis assays (e.g. enzyme 
coupled ATP hydrolysis assay or malachite green assay).  
Furthermore, it is most likely that TraD binds to ssT-DNA to enable the translocation through the 
secretion complex. Therefore, it is worth to test a possible DNA binding activity of TraD with different 
single and double stranded DNA substrates. Additionally, it should be studied whether TraD interact 
with other T4SS proteins of N. gonorrhoeae.   
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The MOBH relaxase TraI 
This study revealed first insights into the enzymatic activity of this novel relaxase family and provides 
enlightening information about the DNA processing activity, as well as on the domain organization 
and the oligomerization of TraI.  
To gain further information about the DNA binding and cleavage activity of TraI it is important to 
identify the active site within the relaxase domain. It is most likely that TraI uses like other relaxases 
a tyrosine or phenylalanine for its cleavage reaction. Two conserved tyrosines (Y93 and Y201) of TraI 
have been reported to be important for the secretion of DNA. Both tyrosines have been mutated to 
phenylalanine and purification trials have been made. Unfortunately, it was not possible up to now 
to isolate mutated TraI without aggregation. Nevertheless, the isolation of these two mutants should 
be in the focus of future experiments since there is strong evidence that these residues possibly 
resemble the active site of TraI. However, it is possible that both tyrosines do not participate in the 
catalytic site of TraI and an up to now unnoticed tyrosine or phenylalanine catalyzes the cleavage 
reaction. Initial evidences strengthening this assumption have been obtained in a structural 
comparison of a modeled structure of TraI and the structure of a relaxase like protein of C. burnetii. 
Comparing the active site of both proteins within a structural overlay, it is most likely that Y212 of TraI 
resembles the active site. Therefore, Y212 should be mutated to phenylalanine and the isolated 
protein should be tested for its DNA processing activity.  
Information about the DNA binding affinity of TraI can be studied by determining different Kd values 
obtained in anisotropy measurements with different DNA substrates. Initial anisotropy 
measurements were already performed and indicate a high affinity of TraI on ssDNA. To study 
possible determinants for the sequence specificity of the cleavage reaction of TraI will be a 
challenging task for future research. Additional relaxosome components that could trigger the 
specificity of the cleavage reaction of TraI have not been reported for the neisserial T4SS. 
Nevertheless, it would be interesting to study a possible influence of the genome encoded IHF on the 
specificity of the cleavage reaction of TraI. Therefore, the IHF of N. gonorrhoeae should be 
recombinantly overproduced and purififed and should be added to the in vitro cleavage assays. Since 
up to now only the oriT regions of N. gonorrhoeae and from E. coli F-plasmid were tested for 
cleavage by TraI, the established cleavage assay should be performed using substrates containing 
oriT regions from other T4SSs like e.g. A. tumefaciens. Besides different DNA substrates and 
additional possible relaxosome components, the reaction conditions of the cleavage assay could be 
altered to obtain a specific reaction of TraI.  
Furthermore, it is important to study the function of the distinct domains of TraI. Limited proteolysis 
revealed that TraI consist of at least three trypsin stable domains. Sequence alignments also indicate 
the presence of a conserved middle part in TraI_2 relaxases with a C-terminal DUF domain. To study 
the function of distinct domains of TraI different truncation of the protein have been generated and 
initial purification trails were performed. The truncated domains of TraI should be further studied 
considering DNA binding and processing, ATP hydrolysis activity, and possible protein-protein 
interactions. These constructs can be further used to characterize the function of the different 
domains in detail, e.g. the conserved HD sequence motifs in the relaxase domain can be mutated to 
study a possible influence on the metal binding mechanism. A possible metal dependent 
phosphatase activity of these sequence motifs can be studied e.g. with phosphatase assays offering 
different substrates. The truncated middle domain, as well as the relaxase domain can be tested for a 
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putative ATP dependent helicase activity by using the approach of molecular beacons (314). This 
approach was already used in initially experiments to study the helicase activity of the full-length 
protein. The putative function of the C-terminal DUF1528 domain in facilitating protein-protein 
interaction could be tested with various approaches like Surface Plasmon Resonance, different pull-
down assays, cross-linking assays or size exclusion chromatography. Different possible binding 
partners like Yaf, TraC, Yaa or TraD could be tested for interaction with the C-terminal domain of TraI.  
Besides the functional characterization of the different domains of TraI, the experimental approach 
with truncated TraI domains can be used to study the ssDNA transfer through the secretion complex 
in N. gonorrhoeae. Therefore, different mutant strains of N. gonorrhoeae carrying different 
truncations of traI could be generated and studied with regard to their levels of DNA secretion. This 
approach could give information about a putative C-terminal signal sequence important for the 
transfer of the processed DNA to the secretion complex.  
To elucidate the DNA processing mechanism of TraI as a prototype of the uncharacterized MOBH 
relaxases, it is important to gain besides biochemical data structural information about the protein. 
Therefore, crystallization attempts with the native full-length protein have been started in 
collaboration with Dr S. Smits from the group of Prof. Dr. L. Schmitt from the Heinrich Heine 
University in Düsseldorf.  
 
The hypothetical protein Yaf 
The biochemical characterization of Yaf revealed a nuclease activity that still needs to be studied 
further to understand its function within the context of DNA secretion in N. gonorrhoeae.  
To obtain insights into the enzymatic function of Yaf, it is of outstanding importance to identify the 
catalytic residue and the metal binding site of Yaf. Previously performed mutagenesis screenings 
forced with the problem of low protein yields and the difficulty to choose an important residue. 
Based on recently obtained structural data of Yaf, it should be possible to identify the catalytic 
residue of the protein and to generate a non-functional mutant. The generated mutant can be used 
for a further biochemical characterization of the nuclease activity of Yaf.  
The observed DNA processing activity of Yaf needs to be studied further to understand the still 
unknown function of this hypothetical protein. It is important to gain detailed information about the 
dsDNA degradation mechanism of Yaf (e.g. the minimal required dsDNA substrate length, a possible 
recognition site, and the determinants for specific degradation of linearized dsDNA, but not 
circularized DNA). Since weak evidence of dsDNA binding is given from the observed results of DNA 
binding and processing assay, further DNA binding experiments with changed reaction conditions 
and different DNA substrates should be performed.   
A possible regulatory function of Yaf on the excision and integration of the GGI, similar to RDF 
proteins, can be studied in vivo with a yaf knock-out strain and the wild type strain. Both strains 
could be grown in certain stress conditions, most likely oxidative stress since N. gonorrhoeae is highly 
sensible to changing oxidative conditions and Yaf is a Mn2+ dependent protein, and the GGI excision 
frequency could be measured with quantitative PCR. A similar approach could be also used for the 
study of a possible regulatory influence on the expression level of the dtr genes (traI, traD, and 
also yaa). 
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